[
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT05197920",
                "orgStudyIdInfo": {
                    "id": "Penn State College of Medicine"
                },
                "secondaryIdInfos": [
                    {
                        "id": "U01DK127384",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/U01DK127384"
                    }
                ],
                "organization": {
                    "fullName": "Milton S. Hershey Medical Center",
                    "class": "OTHER"
                },
                "briefTitle": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms",
                "officialTitle": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms (DREAM) An Observational Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)",
                "acronym": "DREAM"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-05",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2022-01-14",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2025-04-30",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2025-04-30",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2021-12-11",
                "studyFirstSubmitQcDate": "2022-01-14",
                "studyFirstPostDateStruct": {
                    "date": "2022-01-20",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-05-02",
                "lastUpdatePostDateStruct": {
                    "date": "2024-05-06",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "PRINCIPAL_INVESTIGATOR",
                    "investigatorFullName": "Vernon Michael Chinchilli",
                    "investigatorTitle": "Distinguished Professor",
                    "investigatorAffiliation": "Milton S. Hershey Medical Center"
                },
                "leadSponsor": {
                    "name": "Milton S. Hershey Medical Center",
                    "class": "OTHER"
                },
                "collaborators": [
                    {
                        "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                        "class": "NIH"
                    },
                    {
                        "name": "Benaroya Research Institute",
                        "class": "OTHER"
                    },
                    {
                        "name": "Cedars-Sinai Medical Center",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Southern California",
                        "class": "OTHER"
                    },
                    {
                        "name": "Indiana University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Johns Hopkins University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Ohio State University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Stanford University",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Florida",
                        "class": "OTHER"
                    },
                    {
                        "name": "AdventHealth",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Illinois at Chicago",
                        "class": "OTHER"
                    },
                    {
                        "name": "Northwestern University",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Minnesota",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Pittsburgh",
                        "class": "OTHER"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": false,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).",
                "detailedDescription": "The DREAM investigators will conduct dynamic metabolic testing that includes oral glucose tolerance testing (OGTT), mixed meal tolerance testing (MMTT), and frequently sampled intravenous glucose tolerance testing (FSIGTT). These tests will increase the sensitivity for DM diagnosis (with OGTT) and to assess beta cell function and other pancreatic and enteroendocrine hormones involved in maintaining glucose homeostasis (OGTT, MMTT and FSIGTT). The DREAM research hypotheses are as follows.\n\n1. There is a cumulative increase in the risk of any type of DM after an episode of AP, and the development of DM after AP is influenced by several patient and disease-related factors (e.g. age, etiology, disease severity).\n2. After AP is clinically resolved, there is ongoing subclinical beta cell damage that predisposes to delayed-onset of DM.\n3. AP triggers an altered immune state in a subset of individuals that predisposes to islet autoimmunity and DM."
            },
            "conditionsModule": {
                "conditions": [
                    "Acute Pancreatitis"
                ],
                "keywords": [
                    "Diabetes"
                ]
            },
            "designModule": {
                "studyType": "OBSERVATIONAL",
                "patientRegistry": false,
                "designInfo": {
                    "observationalModel": "COHORT",
                    "timePerspective": "PROSPECTIVE"
                },
                "bioSpec": {
                    "retention": "SAMPLES_WITHOUT_DNA",
                    "description": "blood (fasting blood glucose, islet autoantibodies, creatinine, complete blood count (CBC), RNAseq), stool (fecal elastase)"
                },
                "enrollmentInfo": {
                    "count": 800,
                    "type": "ESTIMATED"
                }
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "diabetes mellitus (DM) following a qualifying episode of acute pancreatitis (AP)",
                        "description": "time to onset of DM during the 36-month longitudinal follow-up period",
                        "timeFrame": "any time during the 36-month longitudinal follow-up period"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "PROMIS Global Health",
                        "description": "Patient Reported Outcomes Measurement Information System (PROMIS) Global Health, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS Pain Intensity",
                        "description": "Patient Reported Outcomes Measurement Information System (PROMIS) Pain Intensity, measured on an 11-point scale from 0 (no pain ) to 10 (worst pain imaginable)",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Physical Function",
                        "description": "PROMIS-29 Physical Function, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Anxiety",
                        "description": "PROMIS-29 Anxiety, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Depression",
                        "description": "PROMIS-29 Depression, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Fatigue",
                        "description": "PROMIS-29 Fatigue, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Sleep Disturbance",
                        "description": "PROMIS-29 Sleep Disturbance, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Ability to Participate in Social Roles and Activities",
                        "description": "PROMIS-29 Ability to Participate in Social Roles and Activities, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "PROMIS-29 Pain Interference",
                        "description": "PROMIS-29 Pain Interference, converted to a t-score with a mean of 50 and a standard deviation of 10",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "OGTT Insulin Secretion",
                        "description": "Oral Glucose Tolerance Testing (OGTT) Insulin Secretion, as measured by the insulin area under the curve relative to the glucose area under the curve",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "OGTT Insulin Sensitivity Index",
                        "description": "Oral Glucose Tolerance Testing (OGTT) Insulin Sensitivity Index, as measured by the glucose disposal rate divided by the average plasma insulin concentration",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "MMTT Incretin Hormones: GIP and GLP-1",
                        "description": "Mixed Meal Tolerance Testing (MMTT) Incretin Hormones: Glucose-dependent Insulinotropic Polypeptide (GIP, pmol/L) and Glucagon-like Peptide-1 (GLP-1, pmol/L)",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "MMTT Glucagon",
                        "description": "Mixed Meal Tolerance Testing (MMTT) Glucagon (pg/mL)",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "MMTT Pancreatic Polypeptide (PP)",
                        "description": "Mixed Meal Tolerance Testing (MMTT) Pancreatic Polypeptide (PP, pg/mL)",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "FSIGTT Acute Insulin Response to Glucose (AIRglu)",
                        "description": "Frequently Sampled Intravenous Glucose Tolerance Testing (FSIGTT) Acute Insulin Response to Glucose (AIRglu)",
                        "timeFrame": "months 3 and 12"
                    },
                    {
                        "measure": "FSIGTT Acute C-peptide Response to Glucose (ACRglu)",
                        "description": "Frequently Sampled Intravenous Glucose Tolerance Testing (FSIGTT) Acute C-peptide Response to Glucose (ACRglu)",
                        "timeFrame": "months 3 and 12"
                    },
                    {
                        "measure": "FSIGTT Total Body Insulin Sensitivity Index (SI)",
                        "description": "Frequently Sampled Intravenous Glucose Tolerance Testing (FSIGTT) Total Body Insulin Sensitivity Index (SI)",
                        "timeFrame": "months 3 and 12"
                    },
                    {
                        "measure": "FSIGTT Total Body Insulin Sensitivity Index (SI) Disposition Index",
                        "description": "Frequently Sampled Intravenous Glucose Tolerance Testing (FSIGTT) Disposition Index (DI), calculated as the product of the AIRglu and the Total Body Insulin SI",
                        "timeFrame": "months 3 and 12"
                    },
                    {
                        "measure": "Islet Autoantibodies",
                        "description": "Islet Autoantibodies",
                        "timeFrame": "months 3, 12, 24, and 36"
                    },
                    {
                        "measure": "Fecal Elastase",
                        "description": "Fecal Elastase (ug/g)",
                        "timeFrame": "months 3, 12, 24, and 36"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of acute pancreatitis (AP) 0-90 days prior to enrollment date\n* Participant fully understands and is able to participate in all aspects of the study, including providing informed consent, completion of case report forms (CRFs), telephone interviews, metabolic testing, and planned longitudinal follow-ups\n\nExclusion Criteria:\n\n* Diagnosis of definite chronic pancreatitis (CP) at enrollment based on either of the following criteria met by computed tomography (CT) scan (including non-contrast enhanced) or Magnetic resonance Imaging (MRI) or Magnetic Resonance Cholangiopancreatography (MRCP): (a) Parenchymal or ductal calcifications on CT scan (after excluding the possibility that calcifications are vascular); (b) Intraductal filling defects suggestive of calcifications on MRI and/or MRCP\n* Potential participants with post-endoscopic retrograde cholangiopancreatography (post- ERCP) AP who are hospitalized for \\<48 hours.\n* Prior (i.e., before enrollment) direct endoscopic necrosectomy of the pancreas or percutaneous necrosectomy or drainage of necrotic collection(s). Participants who require this during follow-up will remain in the study\n* Pancreatic tumors, including ductal adenocarcinoma, neuroendocrine tumors, and metastasis\n* Confirmed or suspected cystic tumor associated with main pancreatic duct dilation, or believed to be the cause of AP (in the site-PI's judgement)\n* Prior pancreatic surgery, including, but not limited to: distal pancreatectomy, pancreaticoduodenectomy, pancreatic necrosectomy, Frey procedure\n* Use of disallowed concomitant medications within 30 days prior to enrollment. A comprehensive list of disallowed medications will be included and routinely updated in the study's Manual of Procedures\n* Severe systemic illness that in the judgement of the investigative team will confound outcome assessments of DM and immunological outcomes or pose additional risk for harms, including: history of solid organ transplant, acquired immunodeficiency syndrome (AIDS), active treatment for cancer (except non-melanoma skin cancer) within 12 months prior to enrollment, chronic kidney disease with estimate glomerular filtration rate (eGFR) \\< 30 or on dialysis prior to AP, and cirrhosis (based on imaging or biopsy), or any other medical condition that in the opinion of the site-PI carries a life expectancy of \\<12 months.\n* Known pregnancy at the time of enrollment. Participants who become pregnant during follow-up will remain in the study, but may have modified study assessments for safety\n* Incarceration\n* Any other condition or factor that would compromise the participant's safety or the scientific integrity of the study",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "18 Years",
                "maximumAge": "75 Years",
                "stdAges": [
                    "ADULT",
                    "OLDER_ADULT"
                ],
                "studyPopulation": "Patients hospitalized for acute pancreatitis",
                "samplingMethod": "NON_PROBABILITY_SAMPLE"
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Melissa A Butt, DrPH",
                        "role": "CONTACT",
                        "phone": "717-531-1258",
                        "email": "mbutt1@pennstatehealth.psu.edu"
                    },
                    {
                        "name": "Kendall T Baab, BS",
                        "role": "CONTACT",
                        "phone": "717-531-6308",
                        "email": "kthomas4@pennstatehealth.psu.edu"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Vernon M Chinchilli, PhD",
                        "affiliation": "Penn State College of Medicine",
                        "role": "PRINCIPAL_INVESTIGATOR"
                    },
                    {
                        "name": "Dhiraj Yadav, MD, MPH",
                        "affiliation": "University of Pittsburgh",
                        "role": "STUDY_CHAIR"
                    },
                    {
                        "name": "Melena D Bellin, MD",
                        "affiliation": "University of Minnesota",
                        "role": "STUDY_CHAIR"
                    },
                    {
                        "name": "Phillip A Hart, MD",
                        "affiliation": "Ohio State University",
                        "role": "STUDY_CHAIR"
                    }
                ],
                "locations": [
                    {
                        "facility": "University of Southern California",
                        "status": "RECRUITING",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90033",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jessica Serna",
                                "role": "CONTACT",
                                "phone": "323-409-6939",
                                "email": "sernaj@usc.edu"
                            },
                            {
                                "name": "James L Buxbaum, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "Cedars-Sinai Medical Center",
                        "status": "RECRUITING",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90048",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Eleanor Chang",
                                "role": "CONTACT",
                                "phone": "310-423-0747",
                                "email": "eleanor.chang@cshs.org"
                            },
                            {
                                "name": "Mark O Goodarzi, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Stephen J Pandol, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "status": "RECRUITING",
                        "city": "Stanford",
                        "state": "California",
                        "zip": "94305",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lorena Pineda",
                                "role": "CONTACT",
                                "phone": "650-723-4519",
                                "email": "ljpineda@stanford.edu"
                            },
                            {
                                "name": "Walter Park, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Marina Basina, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.42411,
                            "lon": -122.16608
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "status": "RECRUITING",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32610-0214",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Amber Bouton",
                                "role": "CONTACT",
                                "phone": "352-273-9774",
                                "email": "amber.bouton@surgery.ufl.edu"
                            },
                            {
                                "name": "Chris Forsmark, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Steven J Hughes, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "AdventHealth",
                        "status": "RECRUITING",
                        "city": "Orlando",
                        "state": "Florida",
                        "zip": "32804",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Gina Mercouffer",
                                "role": "CONTACT",
                                "phone": "407-303-7106",
                                "email": "Gina.Mercouffer@adventHealth.com"
                            },
                            {
                                "name": "Richard E Pratley, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 28.53834,
                            "lon": -81.37924
                        }
                    },
                    {
                        "facility": "Northwestern University",
                        "status": "RECRUITING",
                        "city": "Chicago",
                        "state": "Illinois",
                        "zip": "60611",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Christine Nelson",
                                "role": "CONTACT",
                                "phone": "312-695-4513",
                                "email": "c-ebert@northwestern.edu"
                            },
                            {
                                "name": "Rajesh N Keswani, MD, MS",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.85003,
                            "lon": -87.65005
                        }
                    },
                    {
                        "facility": "University of Illinois at Chicago",
                        "status": "RECRUITING",
                        "city": "Chicago",
                        "state": "Illinois",
                        "zip": "60612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Haya Al Rashdan",
                                "role": "CONTACT",
                                "phone": "312-413-0306",
                                "email": "halras2@uic.edu"
                            },
                            {
                                "name": "Cemal Yazici, MD, MSc",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Brian Layden, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.85003,
                            "lon": -87.65005
                        }
                    },
                    {
                        "facility": "Indiana University",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maureen Mullen-Montagano",
                                "role": "CONTACT",
                                "phone": "317-274-7677",
                                "email": "maamulle@iu.edu"
                            },
                            {
                                "name": "Evan L Fogel, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Carmella Evans-Molina, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Johns Hopkins University",
                        "status": "RECRUITING",
                        "city": "Baltimore",
                        "state": "Maryland",
                        "zip": "21205",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Mahya Faghih",
                                "role": "CONTACT",
                                "phone": "443-287-4680",
                                "email": "mfaghih2@jhu.edu"
                            },
                            {
                                "name": "Vikesh Singh, MD, MSc",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Zhaoli Sun, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.29038,
                            "lon": -76.61219
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55454",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Hodgkins",
                                "role": "CONTACT",
                                "phone": "612-626-5293",
                                "email": "Hodg0007@umn.edu"
                            },
                            {
                                "name": "Melena D Bellin, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Guru Trikudanathan, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "Ohio State University",
                        "status": "RECRUITING",
                        "city": "Columbus",
                        "state": "Ohio",
                        "zip": "43210",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Zoe Krebs",
                                "role": "CONTACT",
                                "phone": "614-685-6374",
                                "email": "Zoe.krebs@osumc.edu"
                            },
                            {
                                "name": "Phillip A Hart, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Georgios Papchristou, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.96118,
                            "lon": -82.99879
                        }
                    },
                    {
                        "facility": "University of Pittsburgh",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15213",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Shari Reynolds",
                                "role": "CONTACT",
                                "phone": "412-383-0570",
                                "email": "Reynoldss12@upmc.edu"
                            },
                            {
                                "name": "Dhiraj Yadav, MD, MPH",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Frederico GS Toledo, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kim Varner",
                                "role": "CONTACT",
                                "phone": "206-341-8936",
                                "email": "kvarner@benaroyaresearch.org"
                            },
                            {
                                "name": "Carla J Greenbaum, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Richard A Kozarek, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    }
                ]
            },
            "referencesModule": {
                "seeAlsoLinks": [
                    {
                        "label": "Public web site for the Type 1 Diabetes in Acute Pancreatitis Consortium",
                        "url": "http://t1dapc.net"
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "Data from final locked datasets will be made available to other researchers outside the DREAM investigative team. The plan for data sharing incorporates a strategy that recognizes the importance of protecting participants' rights to individual privacy and is compliant with HIPAA regulations and NIH requirements (https://grants.nih.gov/grants/policy/data_sharing/).",
                "infoTypes": [
                    "STUDY_PROTOCOL",
                    "SAP",
                    "ICF"
                ],
                "timeFrame": "The data will become available one year after publication of the primary manuscript of the DREAM study. The data will be available indefinitely at the NIDDK Central Repository.",
                "accessCriteria": "Instructions for requesting data from the NIDDK Central Repository appear at the following web site:\n\nhttps://repository.niddk.nih.gov/pages/overall_instructions/",
                "url": "https://repository.niddk.nih.gov/home/"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000010195",
                        "term": "Pancreatitis"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000010182",
                        "term": "Pancreatic Diseases"
                    },
                    {
                        "id": "D000004066",
                        "term": "Digestive System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M13115",
                        "name": "Pancreatitis",
                        "asFound": "Pancreatitis",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M13102",
                        "name": "Pancreatic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M8883",
                        "name": "Gastrointestinal Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7255",
                        "name": "Digestive System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "T170",
                        "name": "Acute Graft Versus Host Disease",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC06",
                        "name": "Digestive System Diseases"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    },
                    {
                        "abbrev": "Rare",
                        "name": "Rare Diseases"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT00097292",
                "orgStudyIdInfo": {
                    "id": "NHStudy (IND)"
                },
                "secondaryIdInfos": [
                    {
                        "id": "UC4DK117009",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/UC4DK117009"
                    },
                    {
                        "id": "UC4DK106993",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/UC4DK106993"
                    }
                ],
                "organization": {
                    "fullName": "University of South Florida",
                    "class": "OTHER"
                },
                "briefTitle": "TrialNet Pathway to Prevention of T1D",
                "officialTitle": "TrialNet Pathway to Prevention of T1D"
            },
            "statusModule": {
                "statusVerifiedDate": "2023-12",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2004-02"
                },
                "primaryCompletionDateStruct": {
                    "date": "2025-07",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2025-07",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2004-11-19",
                "studyFirstSubmitQcDate": "2004-11-19",
                "studyFirstPostDateStruct": {
                    "date": "2004-11-22",
                    "type": "ESTIMATED"
                },
                "lastUpdateSubmitDate": "2023-12-20",
                "lastUpdatePostDateStruct": {
                    "date": "2023-12-21",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "University of South Florida",
                    "class": "OTHER"
                },
                "collaborators": [
                    {
                        "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                        "class": "NIH"
                    },
                    {
                        "name": "American Diabetes Association",
                        "class": "OTHER"
                    },
                    {
                        "name": "National Institute of Allergy and Infectious Diseases (NIAID)",
                        "class": "NIH"
                    },
                    {
                        "name": "National Center for Research Resources (NCRR)",
                        "class": "NIH"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true
            },
            "descriptionModule": {
                "briefSummary": "Rationale:\n\nThe accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the early metabolic abnormalities in T1DM is steadily increasing. However, information regarding the natural history of T1DM remains incomplete. The TrialNet Natural History Study of the Development of T1DM (Pathway to Prevention Study) has been designed to clarify this picture, and in so doing, will contribute to the development and implementation of studies aimed at prevention of and early treatment in T1DM.\n\nPurpose:\n\nTrialNet is an international network dedicated to the study, prevention, and early treatment of type 1 diabetes. TrialNet sites are located throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Sweden, Australia, and New Zealand. TrialNet is dedicated to testing new approaches to the prevention of and early intervention for type 1 diabetes.\n\nThe goal of the TrialNet Natural History Study of the Development of Type 1 Diabetes is to enhance our understanding of the demographic, immunologic, and metabolic characteristics of individuals at risk for developing type 1 diabetes.\n\nThe Natural History Study will screen relatives of people with type 1 diabetes to identify those at risk for developing the disease. Relatives of people with type 1 diabetes have about a 5% percent chance of being positive for the antibodies associated with diabetes. TrialNet will identify adults and children at risk for developing diabetes by testing for the presence of these antibodies in the blood. A positive antibody test is an early indication that damage to insulin-secreting cells may have begun. If this test is positive, additional testing will be offered to determine the likelihood that a person may develop diabetes. Individuals with antibodies will be offered the opportunity for further testing to determine their risk of developing diabetes over the next 5 years and to receive close monitoring for the development of diabetes.",
                "detailedDescription": "Detailed Description:\n\nThe Pathway to Prevention Study is conducted in two parts:\n\n* Screening\n* Monitoring (annual and semi-annual depending on risk)\n\nIn Screening , a simple blood test is done to screen for the presence of diabetes-related biochemical autoantibodies (GAD and mIAA). Additional autoantibodies ICA, IA-2A, and ZnT8A will also measured in individuals positive for mIAA. ICA, IA-2A, and ZnT8A will be measured in individuals positive for GAD. Participants can go to a TrialNet Clinical Center, Affiliate, or request a screening kit to have their blood drawn by a local physician or laboratory. Participants will be provided with their screening results within 4-6 weeks.\n\nIf autoantibodies are present, participants will be invited to have additional testing to determine their average risk of developing diabetes over the next 5 years. Participants that are single autoantibody positive will be re-tested annually for the development of multiple autoantibodies. Multiple autoantibody positive participants will undergo an eligibility visit which will include an Oral Glucose Tolerance Test (OGTT), re-testing for biochemical and islet cell autoantibodies if needed, and measurement of HbA1c.\n\nMultiple autoantibody positive individuals with a normal glucose tolerance and an HbA1c \\< 6.0% will be asked to come for follow-up on annual basis; multiple autoantibody positive individuals with an abnormal glucose tolerance or an HbA1c \u2265 6.0%will be asked to come for follow-up visits on semi-annual basis.\n\nParticipants will be monitored for possible progression towards type 1 diabetes and may be offered the opportunity to enter into a prevention study such (e.g., Oral Insulin prevention study) or an early treatment study if they are diagnosed with type 1 diabetes while participating in the Natural History Study."
            },
            "conditionsModule": {
                "conditions": [
                    "Diabetes Mellitus, Type 1"
                ],
                "keywords": [
                    "\"at risk\" for developing type 1 diabetes",
                    "T1DM",
                    "T1D",
                    "juvenile diabetes",
                    "Type 1 Diabetes TrialNet",
                    "TrialNet"
                ]
            },
            "designModule": {
                "studyType": "OBSERVATIONAL",
                "designInfo": {
                    "observationalModel": "COHORT",
                    "timePerspective": "PROSPECTIVE"
                },
                "bioSpec": {
                    "retention": "SAMPLES_WITH_DNA",
                    "description": "Whole blood, serum, plasma"
                },
                "enrollmentInfo": {
                    "count": 75000,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Annual Re-Testing/Annual Metabolic Monitoring",
                        "description": "Participants will be monitored annually for risk of type 1 diabetes."
                    },
                    {
                        "label": "Semi-Annual Metabolic Monitoring",
                        "description": "Participants will be monitored every six months for risk of type 1 diabetes"
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Development of type 1 diabetes",
                        "description": "The primary outcome is the development of diabetes as defined by the American Diabetes Association (ADA) based on glucose testing, or the presence of symptoms and unequivocal hyperglycemia.",
                        "timeFrame": "Monitoring is provided once or twice annually depending on risk level"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Metabolic and Autoantibody Assessments",
                        "description": "Oral Glucose Tolerance Test (OGTT) HbA1c Autoantibodies: ICA, IA-2A, GAD65A, mIAA, ZnT8A",
                        "timeFrame": "Metabolic and Autoantibody assessments are provided once or twice annually depending on risk level"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n* Individuals 2.5 to 45 years old who have an immediate family member with type 1 diabetes (such as a child, parent, or sibling)\n* Individuals 2.5-20 years old who have an extended family member with type 1 diabetes (such as a cousin, niece, nephew, aunt, uncle, grandparent, or half-sibling)\n* Individuals 2.5-45 years old without a type 1 diabetes proband, who are known to have 1 or more islet antibody are eligible for screening if needed to determine eligibility for a clinical trial to delay or prevent disease progression.\n\nExclusion Criteria:\n\nTo be eligible a person must not:\n\n* Have diabetes already\n* Have a previous history of being treated with insulin or oral diabetes medications.\n* Currently be using systemic immunosuppressive agents (topical and inhaled agents are acceptable)\n* Have any known serious diseases",
                "healthyVolunteers": true,
                "sex": "ALL",
                "minimumAge": "30 Months",
                "maximumAge": "45 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ],
                "studyPopulation": "First and second/third degree relatives of individuals with type 1 diabetes.",
                "samplingMethod": "PROBABILITY_SAMPLE"
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "TrialNet Central Information Center general info",
                        "role": "CONTACT",
                        "phone": "1-800-425-8361"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Kevan Herold, M.D.",
                        "affiliation": "Yale School of Medicine",
                        "role": "STUDY_CHAIR"
                    }
                ],
                "locations": [
                    {
                        "facility": "Childrens Hospital of Orange County",
                        "status": "RECRUITING",
                        "city": "Orange",
                        "state": "California",
                        "zip": "92868",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Marissa Erickson",
                                "role": "CONTACT",
                                "phone": "714-509-8613",
                                "email": "merickson@choc.org"
                            },
                            {
                                "name": "Mark Daniels, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.78779,
                            "lon": -117.85311
                        }
                    },
                    {
                        "facility": "University of California San Francisco",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94143-0434",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Karen Ko",
                                "role": "CONTACT",
                                "phone": "844-813-8273",
                                "email": "clinicalresearch@diabetes.ucsf.edu"
                            },
                            {
                                "name": "Stephen Gitelman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Stanford University Medical Center",
                        "status": "RECRUITING",
                        "city": "Stanford",
                        "state": "California",
                        "zip": "94305-5208",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Trudy Esrey, RD",
                                "role": "CONTACT",
                                "phone": "650-498-4450",
                                "email": "tesrey@stanford.edu"
                            },
                            {
                                "name": "Darrell Wilson, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.42411,
                            "lon": -122.16608
                        }
                    },
                    {
                        "facility": "Barbara Davis Center for Childhood Diabetes",
                        "status": "RECRUITING",
                        "city": "Denver",
                        "state": "Colorado",
                        "zip": "80262",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Brenda Bradfield",
                                "role": "CONTACT",
                                "phone": "303-724-8595",
                                "email": "brenda.bradfield@CUANSCHUTZ.EDU"
                            },
                            {
                                "name": "Andrea Steck, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.73915,
                            "lon": -104.9847
                        }
                    },
                    {
                        "facility": "Yale University School of Medicine",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06519",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lori Carria",
                                "role": "CONTACT",
                                "phone": "203-737-3595",
                                "email": "lori.carria@yale.edu"
                            },
                            {
                                "name": "Jennifer Sherr, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "status": "RECRUITING",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32601-0296",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jennifer Hosford",
                                "role": "CONTACT",
                                "phone": "352-294-5759",
                                "email": "jennifer.hosford@peds.ufl.edu"
                            },
                            {
                                "name": "Michael Haller, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "Emory Children's Center",
                        "status": "RECRUITING",
                        "city": "Atlanta",
                        "state": "Georgia",
                        "zip": "30322",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Xiaomiao Lan-Pidhainy, RN",
                                "role": "CONTACT",
                                "phone": "404-712-0051",
                                "email": "xlanpid@emory.edu"
                            },
                            {
                                "name": "Andrew Muir, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.749,
                            "lon": -84.38798
                        }
                    },
                    {
                        "facility": "Riley Hospital for Children, Indiana University",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maria Spall",
                                "role": "CONTACT",
                                "phone": "866-230-8486",
                                "email": "malnicho@iu.edu"
                            },
                            {
                                "name": "Linda DeMeglio, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Joslin Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Boston",
                        "state": "Massachusetts",
                        "zip": "02215",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Nora Bryant",
                                "role": "CONTACT",
                                "phone": "617-309-4141",
                                "email": "nora.bryant@joslin.harvard.edu"
                            },
                            {
                                "name": "Jason Gaglia, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.35843,
                            "lon": -71.05977
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "58944",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Beth Pappenfus",
                                "role": "CONTACT",
                                "phone": "612-624-2922",
                                "email": "papp0086@umn.edu"
                            },
                            {
                                "name": "Antoinette Moran, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "The Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Missouri",
                        "zip": "64111",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Cassandra McClain",
                                "role": "CONTACT",
                                "phone": "816-960-8877",
                                "email": "clmcclain@cmh.edu"
                            },
                            {
                                "name": "Wayne Moore, Md, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.09973,
                            "lon": -94.57857
                        }
                    },
                    {
                        "facility": "Columbia University",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10032",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jamie R Hyatt",
                                "role": "CONTACT",
                                "phone": "212-851-5425",
                                "email": "jh4470@cumc.columbia.edu"
                            },
                            {
                                "name": "Robin S Goland, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "Children's Hospital of Pittsburgh of UPMC",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15213",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kelli DeLallo, RN",
                                "role": "CONTACT",
                                "phone": "412-692-5210",
                                "email": "kelli.delallo@chp.edu"
                            },
                            {
                                "name": "Dorothy Becker, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Vanderbilt University",
                        "status": "RECRUITING",
                        "city": "Nashville",
                        "state": "Tennessee",
                        "zip": "37232",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Faith Brendle, RN",
                                "role": "CONTACT",
                                "phone": "615-936-8638",
                                "email": "faith.brendle@vanderbilt.edu"
                            },
                            {
                                "name": "William Russell, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 36.16589,
                            "lon": -86.78444
                        }
                    },
                    {
                        "facility": "University of Texas Medical Center at Dallas",
                        "status": "RECRUITING",
                        "city": "Dallas",
                        "state": "Texas",
                        "zip": "75390-8858",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lindsay Harter",
                                "role": "CONTACT",
                                "phone": "214-648-4725",
                                "email": "Lindsay.Harter@UTSouthwestern.edu"
                            },
                            {
                                "name": "Perrin White, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 32.78306,
                            "lon": -96.80667
                        }
                    },
                    {
                        "facility": "Baylor College of Medicine",
                        "status": "RECRUITING",
                        "city": "Houston",
                        "state": "Texas",
                        "zip": "77030",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Sandra Pena",
                                "role": "CONTACT",
                                "phone": "832-822-3380",
                                "email": "sypena@texaschildrens.org"
                            },
                            {
                                "name": "Maria Redondo, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.76328,
                            "lon": -95.36327
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101-2795",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Katie Bennett",
                                "role": "CONTACT",
                                "phone": "206-341-8945",
                                "email": "diabetes@benaroyaresearch.org"
                            },
                            {
                                "name": "Carla Greenbaum, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    },
                    {
                        "facility": "Walter and Eliza Hall Institute",
                        "status": "RECRUITING",
                        "city": "Parkville",
                        "state": "Victoria",
                        "zip": "3050",
                        "country": "Australia",
                        "contacts": [
                            {
                                "name": "Felicity Healy",
                                "role": "CONTACT",
                                "phone": "61-3-9342 7063",
                                "email": "felicity.healy@mh.org.au"
                            },
                            {
                                "name": "Peter C Colman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -37.78333,
                            "lon": 144.95
                        }
                    },
                    {
                        "facility": "The Hospital for Sick Children",
                        "status": "RECRUITING",
                        "city": "Toronto",
                        "state": "Ontario",
                        "zip": "M5G-1x8",
                        "country": "Canada",
                        "contacts": [
                            {
                                "name": "Rebecca Stochinsky",
                                "role": "CONTACT",
                                "phone": "(416) 813-7654",
                                "phoneExt": "202634",
                                "email": "rebecca.stochinsky@sickkids.ca"
                            },
                            {
                                "name": "Diane Wherrett, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.70011,
                            "lon": -79.4163
                        }
                    },
                    {
                        "facility": "University of Turku",
                        "status": "SUSPENDED",
                        "city": "Turku",
                        "zip": "FIN-20520",
                        "country": "Finland",
                        "geoPoint": {
                            "lat": 60.45148,
                            "lon": 22.26869
                        }
                    },
                    {
                        "facility": "Vita-Salute San Raffaele University",
                        "status": "SUSPENDED",
                        "city": "Milan",
                        "zip": "+39-02-2643 2818",
                        "country": "Italy",
                        "geoPoint": {
                            "lat": 45.46427,
                            "lon": 9.18951
                        }
                    },
                    {
                        "facility": "University of Bristol",
                        "status": "SUSPENDED",
                        "city": "Bristol",
                        "zip": "BS10 5NB UK",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.45523,
                            "lon": -2.59665
                        }
                    }
                ]
            },
            "referencesModule": {
                "references": [
                    {
                        "pmid": "12037147",
                        "type": "BACKGROUND",
                        "citation": "Diabetes Prevention Trial--Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002 May 30;346(22):1685-91. doi: 10.1056/NEJMoa012350."
                    },
                    {
                        "pmid": "15043959",
                        "type": "BACKGROUND",
                        "citation": "Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet. 2004 Mar 20;363(9413):925-31. doi: 10.1016/S0140-6736(04)15786-3."
                    },
                    {
                        "pmid": "11476858",
                        "type": "BACKGROUND",
                        "citation": "Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001 Jul 21;358(9277):221-9. doi: 10.1016/S0140-6736(01)05415-0. Erratum In: Lancet. 2001 Sep 1;358(9283):766."
                    },
                    {
                        "pmid": "8666144",
                        "type": "BACKGROUND",
                        "citation": "Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 1996 Jul;45(7):926-33. doi: 10.2337/diab.45.7.926."
                    },
                    {
                        "pmid": "7926304",
                        "type": "BACKGROUND",
                        "citation": "Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 1994 Nov;43(11):1304-10. doi: 10.2337/diab.43.11.1304."
                    },
                    {
                        "pmid": "34850014",
                        "type": "DERIVED",
                        "citation": "Triolo TM, Pyle L, Broncucia H, Armstrong T, Yu L, Gottlieb PA, Steck AK. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes. J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1510-e1517. doi: 10.1210/clinem/dgab853."
                    },
                    {
                        "pmid": "30089716",
                        "type": "DERIVED",
                        "citation": "Evans-Molina C, Sims EK, DiMeglio LA, Ismail HM, Steck AK, Palmer JP, Krischer JP, Geyer S, Xu P, Sosenko JM; Type 1 Diabetes TrialNet Study Group. beta Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. JCI Insight. 2018 Aug 9;3(15):e120877. doi: 10.1172/jci.insight.120877. eCollection 2018 Aug 9."
                    },
                    {
                        "pmid": "29092051",
                        "type": "DERIVED",
                        "citation": "Ferrara CT, Geyer SM, Evans-Molina C, Libman IM, Becker DJ, Wentworth JM, Moran A, Gitelman SE, Redondo MJ; Type 1 Diabetes TrialNet Study Group. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4596-4603. doi: 10.1210/jc.2017-01490."
                    },
                    {
                        "pmid": "28531305",
                        "type": "DERIVED",
                        "citation": "Bosi E, Boulware DC, Becker DJ, Buckner JH, Geyer S, Gottlieb PA, Henderson C, Kinderman A, Sosenko JM, Steck AK, Bingley PJ; Type 1 Diabetes TrialNet Study Group. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2881-2886. doi: 10.1210/jc.2017-00569."
                    },
                    {
                        "pmid": "25642774",
                        "type": "DERIVED",
                        "citation": "Herold KC, Usmani-Brown S, Ghazi T, Lebastchi J, Beam CA, Bellin MD, Ledizet M, Sosenko JM, Krischer JP, Palmer JP; Type 1 Diabetes TrialNet Study Group. beta cell death and dysfunction during type 1 diabetes development in at-risk individuals. J Clin Invest. 2015 Mar 2;125(3):1163-73. doi: 10.1172/JCI78142. Epub 2015 Feb 2."
                    }
                ],
                "seeAlsoLinks": [
                    {
                        "label": "TrialNet Study Group",
                        "url": "http://www.diabetestrialnet.org"
                    },
                    {
                        "label": "Type 1 Diabetes Clinical Trials",
                        "url": "https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/special-diabetes-program-clinical-trials-recruiting-patients-families"
                    },
                    {
                        "label": "American Diabetes Association",
                        "url": "http://www.diabetes.org"
                    },
                    {
                        "label": "Juvenile Diabetes Research Foundation International",
                        "url": "http://www.jdrf.org"
                    }
                ]
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Diabetes Mellitus, Type 1",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT05743244",
                "orgStudyIdInfo": {
                    "id": "TN31 JAK Inhibitors"
                },
                "organization": {
                    "fullName": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                },
                "briefTitle": "Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)",
                "officialTitle": "A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subtype-Selective JAK Inhibitors for Preservation of Pancreatic \u03b2 Cell Function in Newly Diagnosed Type 1 Diabetes Mellitus"
            },
            "statusModule": {
                "statusVerifiedDate": "2023-10",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2023-10-19",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2026-06-30",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2027-06-30",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2023-02-03",
                "studyFirstSubmitQcDate": "2023-02-21",
                "studyFirstPostDateStruct": {
                    "date": "2023-02-24",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-07-09",
                "lastUpdatePostDateStruct": {
                    "date": "2024-07-10",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                },
                "collaborators": [
                    {
                        "name": "Pfizer",
                        "class": "INDUSTRY"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes within 100 days of diagnosis.",
                "detailedDescription": "This study has a total sample size of 78 participants. Of that 78, 52 participants will receive active treatment, and a total of 26 participants will receive placebo. Participants will receive 12 months of active treatment with abrocitinib, ritlecitinib, or placebo with up to 12 months of additional follow-up. During the study, participants will undergo frequent assessments of their insulin production, immunologic status, overall health and well-being and diabetes care."
            },
            "conditionsModule": {
                "conditions": [
                    "Diabetes Mellitus, Type 1"
                ],
                "keywords": [
                    "TrialNet",
                    "T1D"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE2"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "interventionModelDescription": "Participants aged 12-35 years will be randomized 1:1:1 to receive abrocitinib, ritlecitinib, and placebo. The planned design is to enroll 26 participants in each of the 3 arms: the abrocitinib arm, the ritlecitinib arm, and the shared placebo arm. Within the shared placebo arm, participants will be randomized 1:1 to receive placebo matched to abrocitinib or placebo matched to ritlecitinib. Randomization will be stratified by the following two age categories: 12-17 years old, and 18 years or above. Within each stratum, participants will be randomized to either the abrocitinib arm, ritlecitinib arm, or the shared placebo arm using random block sizes. The total number of enrolled participants from the older age stratum (18 years or above) will be limited to 33 to replicate the age distribution in previous new-onset trials. Participants will receive 12 months of active treatment with abrocitinib, ritlecitinib, or placebo then enter a follow-up period of up to 12 months.",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "TRIPLE",
                        "maskingDescription": "The randomization method will be stratified by TrialNet study site. The participants will not be informed regarding the intervention assignment until the end of the study. The investigator and clinic personnel will also be masked as to study assignment. Laboratories performing assays for this protocol will be masked as to the identity of biological material to be studied.",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 78,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Abrocitinib",
                        "type": "EXPERIMENTAL",
                        "description": "Abrocitinib will be self-administered as 200-milligram (mg) tablet daily for 52 weeks (12 months). The final prepared product is to be labeled to protect the blind.",
                        "interventionNames": [
                            "Drug: Abrocitinib 200 MG Oral Tablet"
                        ]
                    },
                    {
                        "label": "Ritlecitinib",
                        "type": "EXPERIMENTAL",
                        "description": "Ritlecitnib will be self-administered via oral administration as a 100-mg capsule daily for 52 weeks (12 months). The final prepared product is to be labeled to protect the blind.",
                        "interventionNames": [
                            "Drug: Ritlecitinib"
                        ]
                    },
                    {
                        "label": "Placebo",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "200 mg tablet or 100 mg capsule matching either abrocitinib or ritlecitinib will be self-administered via oral administration daily for 52 weeks (12 months). The final product is to be labeled to protect the blind.",
                        "interventionNames": [
                            "Drug: Placebo"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Abrocitinib 200 MG Oral Tablet",
                        "description": "Abrocitinib",
                        "armGroupLabels": [
                            "Abrocitinib"
                        ],
                        "otherNames": [
                            "CIBINQO"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Ritlecitinib",
                        "description": "Ritlecitinib",
                        "armGroupLabels": [
                            "Ritlecitinib"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Placebo",
                        "description": "Placebo for Abrocitinib or Ritlecitinib",
                        "armGroupLabels": [
                            "Placebo"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "The area under the stimulated C-peptide curve (Y_AUC)",
                        "description": "The primary outcome of interest is the area under the stimulated C-peptide curve over the 2-hour mixed meal glucose tolerance test conducted at the 12-month visit (Y_AUC) over the 2-hour mixed meal glucose tolerance test conducted at the 12-month visit.",
                        "timeFrame": "12 Months"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Provide informed consent or assent as appropriate and, if \\< 18 years of age have a parent or legal guardian provide informed consent\n2. Age 12-35 years (both inclusive) at the time of signing informed consent and assent\n3. Diagnosis of T1D within 100 days of the baseline visit (V0).\n4. Positive for at least one islet cell autoantibody; Glutamate decarboxylase (GAD)65A, mIAA (if obtained within 10 days of the onset of insulin therapy), IA-2A, ICA, or ZnT8A\n5. Stimulated C-peptide of \u22650.2 pmol/mL measured during mixed-meal tolerance test (MMTT) conducted at least 21 days from diagnosis of diabetes\n6. HbA1c \u2264 10 %\n7. Body weight \u2265 35kg at screening\n8. Willing to comply with intensive diabetes management and wear a Continuous Glucose Monitoring Device (CGM)\n9. Participants who are Cytomegalovirus (CMV) and/or Epstein-Barr virus (EBV) seronegative at screening must be CMV and/or EBV Polymerase chain reaction (PCR) negative within 30 days of randomization and may not have had signs or symptoms of a CMV and/or EBV-compatible illness lasting longer than 7 days within 30 days of the baseline visit (V0).\n10. Participants who are CMV and/or EBV seropositive at screening must be CMV PCR negative and/or EBV PCR \\<2,000 IU/mL and must have no signs or symptoms of acute infection at the time of the baseline visit (V0).\n11. Be up to date on recommended vaccinations based on age of participants\\*\n12. Participants are required to receive killed influenza vaccination at least 2 weeks prior to the baseline visit (V0) when vaccine for the current or upcoming flu season is available.\n\n    Enrollment must be delayed at least 4 weeks from administration of a killed vaccine other than influenza and COVID-19 and 6 weeks from a live vaccination. Live vaccinations and non-live vaccinations (other than influzena and COVID-19) should not be given while on study drug and be postponed at least 3 months after the last dose of study drug.\n13. If participant is female with reproductive potential, she must have a negative pregnancy test at screening and be willing to avoid pregnancy using a highly-effective contraceptive method for the duration of the study\n14. Males of reproductive age must use a highly-effective contraceptive method during the treatment phase and for 3 months following last dose of study drug\n\n    * For COVID-19 vaccination, all participants will be strongly encouraged to be up-to-date with COVID-19 vaccine (s) as indicated by country-specific guidelines at least 2 weeks prior to the baseline visit (V0).\n\nExclusion Criteria:\n\n1. Current or ongoing use of non-insulin pharmaceuticals or medication that affect glycemic control or glucose homeostasis within 7 days prior to screening or any prohibited concomitant medication listed in section 4.8\n2. Untreated hypothyroidism or active Graves' disease\n3. Concurrent treatment with other immunosuppressive agents (including biologics or steroids), other than inhaled or topical glucocorticoids\n4. Active acute or chronic infection requiring treatment with oral antibiotics, antivirals, antiparasitics, antiprotozoals, or antifungals within 1 month prior to Day 0 or superficial skin infection within 1 week prior to Day 0\n5. Active acute or chronic infection requiring treatment with intravenous therapy (IV) within a minimum 1 month prior to Day 0\n\n   a. Specific cases should be reviewed by Infectious Disease Committee prior to enrollment\n6. Have active signs or symptoms of acute infection at the time of the baseline visit (V0).\n7. Significant trauma or major surgery within 1 month of signing informed consent.\n8. Considered in imminent need for surgery or with elective surgery scheduled to occur during the study\n9. History of disseminated herpes zoster or disseminated herpes simplex or a recurrent (more than one episode of) localized, dermatomal herpes zoster\n10. Have evidence of prior or current tuberculosis infection as assessed by Purified Protein Derivative (PPD), interferon gamma release assay (IGRA) or by history\n11. Have evidence of current or past HIV or Hepatitis B infection\n12. Have evidence of active Hepatitis C infection\n13. Have current, confirmed COVID-19 infection\n14. Current or history of Deep vein thrombosis (DVT), Pulmonary embolism (PE), or other thromboembolic events or history of inherited coagulopathies\n15. First degree relative with a history of unprovoked venous thromboembolism (i.e. without known underlying cause such as trauma, surgery, immobilization, prolonged travel, pregnancy, hormone use, or plaster cast), which suggests that a participant may be at increased risk of inherited coagulation disorder\n16. Any present malignancies or history of malignancy, other than a successfully treated nonmelanoma skin cancer\n17. History of any lymphoproliferative disorder such as EBV-related lymphoproliferative disorder, history of lymphoma, history of leukemia, or signs and symptoms suggestive of current lymphatic or lymphoid disease\n18. Known or suspected polymorphism in the Cytochrome P450 2C19 (CYP2C19 gene, resulting in classification as a poor CYP2C19 metabolizer).\n19. Have renal impairment (eGFR\\< 60 mL/min)\n20. Currently on anti-platelet therapies, excluding low dose aspirin\n21. One or more screening laboratory values as stated\n\n    1. Neutrophils \\< 1,500 /\u03bcL\n    2. Lymphocytes \\< 800 /\u03bcL\n    3. Platelets \\< 150,000 / \u03bcL\n    4. Hemoglobin \\< 6.2 mmol/L (10.0 g/dL)\n    5. Potassium \\> 5.5 mmol/L or \\<3.0 mmol/L\n    6. Sodium \\> 150mmol/L or \\< 130mmol/L\n    7. AST or ALT \u2265 2.5 times the upper limit of normal\n    8. Bilirubin \u2265 1.5 times upper limit of normal unless diagnosed with Gilbert's syndrome\n    9. LDL \\>160 mg/dL\n22. Vaccination with a live virus within the last 6 weeks and killed vaccine within 4 weeks (except 2 weeks for flu vaccine and COVID vaccine)\n23. Be currently pregnant or lactating or anticipate becoming pregnant during the study\n24. Male participants able to father children and female participants of childbearing potential who are unwilling or unable to use 2 effective methods (at least 1 highly effective method) of contraception, including abstinence, as outlined in this protocol for the duration of the study and for at least 3 months after the last dose of investigational product\n25. Be currently participating in another T1D treatment study\n26. Have hearing loss with progression over the previous 5 years, or sudden hearing loss, or middle or inner ear disease such as otitis media, cholesteatoma, Meniere's disease, labyrinthitis, or other auditory condition that is considered acute, fluctuating, or progressive\n27. Acute coronary syndrome (e.g., myocardial infarction, unstable angina pectoris) and any history of cerebrovascular disease within 24 weeks before screening; Heart failure NYHA (New York Heart Association) III, NYHA IV\n28. ANY of the following conditions at screening:\n\n    a. Screening 12-lead electrocardiogram (ECG) that demonstrates: i. Clinically significant abnormalities requiring treatment (eg, acute myocardial infarction, serious tachy- or brady-arrhythmias) or indicating serious underlying heart disease (eg, cardiomyopathy, Wolff-Parkinson- White syndrome); ii. Confirmed QT corrected using Fridericia's correction factor (QTcF) prolongation (\\>450 milliseconds).\n\n    b. Long QT Syndrome, a family history of Long QT Syndrome, or a history of Torsades de Pointes (TdP).\n29. History of chronic alcohol abuse or intravenous drug abuse or other illicit drug abuse within 2 years prior to screening\n30. Current or past use of tobacco or nicotine containing products more than the equivalent of 5 cigarettes per day\n31. Participant is the investigator or any sub-investigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the trial\n32. Have any complicating medical issues or abnormal clinical laboratory results that may interfere with study conduct, or cause increased risk\n33. Any condition that in the investigator's opinion may adversely affect study participation or may compromise the study results",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "12 Years",
                "maximumAge": "35 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Jessica S Conaty",
                        "role": "CONTACT",
                        "phone": "8133969234",
                        "email": "Jessica.Conaty@epi.usf.edu"
                    },
                    {
                        "name": "Melissa Parker",
                        "role": "CONTACT",
                        "phone": "8133969378",
                        "email": "Melissa.Parker@epi.usf.edu"
                    }
                ],
                "locations": [
                    {
                        "facility": "Children's Hospital Orange County",
                        "status": "RECRUITING",
                        "city": "Orange",
                        "state": "California",
                        "zip": "92868",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Speer",
                                "role": "CONTACT",
                                "phone": "714-509-8613",
                                "email": "hspeer@choc.org"
                            },
                            {
                                "name": "Hunter Vallejo",
                                "role": "CONTACT",
                                "email": "hvallejo@choc.org"
                            },
                            {
                                "name": "Mark Daniels, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.78779,
                            "lon": -117.85311
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "status": "RECRUITING",
                        "city": "Palo Alto",
                        "state": "California",
                        "zip": "94304",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Trudy Esrey",
                                "role": "CONTACT",
                                "phone": "650-498-4450",
                                "email": "tesrey@stanford.edu"
                            },
                            {
                                "name": "Priya Prahalad, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.44188,
                            "lon": -122.14302
                        }
                    },
                    {
                        "facility": "University of California- San Francisco",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94143",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Rebecca Wesch",
                                "role": "CONTACT",
                                "phone": "415-476-5984",
                                "email": "mailto:Rebecca.Wesch@ucsf.edu"
                            },
                            {
                                "name": "Stephen Gitelman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Barbara Davis Center at University of Colorado Anschutz Medical Campus",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Morgan Sooy",
                                "role": "CONTACT",
                                "phone": "303-724-5686",
                                "email": "MORGAN.SOOY@CUANSCHUTZ.EDU"
                            },
                            {
                                "name": "Andrea Steck, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Yale University School of Medicine",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06511",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Marcia DeSousa",
                                "role": "CONTACT",
                                "phone": "203-737-4805",
                                "email": "marcia.desousa@yale.edu"
                            },
                            {
                                "name": "Jennifer L. Sherr, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "status": "RECRUITING",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32610",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jennifer Hosford",
                                "role": "CONTACT",
                                "phone": "352-294-5759",
                                "email": "jennifer.hosford@medicine.ufl.edu"
                            },
                            {
                                "name": "Danielle Poulton",
                                "role": "CONTACT",
                                "phone": "352-294-5761",
                                "email": "Danielle.Poulton@medicine.ufl.edu"
                            },
                            {
                                "name": "Michael J Haller, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "University of Miami",
                        "status": "RECRUITING",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33136",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Carlos Blaschke",
                                "role": "CONTACT",
                                "email": "cblaschke@med.miami.edu"
                            },
                            {
                                "name": "David Baidal, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "University of South Florida Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Tampa",
                        "state": "Florida",
                        "zip": "33612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Juanita O'Brian",
                                "role": "CONTACT",
                                "phone": "813-974-9817",
                                "email": "jobrian@usf.edu"
                            },
                            {
                                "name": "Henry Rodriguez, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 27.94752,
                            "lon": -82.45843
                        }
                    },
                    {
                        "facility": "Emory Children's Center",
                        "status": "RECRUITING",
                        "city": "Atlanta",
                        "state": "Georgia",
                        "zip": "30322",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lynette Gonzalez",
                                "role": "CONTACT",
                                "phone": "404-712-0051",
                                "email": "lynette.gonzalez@emory.edu"
                            },
                            {
                                "name": "Xiaomiao Lan-Pidhainy, RN",
                                "role": "CONTACT",
                                "phone": "404-712-0051",
                                "email": "xlanpid@emory.edu"
                            },
                            {
                                "name": "Andrew Muir, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.749,
                            "lon": -84.38798
                        }
                    },
                    {
                        "facility": "Indiana University",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maria Spall",
                                "role": "CONTACT",
                                "phone": "317-278-8879",
                                "email": "malnicho@iu.edu"
                            },
                            {
                                "name": "Carmella Evans-Molina, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55455",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kali Johnson",
                                "role": "CONTACT",
                                "phone": "612-624-6682",
                                "email": "joh13933@umn.edu"
                            },
                            {
                                "name": "Toni Moran, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "The Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Missouri",
                        "zip": "64111",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Krystin Quilty Sanford",
                                "role": "CONTACT",
                                "phone": "913-927-9107"
                            },
                            {
                                "name": "Heather Harding",
                                "role": "CONTACT",
                                "phone": "816-683-9242"
                            },
                            {
                                "name": "Wayne Moore, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.09973,
                            "lon": -94.57857
                        }
                    },
                    {
                        "facility": "Columbia University-Naomi Berrie Diabetes Center",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10032",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Nathan Schwab",
                                "role": "CONTACT",
                                "phone": "212-851-5425",
                                "email": "ns3700@cumc.columbia.edu"
                            },
                            {
                                "name": "Jacqueline Lonier, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "University of Pittsburgh",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15224",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kelli DeLallo",
                                "role": "CONTACT",
                                "phone": "412-692-5210",
                                "email": "kelli.delallo@chp.edu"
                            },
                            {
                                "name": "Ingrid Libman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Vanderbilt University Medical Center",
                        "status": "RECRUITING",
                        "city": "Nashville",
                        "state": "Tennessee",
                        "zip": "37232",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kim Rainer",
                                "role": "CONTACT",
                                "phone": "615-936-8638",
                                "email": "kim.rainer@vumc.org"
                            },
                            {
                                "name": "William E Russell, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 36.16589,
                            "lon": -86.78444
                        }
                    },
                    {
                        "facility": "University of Texas Southwestern",
                        "status": "RECRUITING",
                        "city": "Dallas",
                        "state": "Texas",
                        "zip": "75390",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Michelle Murphy",
                                "role": "CONTACT",
                                "phone": "972-754-4794",
                                "email": "Michelle.Murphy@UTSouthwestern.edu"
                            },
                            {
                                "name": "Perrin White, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 32.78306,
                            "lon": -96.80667
                        }
                    },
                    {
                        "facility": "University of Utah",
                        "status": "RECRUITING",
                        "city": "Salt Lake City",
                        "state": "Utah",
                        "zip": "84112",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Hillarie Slater",
                                "role": "CONTACT",
                                "email": "hillarie.slater@hsc.utah.edu"
                            },
                            {
                                "name": "Zoe Raleigh, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.76078,
                            "lon": -111.89105
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kate Bennett",
                                "role": "CONTACT",
                                "phone": "206-341-8945",
                                "email": "kbennett@benaroyaresearch.org"
                            },
                            {
                                "name": "Sandra Lord, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    }
                ]
            },
            "referencesModule": {
                "seeAlsoLinks": [
                    {
                        "label": "TrialNet",
                        "url": "http://www.diabetestrialnet.org"
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "Data will be available at the NIDDK Central Repository"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes Mellitus",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Diabetes Mellitus, Type 1",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "C000634427",
                        "term": "Abrocitinib"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000047428",
                        "term": "Protein Kinase Inhibitors"
                    },
                    {
                        "id": "D000004791",
                        "term": "Enzyme Inhibitors"
                    },
                    {
                        "id": "D000045504",
                        "term": "Molecular Mechanisms of Pharmacological Action"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M1474",
                        "name": "Janus Kinase Inhibitors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M274125",
                        "name": "Abrocitinib",
                        "asFound": "Microliters",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M25820",
                        "name": "Protein Kinase Inhibitors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7951",
                        "name": "Enzyme Inhibitors",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT03929601",
                "orgStudyIdInfo": {
                    "id": "Rituximab-pvvr and Abatacept"
                },
                "secondaryIdInfos": [
                    {
                        "id": "UC4DK117009",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/UC4DK117009"
                    }
                ],
                "organization": {
                    "fullName": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                },
                "briefTitle": "Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes",
                "officialTitle": "Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes",
                "acronym": "TN25"
            },
            "statusModule": {
                "statusVerifiedDate": "2023-12",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2023-10-30",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2027-10",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2029-10",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2018-05-16",
                "studyFirstSubmitQcDate": "2019-04-23",
                "studyFirstPostDateStruct": {
                    "date": "2019-04-29",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-07-16",
                "lastUpdatePostDateStruct": {
                    "date": "2024-07-18",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                },
                "collaborators": [
                    {
                        "name": "National Institutes of Health (NIH)",
                        "class": "NIH"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false,
                "isUsExport": true
            },
            "descriptionModule": {
                "briefSummary": "The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr alone in new onset T1D. The primary objective is to test whether the C-peptide response to a 2-hour mixed meal tolerance test, will be improved in participants with new onset T1D who are treated with Abatacept after Rituximab-pvvr compared to those treated with Rituximab-pvvr and placebo 24 months after enrollment.",
                "detailedDescription": "This is a two-arm, double-blind, multicenter clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr alone in individuals with new onset T1D to determine whether rituximab-pvvr followed by abatacept results in an improvement in the AUC C-Peptide during a MMTT compared to Rituximab-pvvr alone at 24 months. Additional aims will compare the safety, tolerability in the two treatment arms as well as other clinical metabolic measures: exogenous insulin use, hemoglobin A1c, time in range from continuous glucose monitors, and severe hypoglycemia. Exploratory studies will assess changes in immune markers."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 1 Diabetes Mellitus"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE2"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "SEQUENTIAL",
                    "interventionModelDescription": "This protocol will enroll 74 participants who will be treated with a course of rituximab-pvvr (weekly infusion for 4 weeks), followed by treatment with abatacept or placebo starting at 4 months after initial rituximab-pvvr treatment and continuing to month 24. The abatacept/placebo treatment will be self-administered by participants (or their families/guardians, where most appropriate, particularly with pediatric participants) weekly for 20 months. Rituximab-pvvr will be given by IV infusion over at least 3 hours, at a dose of 375mg/m2 on four visits each one week apart, starting at Week 0 of the study. Abatacept/placebo will be given by a subcutaneous formulation weekly for 20 months, beginning at Week 16 (Month 4) of the study. Dosing will be determined by weight: Up to 25 kg: 50 mg (0.4 mL); 25 to \\<50 kg receive 87.5 mg (0.7 mL), and \\> 50 kg receive 125 mg (1.0 mL).",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "QUADRUPLE",
                        "maskingDescription": "This study is double blinded.",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR",
                            "OUTCOMES_ASSESSOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 74,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Rituximab-pvvr followed by Abatacept",
                        "type": "ACTIVE_COMPARATOR",
                        "description": "Rituximab-pvvr will be given by IV infusion over at least 3 hours, at a dose of 375mg/m2 on four visits each one week apart, starting at Week 0 of the study.\n\nAbatacept will be given by a subcutaneous formulation weekly for 20 months, beginning at Week 16 (Month 4) of the study. Dosing will be determined by weight: Up to 25 kg: 50 mg (0.4 mL); 25 to \\<50 kg receive 87.5 mg (0.7 mL), and \\> 50 kg receive 125 mg (1.0 mL).",
                        "interventionNames": [
                            "Drug: Rituximab-pvvr",
                            "Drug: Abatacept"
                        ]
                    },
                    {
                        "label": "Rituximab-pvvr followed by Placebo",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "Rituximab-pvvr will be given by IV infusion over at least 3 hours, at a dose of 375mg/m2 on four visits each one week apart, starting at Week 0 of the study.\n\nPlacebo will be given by a subcutaneous isotonic saline formulation weekly for 20 months, beginning at Week 16 (Month 4) of the study. Dosing will be match to active comparator, determined by weight: Up to 25 kg: 0.4 mL; 25 to \\<50 kg rec 0.7 mL, and \\> 50 kg receive 1.0 mL.",
                        "interventionNames": [
                            "Drug: Rituximab-pvvr",
                            "Drug: Sterile Sodium Chloride"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Rituximab-pvvr",
                        "description": "All participants will receive Rituximab-pvvr dosing from Week 1 to Week 4 of the trial. Rituximab-pvvr will be given by IV infusion over at least 3 hours, at a dose of 375mg/m2 on four visits each one week apart.",
                        "armGroupLabels": [
                            "Rituximab-pvvr followed by Abatacept",
                            "Rituximab-pvvr followed by Placebo"
                        ],
                        "otherNames": [
                            "Ruxience"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Abatacept",
                        "description": "Participants in the active drug arm will receive initial Abatacept dosing at Week 16 of trial. Abatacept will be given by a subcutaneous (SC) formulation weekly for 20 months, and dosing be will determined according to weight: Up to 25 kg: 50 mg (0.4 mL); 25 to \\<50 kg receive 87.5 mg (0.7 mL), and \\> 50 kg receive 125 mg (1.0 mL).",
                        "armGroupLabels": [
                            "Rituximab-pvvr followed by Abatacept"
                        ],
                        "otherNames": [
                            "Orencia"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Sterile Sodium Chloride",
                        "description": "Participants in the placebo arm will receive initial placebo injection at Week 16 of trial. Saline Placebo will be given by a subcutaneous (SC) formulation weekly for 20 months, and dosing volume be will determined according to weight to match active comparator: Up to 25 kg: 0.4 mL; 25 to \\<50 kg receive 0.7 mL and \\> 50 kg receive 1.0 mL.",
                        "armGroupLabels": [
                            "Rituximab-pvvr followed by Placebo"
                        ],
                        "otherNames": [
                            "0.9% Sodium Chloride Water for Injection"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "C-Peptide Response to 2-hr MMTT at 24 months post-randomization",
                        "description": "The primary objective is to test whether the C-peptide response to a 2-hour mixed meal tolerance test, will be improved in participants with new onset T1D who are treated with Abatacept after Rituximab compared to those participants treated with Rituximab and placebo 24 months after enrollment.",
                        "timeFrame": "48-months from Day 0"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "C-peptide AUC Means",
                        "description": "C-peptide AUC Mean at 0, 6, 12, 18, 24, 30, 36, 42 and 48 months using the ANCOVA model.",
                        "timeFrame": "Day 0 and every 6 months to trial end (up to 4 years)"
                    },
                    {
                        "measure": "Analysis of changes in immune responses to known diabetes antigens and a neoantigen over time by treatment group",
                        "description": "Analysis of changes in immune responses to known diabetes antigens and a neoantigen. The investigators will compare the effects of drug treatments on the titers of autoantibodies: anti-insulin, anti-GAD65, anti-IA-2, anti-ZnT8. The investigators will also compare the effects of drug treatments on the response to Keyhole Limpet Hemocyanin (KLH) for which standardized immunological responses have been characterized.",
                        "timeFrame": "Day 0, month 2, 4, 5, 6, 12, 13, 18, 24, 25, 30, and 36"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u2265 8 and \u2264 45 years old at time of signing informed consent.\n2. Fulfill the ADA criteria for diagnosis of T1D within 100 days of randomization.\n3. Must be willing to provide informed consent or assent with a parent or legal guardian providing informed consent if \\< 18 years of age.\n4. Positive for at least one islet cell autoantibody; GAD65A, mIAA (if obtained within 10 days of the onset of insulin therapy), IA-2A, ICA, or ZnT8A\n5. Must have stimulated C-peptide of \u22650.2 pmol/mL measured during mixed-meal tolerance test (MMTT) conducted at least 21 days after the diagnosis of diabetes.\n6. Enrollees must be willing to comply with intensive diabetes management.\n7. Body weight must be \u2265 20.0 kg for study agent administration.\n8. Subjects who are CMV and/or EBV seronegative at screening must be CMV and/or EBV PCR negative and may not have had signs or symptoms of a CMV and/or EBV compatible illness prior to randomization.\n9. Female participants with reproductive potential must have a negative pregnancy test at screening and be willing to avoid pregnancy for the duration of treatment and until 3 months after the last dose of Abatacept. Female participants with reproductive potential who are sexually active will be instructed to use a highly effective contraceptive method until one year after the last dose of rituximab-pvvr.\n10. Male participants of reproductive age must use an adequate contraceptive method for the duration of rituximab-pvvr treatment and 12 months following the last dose of rituximab-pvvr.\n11. The following additional inclusion criteria regarding vaccines must be met:\n\n    1. More than 4 weeks from immunization with a live viral vaccine\n    2. Be up to date on all recommended vaccinations based on age of subject\\*\n    3. Receive non-live influenza vaccination at least 2 weeks prior to randomization when vaccine for the current or upcoming flu season is available\n    4. Willingness to forgo vaccines (other than killed influenza) during the 6 months after the rituximab-pvvr treatment period\n12. Participants must be willing to practice public health prevention measures such as social distancing, masking, and good hand hygiene, and/or receive therapeutics such as monoclonal antibodies and antivirals as directed by the study and recommended by local health authorities to prevent SARS-Cov-2 infection.\n13. Willing to wear a continuous glucose monitoring device for a minimum of 10 days every 6 months \\* Adult subjects must be fully immunized. Pediatric subjects who have not completed their primary vaccination schedule must receive all vaccinations allowable per local public health immunization guidelines for their current age prior to study drug delivery. Any remaining vaccinations should be given and continue per the schedule at least 6 months after rituximab-pvvr is administered. For COVID-19 vaccination, all participants will be strongly encouraged to be up-to-date with COVID-19 vaccine(s) as indicated by country-specific guidelines at least 2 weeks prior to randomization.\n\nExclusion Criteria:\n\n1. One or more screening laboratory values as stated:\n\n   1. Leukocytes \\<3,000/\u03bcL\n   2. Neutrophils \\<1,500/\u03bcL\n   3. Lymphocytes \\<800/\u03bcL\n   4. Platelets \\<100,000/\u03bcL\n   5. Hemoglobin \\<6.2 mmol/L (10.0 g/dL)\n   6. Potassium \\>5.5 mmol/L or \\<3.0 mmol/L\n   7. Sodium \\>150 mmol/L or \\<130 mmol/L\n   8. AST or ALT \u2265 2.5 times the upper limits of normal\n   9. Bilirubin \u2265 1.5 times upper limit of normal\n2. History of immune deficiency\n3. Current or ongoing use of non-insulin pharmaceuticals that affect glycemic control within 7 days of screening visit.\n4. Chronic active infection other than localized skin infections.\n5. Have active signs or symptoms of acute infection at the time of randomization.\n6. Have IgG and/or IgM levels below the normal reference ranges.\n7. Positive PPD, interferon gamma release assay (IGRA) or history of previous treatment for TB.\n8. Vaccination with a live virus within 4 weeks prior to initiating study treatment.\n9. A history of confirmed infectious mononucleosis within the 3 months prior to initiating study treatment, as documented by EBV serology (EBV VCA-IgM and VCA-IgG; PCR would be confirmatory).\n10. Laboratory evidence of current or past HIV or Hepatitis B or active Hepatitis C infection.\n11. Be currently pregnant, lactating or anticipate pregnancy within 14 weeks of the last study drug administration (Visit 15).\n12. Chronic use of oral or inhaled steroids or other immunosuppressive agents.\n13. Known and untreated hypothyroidism or active Graves' disease at randomization.\n14. History of malignancy.\n15. Prior treatment with active study agent from a previous clinical trial.\n16. Any laboratory abnormality or condition that, in the opinion of the investigator, would interfere with the study conduct or the safety of the participant.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "8 Years",
                "maximumAge": "45 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Ariana Rojas",
                        "role": "CONTACT",
                        "phone": "813-974-6827",
                        "email": "ariana.rojas@epi.usf.edu"
                    },
                    {
                        "name": "Melissa Parker",
                        "role": "CONTACT",
                        "phone": "813-396-9378",
                        "email": "melissa.parker@epi.usf.edu"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Stephen Gitelman, MD",
                        "affiliation": "Type 1 Diabetes TrialNet",
                        "role": "STUDY_CHAIR"
                    },
                    {
                        "name": "Kevan Herold, MD",
                        "affiliation": "Type 1 Diabetes TrialNet Chairman",
                        "role": "STUDY_DIRECTOR"
                    },
                    {
                        "name": "Daniel Moore, MD",
                        "affiliation": "Type 1 Diabetes TrialNet",
                        "role": "STUDY_CHAIR"
                    }
                ],
                "locations": [
                    {
                        "facility": "Stanford University",
                        "status": "RECRUITING",
                        "city": "Palo Alto",
                        "state": "California",
                        "zip": "94304",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Trudy Esrey",
                                "role": "CONTACT",
                                "phone": "650-498-4450",
                                "email": "tesrey@stanford.edu"
                            },
                            {
                                "name": "Priya Pahalad, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.44188,
                            "lon": -122.14302
                        }
                    },
                    {
                        "facility": "University of California San Francisco",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94158",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Rebecca Wesch",
                                "role": "CONTACT",
                                "phone": "415-476-5356",
                                "email": "rebecca.wesch@ucsf.edu"
                            },
                            {
                                "name": "Stephen Gitelman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Barbara Davis Center for Childhood Diabetes",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Alison Altomari",
                                "role": "CONTACT",
                                "phone": "303-724-6774",
                                "email": "ALISON.ALTOMARI@UCDENVER.EDU"
                            },
                            {
                                "name": "Peter Gottlieb, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Yale University",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06520",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Marcia DeSousa",
                                "role": "CONTACT",
                                "phone": "203-737-4805",
                                "email": "marcia.desousa@yale.edu"
                            },
                            {
                                "name": "Jennifer Sherr, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "status": "RECRUITING",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32610",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jennifer Hosford",
                                "role": "CONTACT",
                                "phone": "352-294-5759",
                                "email": "jennifer.hosford@medicine.ufl.edu"
                            },
                            {
                                "name": "Danielle Poulton",
                                "role": "CONTACT",
                                "phone": "352-294-5761",
                                "email": "Danielle.Poulton@medicine.ufl.edu"
                            },
                            {
                                "name": "Michael J Haller, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "University of Miami",
                        "status": "RECRUITING",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33136",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Carlos Blaschke, MD",
                                "role": "CONTACT",
                                "phone": "305-243-6616",
                                "email": "cblaschke@med.miami.edu"
                            },
                            {
                                "name": "David Baidal, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "Indiana University - Riley Hospital for Children",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maria Spall",
                                "role": "CONTACT",
                                "phone": "317-278-8879",
                                "email": "malnicho@iu.edu"
                            },
                            {
                                "name": "Linda DiMeglio, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "The Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Kansas",
                        "zip": "64114",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Harding",
                                "role": "CONTACT",
                                "phone": "816-960-8985",
                                "email": "hrharding@cmh.edu"
                            },
                            {
                                "name": "Wayne Moore, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.11417,
                            "lon": -94.62746
                        }
                    },
                    {
                        "facility": "Joslin Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Boston",
                        "state": "Massachusetts",
                        "zip": "02215",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Brittany Resnick",
                                "role": "CONTACT",
                                "phone": "607-309-4148",
                                "email": "brittany.resnick@joslin.harvard.edu"
                            },
                            {
                                "name": "Jason Gaglia",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.35843,
                            "lon": -71.05977
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55455",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Beth Pappenfus",
                                "role": "CONTACT",
                                "phone": "612-624-2922",
                                "email": "papp0086@umn.edu"
                            },
                            {
                                "name": "Antoinette Moran, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "Columbia University",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10032",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kaisha Mofford",
                                "role": "CONTACT",
                                "phone": "212-851-5364",
                                "email": "km3870@cumc.columbia.edu"
                            },
                            {
                                "name": "Robin Goland, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "University of Pittsburg",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15224",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kelli DeLallo",
                                "role": "CONTACT",
                                "phone": "412-692-5210",
                                "email": "kelli.delallo@chp.edu"
                            },
                            {
                                "name": "Ingrid Libman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Sanford Children's Specialty Clinic",
                        "status": "RECRUITING",
                        "city": "Sioux Falls",
                        "state": "South Dakota",
                        "zip": "57105",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Staci Schwingler",
                                "role": "CONTACT",
                                "phone": "605-312-6977",
                                "email": "Staci.Schwingler@SanfordHealth.org"
                            },
                            {
                                "name": "Kurt Griffin, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.54997,
                            "lon": -96.70033
                        }
                    },
                    {
                        "facility": "Vanderbilt Eskind Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Nashville",
                        "state": "Tennessee",
                        "zip": "37232",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Brenna Hammel",
                                "role": "CONTACT",
                                "phone": "615-337-9597",
                                "email": "brenna.hammel@vumc.org"
                            },
                            {
                                "name": "William Russell, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 36.16589,
                            "lon": -86.78444
                        }
                    },
                    {
                        "facility": "University of Texas Southwestern",
                        "status": "RECRUITING",
                        "city": "Dallas",
                        "state": "Texas",
                        "zip": "75390",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Michelle Murphy",
                                "role": "CONTACT",
                                "phone": "214-456-9238",
                                "email": "michelle.murphy@utsouthwestern.edu"
                            },
                            {
                                "name": "Jamie Girard",
                                "role": "CONTACT",
                                "phone": "469-744-9289",
                                "email": "jamie.girard@utsouthwestern.edu"
                            },
                            {
                                "name": "Perrin White, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 32.78306,
                            "lon": -96.80667
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Natalie Clary",
                                "role": "CONTACT",
                                "phone": "206-342-6963",
                                "email": "nclary@benaroyaresearch.org"
                            },
                            {
                                "name": "Sandra Lord, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    },
                    {
                        "facility": "Queensland Children's Hospital",
                        "status": "RECRUITING",
                        "city": "South Brisbane",
                        "state": "Queensland",
                        "zip": "4101",
                        "country": "Australia",
                        "contacts": [
                            {
                                "name": "Julie Kirby",
                                "role": "CONTACT",
                                "phone": "60730685264",
                                "email": "Julie.Kirby2@health.qld.gov.au"
                            },
                            {
                                "name": "Tony Huynh, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -27.48034,
                            "lon": 153.02049
                        }
                    },
                    {
                        "facility": "Walter and Eliza Hall Institute of Medical Research",
                        "status": "RECRUITING",
                        "city": "Melbourne",
                        "state": "Victoria",
                        "zip": "3050",
                        "country": "Australia",
                        "contacts": [
                            {
                                "name": "Felicity Healy",
                                "role": "CONTACT",
                                "phone": "9342-7063",
                                "email": "felicity.healy@mh.org.au"
                            },
                            {
                                "name": "John Wentworth, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -37.814,
                            "lon": 144.96332
                        }
                    }
                ]
            },
            "referencesModule": {
                "seeAlsoLinks": [
                    {
                        "label": "Study Sponsor Website",
                        "url": "http://www.trialnet.org/"
                    }
                ]
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Type 1 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000069283",
                        "term": "Rituximab"
                    },
                    {
                        "id": "D000069594",
                        "term": "Abatacept"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000074322",
                        "term": "Antineoplastic Agents, Immunological"
                    },
                    {
                        "id": "D000000970",
                        "term": "Antineoplastic Agents"
                    },
                    {
                        "id": "D000007155",
                        "term": "Immunologic Factors"
                    },
                    {
                        "id": "D000045505",
                        "term": "Physiological Effects of Drugs"
                    },
                    {
                        "id": "D000018501",
                        "term": "Antirheumatic Agents"
                    },
                    {
                        "id": "D000082082",
                        "term": "Immune Checkpoint Inhibitors"
                    },
                    {
                        "id": "D000045504",
                        "term": "Molecular Mechanisms of Pharmacological Action"
                    },
                    {
                        "id": "D000007166",
                        "term": "Immunosuppressive Agents"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M373",
                        "name": "Rituximab",
                        "asFound": "Infusion",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M483",
                        "name": "Abatacept",
                        "asFound": "One month",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M1346",
                        "name": "Antineoplastic Agents, Immunological",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10201",
                        "name": "Immunologic Factors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M20604",
                        "name": "Antirheumatic Agents",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M2342",
                        "name": "Immune Checkpoint Inhibitors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10212",
                        "name": "Immunosuppressive Agents",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "ANeo",
                        "name": "Antineoplastic Agents"
                    },
                    {
                        "abbrev": "ARhu",
                        "name": "Antirheumatic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT05757713",
                "orgStudyIdInfo": {
                    "id": "PRV-031-005"
                },
                "organization": {
                    "fullName": "Sanofi",
                    "class": "INDUSTRY"
                },
                "briefTitle": "Teplizumab in Pediatric Stage 2 Type 1 Diabetes",
                "officialTitle": "Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoantibodies and Dysglycemia)",
                "acronym": "PETITE-T1D"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-04",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2023-07-25",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2026-10",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2026-10",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2023-02-13",
                "studyFirstSubmitQcDate": "2023-02-23",
                "studyFirstPostDateStruct": {
                    "date": "2023-03-07",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-04-12",
                "lastUpdatePostDateStruct": {
                    "date": "2024-04-16",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "Provention Bio, a Sanofi Company",
                    "class": "INDUSTRY"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who are \\<8 years of age.",
                "detailedDescription": "This is a single-arm, non-randomized, open-label, multicenter study in the U.S. to assess the safety and pharmacokinetics of teplizumab in pediatric participants with Stage 2 type 1 diabetes (T1D) (two T1D-related autoantibodies and dysglycemia) who are 0 to \\<8 years of age. Anti-drug antibodies/neutralizing antibodies (ADA/NAb) will also be assessed.\n\nApproximately 20 participants will be enrolled. The regimen consists of an intravenous infusion of teplizumab once daily for 14 consecutive days. The study duration for each individual may last up to approximately 26 months.\n\nThe safety, tolerability, PK, ADA, and T1D clinical feature data will be summarized using descriptive statistics."
            },
            "conditionsModule": {
                "conditions": [
                    "Diabetes Mellitus, Type 1"
                ],
                "keywords": [
                    "Type 1 diabetes",
                    "Stage 2",
                    "Pediatric type 1 diabetes",
                    "T1D",
                    "At-risk"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE4"
                ],
                "designInfo": {
                    "allocation": "NA",
                    "interventionModel": "SINGLE_GROUP",
                    "interventionModelDescription": "Single arm, non-randomized, open-label, multi-center study",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "NONE"
                    }
                },
                "enrollmentInfo": {
                    "count": 20,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "teplizumab injection",
                        "type": "EXPERIMENTAL",
                        "description": "teplizumab injection, sterile solution for intravenous use",
                        "interventionNames": [
                            "Biological: teplizumab"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "BIOLOGICAL",
                        "name": "teplizumab",
                        "description": "CD3-directed humanized monoclonal antibody",
                        "armGroupLabels": [
                            "teplizumab injection"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Treatment-emergent adverse events (TEAEs), adverse events of special interest (AESIs), TEAEs leading to withdrawal, and serious adverse events (SAEs)",
                        "description": "Safety and tolerability endpoint",
                        "timeFrame": "Through 104 Weeks"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Serum concentrations of teplizumab",
                        "description": "Pharmacokinetic (PK) endpoint",
                        "timeFrame": "Sparse PK samples between Days 1 and 28"
                    },
                    {
                        "measure": "Anti-drug antibody (ADA) titers and presence of neutralizing antibodies (Nab)",
                        "description": "Immunogenicity endpoint",
                        "timeFrame": "Through 104 weeks"
                    },
                    {
                        "measure": "CD3 receptor occupancy",
                        "description": "To assess the effects of teplizumab on cluster of differentiation 3 (CD3) receptor occupancy",
                        "timeFrame": "Days 1 and 9"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Participant is a male or female 0 to \\< 8 years of age, inclusive, at Day 1\n2. Participant has Stage 2 T1D (two T1D-related autoantibodies and dysglycemia)\n\nExclusion Criteria:\n\n1. Participant has any autoimmune disease other than T1D with the exception of stable thyroid or celiac disease\n2. Has an active infection and/or fever\n3. Has a history of or serologic evidence at screening of current or past infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV).\n4. Has any condition that, in the opinion of the Investigator, would interfere with the study conduct or the safety of the participant.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "0 Years",
                "maximumAge": "7 Years",
                "stdAges": [
                    "CHILD"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Trial Transparency email recommended (Toll free for US & Canada)",
                        "role": "CONTACT",
                        "phone": "800-633-1610",
                        "phoneExt": "option 6",
                        "email": "Contact-us@sanofi.com"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Clinical Sciences & Operations",
                        "affiliation": "Sanofi",
                        "role": "STUDY_DIRECTOR"
                    }
                ],
                "locations": [
                    {
                        "facility": "Clinical Site 107",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94143",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Clinical Site 102",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Clinical Site 101",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06511",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "Clinical Site 104",
                        "status": "RECRUITING",
                        "city": "Columbus",
                        "state": "Georgia",
                        "zip": "31904",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 32.46098,
                            "lon": -84.98771
                        }
                    },
                    {
                        "facility": "Clinical Site 110",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Clinical Site 105",
                        "status": "RECRUITING",
                        "city": "Buffalo",
                        "state": "New York",
                        "zip": "14203",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.88645,
                            "lon": -78.87837
                        }
                    },
                    {
                        "facility": "Clinical Site 108",
                        "status": "RECRUITING",
                        "city": "Philadelphia",
                        "state": "Pennsylvania",
                        "zip": "19104",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.95233,
                            "lon": -75.16379
                        }
                    },
                    {
                        "facility": "Clinical Site 106",
                        "status": "RECRUITING",
                        "city": "Sioux Falls",
                        "state": "South Dakota",
                        "zip": "57105",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.54997,
                            "lon": -96.70033
                        }
                    },
                    {
                        "facility": "Clinical Site 109",
                        "status": "RECRUITING",
                        "city": "Nashville",
                        "state": "Tennessee",
                        "zip": "37232",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 36.16589,
                            "lon": -86.78444
                        }
                    },
                    {
                        "facility": "Clinical Site 103",
                        "status": "RECRUITING",
                        "city": "Tacoma",
                        "state": "Washington",
                        "zip": "98405",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Clinical and Translational Medicine Lead",
                                "role": "CONTACT"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.25288,
                            "lon": -122.44429
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Diabetes Mellitus, Type 1",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "browseLeaves": [
                    {
                        "id": "M4225",
                        "name": "Antibodies",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10184",
                        "name": "Immunoglobulins",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M21860",
                        "name": "Pharmaceutical Solutions",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4230",
                        "name": "Antibodies, Monoclonal",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4625",
                        "name": "Autoantibodies",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    },
                    {
                        "abbrev": "PhSol",
                        "name": "Pharmaceutical Solutions"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT02748018",
                "orgStudyIdInfo": {
                    "id": "CEP 304"
                },
                "organization": {
                    "fullName": "Medtronic Diabetes",
                    "class": "INDUSTRY"
                },
                "briefTitle": "Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home",
                "officialTitle": "Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-01",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2017-05-25",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2024-03",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2024-09",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2016-04-19",
                "studyFirstSubmitQcDate": "2016-04-21",
                "studyFirstPostDateStruct": {
                    "date": "2016-04-22",
                    "type": "ESTIMATED"
                },
                "lastUpdateSubmitDate": "2024-01-18",
                "lastUpdatePostDateStruct": {
                    "date": "2024-01-22",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "Medtronic Diabetes",
                    "class": "INDUSTRY"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": false,
                "isFdaRegulatedDevice": true
            },
            "descriptionModule": {
                "briefSummary": "The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)",
                "detailedDescription": "This is a 6 month, multi-center, randomized, parallel, adaptive study in type 1 diabetes with a 6 month continuation period. The study will have three periods, per Cohort:\n\n1. Run-in Period: The run-in period can be up to 60 days during which time a blinded CGM sensor will be worn for two weeks.\n2. Study Period: There will be a 6 month randomized study period with two arms: The HCL system and Control.\n3. Continuation Period: There will be a 6 month continuation period during which time all subjects will use the HCL system with Auto Mode.\n\nUp to 1500 subjects will be enrolled in order to have 1000 subjects complete the study. Up to 70 investigational Centers in the US, Europe, Canada, Australia and New Zealand will be enrolled."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 1 Diabetes"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "NA"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "interventionModelDescription": "There will be three cohorts sequentially enrolled for the study. Cohort 1: Continuous Subcutaneous Insulin Infusion (CSII cohort): randomized to HCL (treatment arm) or CSII (Control arm) Cohort 2: Multiple Daily Injections (MDI cohort): randomized to HCL (treatment arm) or MDI (Control arm) Cohort 3: Sensor-Augmented Pump therapy (SAP cohort): randomized to HCL (treatment arm) or SAP (Control arm) Note: Subjects 2-6 years of age will automatically enter the HCL arm at the end of the run-in period",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "NONE"
                    }
                },
                "enrollmentInfo": {
                    "count": 280,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Hybrid Closed Loop Arm",
                        "type": "EXPERIMENTAL",
                        "description": "The HCL Arm will use the MiniMed System (i.e., using Auto Mode) for 6 months during the study period.",
                        "interventionNames": [
                            "Device: 670G and 770G Insulin Pump"
                        ]
                    },
                    {
                        "label": "Control Arm",
                        "type": "ACTIVE_COMPARATOR",
                        "description": "The Control Arm will use individual subject's current diabetes therapy: CSII (Continuous Subcutaneous Insulin Infusion), MDI (Multiple Daily Injections) or SAP (Sensor Augmented Pump). Each cohort (CSII, MDI, or SAP) will be used as the control arm to be compared to the experimental arm (HCL).",
                        "interventionNames": [
                            "Device: Subject's Current Diabetes Therapy"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DEVICE",
                        "name": "670G and 770G Insulin Pump",
                        "description": "Medtronic 670G and 770G Hybrid Closed Loop Systems",
                        "armGroupLabels": [
                            "Hybrid Closed Loop Arm"
                        ]
                    },
                    {
                        "type": "DEVICE",
                        "name": "Subject's Current Diabetes Therapy",
                        "description": "Subject will use current diabetes therapy: CSII (Continuous Subcutaneous Insulin Infusion), MDI (Multiple Daily Injections) or SAP (Sensor Augmented Pump).",
                        "armGroupLabels": [
                            "Control Arm"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "CSII Cohort: change of A1C (\u2206A1C) for subjects with baseline A1c > 8%",
                        "description": "CSII Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Time in Hypoglycemic Range for subjects with baseline A1c \u2264 8%",
                        "description": "CSII Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: change of A1C (\u2206A1C) for subjects with baseline A1c > 8%",
                        "description": "MDI Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Hypoglycemic Range for subjects with baseline A1c \u2264 8%",
                        "description": "MDI Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: change of A1C (\u2206A1C) for subjects with baseline A1c > 8%",
                        "description": "SAP Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Hypoglycemic Range for subjects with baseline A1c \u2264 8%",
                        "description": "SAP Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "CSII Cohort: Time in Hypoglycemic Range for subjects with baseline A1c > 8%",
                        "description": "CSII Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Change in A1C (\u2206A1C) for subjects with baseline A1c \u2264 8%",
                        "description": "CSII Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Time in Hypoglycemic Range during Night for all subjects",
                        "description": "CSII Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "description": "CSII Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "description": "CSII Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Time in Hypoglycemic Range during Day and Night for all subjects",
                        "description": "CSII Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "CSII Cohort: Change in A1C for all subjects",
                        "description": "CSII Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Hypoglycemic Range for subjects with baseline A1c > 8%",
                        "description": "MDI Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Change in A1C (\u2206A1C) for subjects with baseline A1c \u2264 8%",
                        "description": "MDI Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Hypoglycemic Range during Night for all subjects",
                        "description": "MDI Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "description": "MDI Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "description": "MDI Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Time in Hypoglycemic Range during Day and Night for all subjects",
                        "description": "MDI Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "MDI Cohort: Change in A1C for all subjects",
                        "description": "MDI Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Hypoglycemic Range for subjects with baseline A1c > 8%",
                        "description": "SAP Cohort: Time with sensor glucose (SG) below 70 mg/dL (3.9mmol/L) during the six-month study period. This is only for subjects with baseline A1c \\> 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Change in A1C (\u2206A1C) for subjects with baseline A1c \u2264 8%",
                        "description": "SAP Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit. This is only for subjects with baseline A1c \u2264 8%",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Hypoglycemic Range during Night for all subjects",
                        "description": "SAP Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "description": "SAP Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Target Range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "description": "SAP Cohort: Time in target range measures the time with SG in target range 70mg/dL (3.9mmol/L) - 180 mg/dL (10.0mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Time in Hypoglycemic Range during Day and Night for all subjects",
                        "description": "SAP Cohort: Time with SG below 70 mg/dL (3.9mmol/L) during Day and Night for all subjects",
                        "timeFrame": "6 months"
                    },
                    {
                        "measure": "SAP Cohort: Change in A1C for all subjects",
                        "description": "SAP Cohort: Change in A1C from baseline to the end of the six-month treatment period, defined as A1C measured at the six-month treatment visit minus A1C measured at the randomization visit for all subjects",
                        "timeFrame": "6 months"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria\n\n1. Subject is age 2-80 years at time of screening\n\n   1. US, Canada, Australia and New Zealand: Subjects 2-80 years of age will be allowed to enroll in the post approval study.\n   2. Europe: Only subjects \u22657 years of age are allowed to enroll in the post-market study.\n2. Subjects who are 2-21 years are determined by the investigator to have the appropriate, requisite support (family, caregiver or social network) to successfully participate in this study\n3. Subject must have a minimum daily insulin requirement (Total Daily Dose) of equal to or greater than 8 units/day\n4. Subjects who are determined by the investigator to be psychologically sound in order to successfully participate in this study\n5. Subject has been diagnosed with type 1 diabetes for at least three months Note: Determination of classification for diabetes will be based on American Diabetes Association Clinical Practice Guidelines accounting for several patient characteristics such as: age of onset, patient's weight or BMI, history of diabetic ketoacidosis, history of therapy management, if available in the medical records.\n6. Subject must be on one of the following management therapies:\n\n   1. Multiple daily injections defined by use of rapid analogue with meals and approved long acting analogue (e.g. detemir or glargine) with or without CGM\n   2. Insulin pump therapy with or without CGM\n7. Subject is willing to perform \u2265 4 finger stick blood glucose measurements daily\n8. Subject is willing to perform required study procedures\n9. Subject is willing to wear the system continuously throughout the study for at least 80% of the time.\n10. Subject is willing to upload data at least weekly from the study pump/meter, must have Internet access and a computer system that meets the requirements for uploading the study pump/meter for data collection\n11. Subject must be willing to use the study glucose meter system (i.e. along with study meter strips).\n12. If subject has celiac disease, it has been adequately treated as determined by the investigator\n13. Subject with the diagnosis of myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack, cerebrovascular accident, angina, congestive heart failure, ventricular rhythm disturbances or thromboembolic disease, within 1 year of screening, will be included in the study with the consent of the Investigator\n14. Subject is willing to take one of the following insulins and can financially afford to use either of the 2 insulin preparations throughout the course of the study (i.e. co-payments for insulin with insurance or able to pay full amount)\n\n    1. Humalog\u00ae (insulin lispro injection)\n    2. NovoLog\u00ae (insulin aspart)\n\nExclusion Criteria:\n\n1. Subject participated in any Closed Loop study in the past.\n2. Subject is unable to tolerate tape adhesive in the area of sensor placement\n3. Subject has any unresolved adverse skin condition in the area of sensor placement (e.g., psoriasis, rash, Staphylococcus infection) or area of infusion set placement\n4. Women of child-bearing potential who have a positive pregnancy test at screening or plan to become pregnant during the course of the study\n5. Subject is being treated for hyperthyroidism at time of screening\n6. Subject has an abnormality (out of reference range) in thyroid-stimulating hormone (TSH) at time of screening visit. TSH is not required for subjects 2-13 years of age.\n7. Subject has taken any oral, injectable, or IV glucocorticoids within 8 weeks from time of screening visit, or plans to take any oral, injectable, or IV glucocorticoids during the course of the study.\n8. Subject is actively participating in an investigational study (drug or device) wherein he/she has received treatment from an investigational study drug or investigational study device in the last 2 weeks\n9. Subject is currently abusing illicit drugs or marijuana\n10. Subject is currently abusing prescription drugs\n11. Subject is currently abusing alcohol\n12. Subject is using pramlintide (Symlin), SGLT2 inhibitors, GLP agonists, biguanides, DPP-4 inhibitors or sulfonylureas at time of screening\n13. Subject is using hydroxyurea at the time of screening or plans to use it during the study\n14. Subject has a history of visual impairment which would not allow subject to participate in the study and perform all study procedures safely, as determined by the investigator\n15. Subject has a sickle cell disease, hemoglobinopathy; or has received red blood cell transfusion or erythropoietin within 3 months prior to time of screening\n16. Subject plans to receive red blood cell transfusion or erythropoietin over the course of study participation\n17. Subject diagnosed with current moderate to severe eating disorder such as anorexia or bulimia\n18. Subject has been diagnosed with chronic kidney disease requiring dialysis or resulting in chronic anemia\n19. Subjects who are currently being actively treated for cancer.\n20. Subject who is designated as a research staff member for this study",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "2 Years",
                "maximumAge": "80 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT",
                    "OLDER_ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Thomas Troub",
                        "role": "CONTACT",
                        "phone": "818-576-3142",
                        "email": "thomas.troub@medtronic.com"
                    },
                    {
                        "name": "Briggitte Marinos",
                        "role": "CONTACT",
                        "phone": "818-576-5373",
                        "email": "briggitte.s.marinos@medtronic.com"
                    }
                ],
                "locations": [
                    {
                        "facility": "Scripps Health System",
                        "status": "COMPLETED",
                        "city": "La Jolla",
                        "state": "California",
                        "zip": "92037",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 32.84727,
                            "lon": -117.2742
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "status": "COMPLETED",
                        "city": "Palo Alto",
                        "state": "California",
                        "zip": "94304",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 37.44188,
                            "lon": -122.14302
                        }
                    },
                    {
                        "facility": "Center of Excellence in Diabetes & Endocrinology",
                        "status": "ACTIVE_NOT_RECRUITING",
                        "city": "Sacramento",
                        "state": "California",
                        "zip": "95821",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.58157,
                            "lon": -121.4944
                        }
                    },
                    {
                        "facility": "Sansum Diabetes Research Institute",
                        "status": "COMPLETED",
                        "city": "Santa Barbara",
                        "state": "California",
                        "zip": "93105",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.42083,
                            "lon": -119.69819
                        }
                    },
                    {
                        "facility": "SoCal Diabetes",
                        "status": "COMPLETED",
                        "city": "Torrance",
                        "state": "California",
                        "zip": "90505",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.83585,
                            "lon": -118.34063
                        }
                    },
                    {
                        "facility": "Diablo Clinical Research",
                        "status": "COMPLETED",
                        "city": "Walnut Creek",
                        "state": "California",
                        "zip": "94598",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 37.90631,
                            "lon": -122.06496
                        }
                    },
                    {
                        "facility": "Barbara Davis Center",
                        "status": "COMPLETED",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Yale School of Medicine",
                        "status": "WITHDRAWN",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06511",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "University of South Florida Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Tampa",
                        "state": "Florida",
                        "zip": "33612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Janet Rodriguez",
                                "role": "CONTACT",
                                "phone": "813-974-5499",
                                "email": "janetrodriguez@health.usf.edu"
                            },
                            {
                                "name": "Dorothy Shulman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 27.94752,
                            "lon": -82.45843
                        }
                    },
                    {
                        "facility": "Atlanta Diabetes Associates",
                        "status": "COMPLETED",
                        "city": "Atlanta",
                        "state": "Georgia",
                        "zip": "30318",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.749,
                            "lon": -84.38798
                        }
                    },
                    {
                        "facility": "Endocrine Research Solutions",
                        "status": "COMPLETED",
                        "city": "Roswell",
                        "state": "Georgia",
                        "zip": "30076",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.02316,
                            "lon": -84.36159
                        }
                    },
                    {
                        "facility": "Rocky Mountain Diabetes",
                        "status": "RECRUITING",
                        "city": "Idaho Falls",
                        "state": "Idaho",
                        "zip": "93404",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Joanne Malone",
                                "role": "CONTACT",
                                "phone": "208-522-6005",
                                "email": "joann@idahomed.com"
                            },
                            {
                                "name": "David Liljenquist, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.46658,
                            "lon": -112.03414
                        }
                    },
                    {
                        "facility": "Indiana University Health Riley Hospital for Children",
                        "status": "COMPLETED",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "IDERC",
                        "status": "ACTIVE_NOT_RECRUITING",
                        "city": "Des Moines",
                        "state": "Iowa",
                        "zip": "50265",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.60054,
                            "lon": -93.60911
                        }
                    },
                    {
                        "facility": "University of Michigan",
                        "status": "COMPLETED",
                        "city": "Ann Arbor",
                        "state": "Michigan",
                        "zip": "48109",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 42.27756,
                            "lon": -83.74088
                        }
                    },
                    {
                        "facility": "Grunberger Diabetes Institute",
                        "status": "COMPLETED",
                        "city": "Bloomfield Hills",
                        "state": "Michigan",
                        "zip": "48302",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 42.58364,
                            "lon": -83.24549
                        }
                    },
                    {
                        "facility": "Initernational Diabetes Center",
                        "status": "COMPLETED",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55416",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "International Diabetes Center",
                        "status": "ACTIVE_NOT_RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55416",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "Mayo Clinic",
                        "status": "COMPLETED",
                        "city": "Rochester",
                        "state": "Minnesota",
                        "zip": "55905",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 44.02163,
                            "lon": -92.4699
                        }
                    },
                    {
                        "facility": "Washington University St. Louis",
                        "status": "COMPLETED",
                        "city": "Saint Louis",
                        "state": "Missouri",
                        "zip": "63110",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.62727,
                            "lon": -90.19789
                        }
                    },
                    {
                        "facility": "SUNY Upstate Medical University",
                        "status": "COMPLETED",
                        "city": "Syracuse",
                        "state": "New York",
                        "zip": "13210",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 43.04812,
                            "lon": -76.14742
                        }
                    },
                    {
                        "facility": "Sanford Health",
                        "status": "COMPLETED",
                        "city": "Sioux Falls",
                        "state": "South Dakota",
                        "zip": "57104",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 43.54997,
                            "lon": -96.70033
                        }
                    },
                    {
                        "facility": "Texas Diabetes & Endocrinology",
                        "status": "COMPLETED",
                        "city": "Austin",
                        "state": "Texas",
                        "zip": "78731",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 30.26715,
                            "lon": -97.74306
                        }
                    },
                    {
                        "facility": "Texas Children's Hospital / Baylor University",
                        "status": "WITHDRAWN",
                        "city": "Houston",
                        "state": "Texas",
                        "zip": "77030",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 29.76328,
                            "lon": -95.36327
                        }
                    },
                    {
                        "facility": "Diabetes and Glandular Disease Clinic, P.A.",
                        "status": "RECRUITING",
                        "city": "San Antonio",
                        "state": "Texas",
                        "zip": "78229",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Terri Ryan",
                                "role": "CONTACT",
                                "phone": "210-614-8612",
                                "email": "terri.ryan@dgdclinic.com"
                            },
                            {
                                "name": "Mark S Kipnes, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.42412,
                            "lon": -98.49363
                        }
                    },
                    {
                        "facility": "Rainier Clinical Research",
                        "status": "COMPLETED",
                        "city": "Renton",
                        "state": "Washington",
                        "zip": "98057",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 47.48288,
                            "lon": -122.21707
                        }
                    },
                    {
                        "facility": "University of Washington",
                        "status": "COMPLETED",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98105",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    },
                    {
                        "facility": "Westminster Endocrine & Diabetes Research Society",
                        "status": "COMPLETED",
                        "city": "New Westminster",
                        "state": "British Columbia",
                        "zip": "V3L 3W5",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 49.20678,
                            "lon": -122.91092
                        }
                    },
                    {
                        "facility": "Children's Hospital of Eastern Ontario",
                        "status": "COMPLETED",
                        "city": "Ottawa",
                        "zip": "K1H 8L1",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.41117,
                            "lon": -75.69812
                        }
                    },
                    {
                        "facility": "H\u00f4pital Necker Enfants Malades",
                        "status": "COMPLETED",
                        "city": "Paris",
                        "zip": "75015",
                        "country": "France",
                        "geoPoint": {
                            "lat": 48.85341,
                            "lon": 2.3488
                        }
                    },
                    {
                        "facility": "HCL - Lyon Sud",
                        "status": "COMPLETED",
                        "city": "Pierre-B\u00e9nite",
                        "zip": "69495",
                        "country": "France",
                        "geoPoint": {
                            "lat": 45.7009,
                            "lon": 4.82511
                        }
                    },
                    {
                        "facility": "Diabeteszentrum f\u00fcr Kinder und Jugendliche, Kinder- und Jugendkrankenhaus Auf der Bult",
                        "status": "COMPLETED",
                        "city": "Hannover",
                        "zip": "30173",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 52.37052,
                            "lon": 9.73322
                        }
                    },
                    {
                        "facility": "A.S.S.T. Spedali Civili",
                        "status": "COMPLETED",
                        "city": "Brescia",
                        "zip": "25028",
                        "country": "Italy",
                        "geoPoint": {
                            "lat": 45.53558,
                            "lon": 10.21472
                        }
                    },
                    {
                        "facility": "New Zealand Clinical Research",
                        "status": "RECRUITING",
                        "city": "Christchurch",
                        "zip": "8011",
                        "country": "New Zealand",
                        "contacts": [
                            {
                                "name": "Antony Watson",
                                "role": "CONTACT",
                                "email": "antony.watson@otago.ac.nz"
                            },
                            {
                                "name": "Martin de Bock, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -43.53333,
                            "lon": 172.63333
                        }
                    },
                    {
                        "facility": "Dunedin Public Hospital",
                        "status": "RECRUITING",
                        "city": "Dunedin",
                        "zip": "9016",
                        "country": "New Zealand",
                        "contacts": [
                            {
                                "name": "Alisa Boucsein",
                                "role": "CONTACT",
                                "email": "a.boucsein@otago.ac.nz"
                            },
                            {
                                "name": "Benjamin Wheeler, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -45.87416,
                            "lon": 170.50361
                        }
                    },
                    {
                        "facility": "Hospital Universitario Virgen del Roc\u00edo",
                        "status": "COMPLETED",
                        "city": "Sevilla",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 37.38283,
                            "lon": -5.97317
                        }
                    },
                    {
                        "facility": "Dept Internal Medicine, \u00d6rebro University Hospital",
                        "status": "COMPLETED",
                        "city": "\u00d6rebro",
                        "zip": "SE-70185",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 59.27412,
                            "lon": 15.2066
                        }
                    },
                    {
                        "facility": "Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital",
                        "status": "COMPLETED",
                        "city": "Cambridge",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 52.2,
                            "lon": 0.11667
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "NO"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Type 1 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000007328",
                        "term": "Insulin"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000007004",
                        "term": "Hypoglycemic Agents"
                    },
                    {
                        "id": "D000045505",
                        "term": "Physiological Effects of Drugs"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M10365",
                        "name": "Insulin",
                        "asFound": "Day 1",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M173166",
                        "name": "Insulin, Globin Zinc",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10054",
                        "name": "Hypoglycemic Agents",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Hypo",
                        "name": "Hypoglycemic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT05594563",
                "orgStudyIdInfo": {
                    "id": "4-SRA-2022-1205-M-B"
                },
                "organization": {
                    "fullName": "Indiana University",
                    "class": "OTHER"
                },
                "briefTitle": "TArgeting Type 1 Diabetes Using POLyamines (TADPOL)",
                "officialTitle": "TArgeting Type 1 Diabetes Using POLyamines (TADPOL): A Randomized, Double-Masked, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Difluoromethylornithine (DFMO) to Preserve Insulin Production in Type 1 Diabetes",
                "acronym": "TADPOL"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-05",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2023-03-14",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2027-12",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2027-12",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2022-10-12",
                "studyFirstSubmitQcDate": "2022-10-21",
                "studyFirstPostDateStruct": {
                    "date": "2022-10-26",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-05-30",
                "lastUpdatePostDateStruct": {
                    "date": "2024-05-31",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR_INVESTIGATOR",
                    "investigatorFullName": "Emily K. Sims",
                    "investigatorTitle": "Associate Professor of Pediatrics",
                    "investigatorAffiliation": "Indiana University School of Medicine"
                },
                "leadSponsor": {
                    "name": "Emily K. Sims",
                    "class": "OTHER"
                },
                "collaborators": [
                    {
                        "name": "Juvenile Diabetes Research Foundation",
                        "class": "OTHER"
                    },
                    {
                        "name": "Cancer Prevention Pharmaceuticals, Inc.",
                        "class": "INDUSTRY"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\\[s\\] it aims to answer are:\n\n* Does it reduce stress on the cells that make insulin?\n* Does it preserve what is left of the body's insulin production? Participants will take either DFMO or a placebo (looks like DFMO but has no active ingredients) two times a day for about 6 months. Participants will have 6 in person visits and 1 phone visit over a period of 12 months. Visits will include blood draws urine collection and other tests.",
                "detailedDescription": "This study will be a multicenter, double-blind, placebo-controlled, 2:1 random assigned, phase II clinical trial for individuals with recent onset type 1 diabetes. The investigators are conducting a double masked placebo-controlled intention to treat study enrolling persons with new onset T1D with documented continued residual C-peptide production. Within 45 days of screening and a run-in period during which eligibility will be determined and glycemic control optimized, subjects will have a 6-month double-masked treatment period with either DFMO or placebo. After a 6-month wash-out period the durability of effect will be assessed. Subjects will be randomly assigned either 1000mg/m2/day oral DFMO or placebo treatment at a 2:1 ratio."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 1 Diabetes"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE2"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "interventionModelDescription": "Subject are randomized to either treatment or placebo arm.",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "TRIPLE",
                        "maskingDescription": "Participant, Care provider and Investigator blinded",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 70,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Treatment Arm",
                        "type": "ACTIVE_COMPARATOR",
                        "description": "Difluoromethylornithine (DFMO) pill ,1000mg/m2/day, for 6 months",
                        "interventionNames": [
                            "Drug: DFMO"
                        ]
                    },
                    {
                        "label": "Placebo Arm",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "Placebo pill taken twice a day orally for 6 months",
                        "interventionNames": [
                            "Drug: Placebo"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "DFMO",
                        "description": "DFMO orally twice a day",
                        "armGroupLabels": [
                            "Treatment Arm"
                        ],
                        "otherNames": [
                            "Difluoromethylornithine"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Placebo",
                        "description": "Placebo orally twice a day",
                        "armGroupLabels": [
                            "Placebo Arm"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Clinical efficacy of 1000 mg/m2/day of oral DFMO after 6 months of treatment",
                        "description": "Primary endpoint defining clinical efficacy will be based on mixed-meal stimulated C-peptide area under the curve (AUC; in arbitrary units) in the treatment group compared to placebo after 6 months of DFMO treatment",
                        "timeFrame": "6 month"
                    },
                    {
                        "measure": "Number of participants with treatment-related adverse events as assessed by CTCAE v5",
                        "description": "A summary of serious and non-serious adverse events (AEs) will be reported.",
                        "timeFrame": "through study completion, an average of one year"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Clinical efficacy of 1000 mg/m2/day of oral DFMO after 3 months of treatment, 9 months after treatment (or 3 months after treatment end), and 12 months after treatment (or 6 months after treatment end).",
                        "description": "Secondary endpoints will be based on mixed meal stimulated C-peptide AUC (arbitrary units) at 3 months after treatment, 9 months after treatment, and 12 months after treatment.",
                        "timeFrame": "through study completion, an average of one year"
                    },
                    {
                        "measure": "Decrease in urinary polyamides after 6 months of DFMO treatment.",
                        "description": "Decrease in urinary putrescine (in umol/g Cr) from baseline after 6 months of DFMO treatment, measured using high performance liquid chromatography.",
                        "timeFrame": "up to 24 weeks after treatment"
                    },
                    {
                        "measure": "Biomarkers of \u03b2 cell stress at 3, 6, 9, and 12 months after treatment.",
                        "description": "Fasting and stimulated proinsulin/c-peptide ratios (%) will be measured using immunoassays and reported at baseline, 3 months after treatment, 6 months after treatment, 9 months after treatment, and 12 months after treatment.",
                        "timeFrame": "through study completion, an average of one year"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Males and females 6- \u226540 years of age with a clinical diagnosis of T1D\n2. T1D clinical diagnosis with insulin start date no more than 100 days prior to the time of randomization\n3. Random non-fasting C-peptide level of \\>0.2 pmol/mL (equivalent to \\>0.6ng/ml) at screening.\n4. Positive for any one of the following diabetes-related autoantibodies (IAA, GAA, IA-2, or ZnT8)\n5. Treatment na\u00efve of any immunomodulatory agent\n6. Normal hearing at screening, defined as acceptable results of pure-tone audiometry (\\<20 decibel \\[dB\\] baseline thresholds for frequencies 250, 500, 1000, and 2000 Hz\n\nExclusion Criteria:\n\n1. Presence of severe, active disease that interferes with dietary intake or requires the use of chronic medication, with the exception of well-controlled hypothyroidism and mild asthma not requiring oral steroids. Presence of any psychiatric disorder that will affect ability to participate in study.\n2. Diabetes other than T1D\n3. Chronic illness known to affect glucose metabolism (e.g. Cushing syndrome, polycystic ovarian disorder, cystic fibrosis) or taking medications that affect glucose metabolism (e.g. steroids, metformin)\n4. Inability to swallow pills\n5. Psychiatric impairment or current use of anti-psychotic medication\n6. Any condition that, in the investigator's opinion, may compromise study participation or may confound the interpretation of the study results.\n7. Neutropenia (\\< 1,500 neutrophils/\u03bcL)\n8. Leukopenia (\\< 3,000 leukocytes /\u03bcL)\n9. Lymphopenia ( \\< 800 lymphocytes/\u03bcL)\n10. Thrombocytopenia (\\<100,000 platelets/\u03bcL)\n11. Clinically significant anemia or Hemoglobin as defined below:\n\n    In Adults: Hgb \\<12.0g/dL in females and \\<13.0g/dL in males In Children: 12- \\<18: \\<11.4 g/dL in females and \\<12.4 g/dL in males In Children: 6- \\<12: Hgb \\<11.2 g/dL\n12. Impaired renal function (assessed by history and BUN/Creatinine, DFMO is renally excreted)\n13. Allergy to milk or soy (components of Boost\u00ae drink used for mixed meal tolerance testing)\n14. Female participants of child-bearing age with reproductive potential, must not be pregnant and agree to use 2 effective forms of birth control or be abstinent during the study period (see below). Male participants (including men who have had vasectomies) whose partners are pregnant or may be pregnant should use condoms while on study drug, until 2 weeks after discontinuation of drug, while the partner is pregnant.\n15. Active seizure disorder, defined as requiring chronic medication at the time of study or having had a seizure within the past 12 months at the time of screening\n16. Enrollment into another intervention trial.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "4 Years",
                "maximumAge": "40 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Maria L Spall, BSN",
                        "role": "CONTACT",
                        "phone": "317-278-7034",
                        "email": "malnicho@iu.edu"
                    },
                    {
                        "name": "Operations Manager",
                        "role": "CONTACT",
                        "phone": "317-278-8879",
                        "email": "tadpol@iu.edu"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Emily K Sims, MD,MS",
                        "affiliation": "Indiana University School of Medicine",
                        "role": "STUDY_CHAIR"
                    }
                ],
                "locations": [
                    {
                        "facility": "Barbara Davis Center",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lexie Chesshir, RN",
                                "role": "CONTACT",
                                "phone": "303-724-1755",
                                "email": "lexie.chesshir@cuanschutz.edu"
                            },
                            {
                                "name": "Kimber Simmons, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "University of Chicago",
                        "status": "RECRUITING",
                        "city": "Chicago",
                        "state": "Illinois",
                        "zip": "60637",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Triniece Pearson, PhD,RN",
                                "role": "CONTACT",
                                "phone": "773-359-7556",
                                "email": "tpearson1@medicine.bsd.uchicago.edu"
                            },
                            {
                                "name": "Siri Greeley, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.85003,
                            "lon": -87.65005
                        }
                    },
                    {
                        "facility": "IU Health Riley Hospital for Children",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Moreau M Ryan",
                                "role": "CONTACT",
                                "phone": "317-278-7037",
                                "email": "elmryan@iu.edu"
                            },
                            {
                                "name": "T1D Research",
                                "role": "CONTACT",
                                "phone": "317-278-8879",
                                "email": "tadpol@iu.edu"
                            },
                            {
                                "name": "Emily K Sims, MD, MS",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Linda A DiMeglio, MD, MPH",
                                "role": "SUB_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Kansas",
                        "zip": "64108",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Britt Schmalzbach, RN",
                                "role": "CONTACT",
                                "phone": "816-460-1097",
                                "email": "endoclinicaltrials@cmh.edu"
                            },
                            {
                                "name": "Mark Clements, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.11417,
                            "lon": -94.62746
                        }
                    },
                    {
                        "facility": "University of Michigan",
                        "status": "RECRUITING",
                        "city": "Ann Arbor",
                        "state": "Michigan",
                        "zip": "48109",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Aimee Katona",
                                "role": "CONTACT",
                                "phone": "734-615-4079",
                                "email": "PEDS-ENDO-DM-Research@med.umich.edu"
                            },
                            {
                                "name": "Inas Thomas, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.27756,
                            "lon": -83.74088
                        }
                    },
                    {
                        "facility": "Medical College of Wisconsin",
                        "status": "RECRUITING",
                        "city": "Milwaukee",
                        "state": "Wisconsin",
                        "zip": "53226",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Joanne Kramer, BS",
                                "role": "CONTACT",
                                "phone": "414-955-8486",
                                "email": "T1Dinfo@mcw.edu"
                            },
                            {
                                "name": "Susanne Cabrera, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.0389,
                            "lon": -87.90647
                        }
                    }
                ]
            },
            "referencesModule": {
                "references": [
                    {
                        "pmid": "22116709",
                        "type": "BACKGROUND",
                        "citation": "Brooks WH. Autoimmune diseases and polyamines. Clin Rev Allergy Immunol. 2012 Feb;42(1):58-70. doi: 10.1007/s12016-011-8290-y."
                    },
                    {
                        "pmid": "15221502",
                        "type": "BACKGROUND",
                        "citation": "Seiler N. Catabolism of polyamines. Amino Acids. 2004 Jun;26(3):217-33. doi: 10.1007/s00726-004-0070-z. Epub 2004 Apr 20."
                    },
                    {
                        "pmid": "23221207",
                        "type": "BACKGROUND",
                        "citation": "Jeter JM, Alberts DS. Difluoromethylornithine: the proof is in the polyamines. Cancer Prev Res (Phila). 2012 Dec;5(12):1341-4. doi: 10.1158/1940-6207.CAPR-12-0429."
                    },
                    {
                        "pmid": "20670594",
                        "type": "BACKGROUND",
                        "citation": "Maier B, Tersey SA, Mirmira RG. Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med. 2010 Jul;10(50):18-23."
                    },
                    {
                        "pmid": "7632663",
                        "type": "BACKGROUND",
                        "citation": "Bardocz S, Duguid TJ, Brown DS, Grant G, Pusztai A, White A, Ralph A. The importance of dietary polyamines in cell regeneration and growth. Br J Nutr. 1995 Jun;73(6):819-28. doi: 10.1079/bjn19950087."
                    },
                    {
                        "pmid": "21460598",
                        "type": "BACKGROUND",
                        "citation": "Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011;60(1):10-6. doi: 10.2302/kjm.60.10."
                    },
                    {
                        "pmid": "1438532",
                        "type": "BACKGROUND",
                        "citation": "McCann PP, Pegg AE. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992;54(2):195-215. doi: 10.1016/0163-7258(92)90032-u."
                    },
                    {
                        "pmid": "20127992",
                        "type": "RESULT",
                        "citation": "Hong SK, Chaturvedi R, Piazuelo MB, Coburn LA, Williams CS, Delgado AG, Casero RA Jr, Schwartz DA, Wilson KT. Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity. Inflamm Bowel Dis. 2010 Sep;16(9):1557-66. doi: 10.1002/ibd.21224."
                    },
                    {
                        "pmid": "20501948",
                        "type": "RESULT",
                        "citation": "Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest. 2010 Jun;120(6):2156-70. doi: 10.1172/JCI38924. Epub 2010 May 24."
                    },
                    {
                        "pmid": "21389784",
                        "type": "RESULT",
                        "citation": "Templin AT, Maier B, Nishiki Y, Tersey SA, Mirmira RG. Deoxyhypusine synthase haploinsufficiency attenuates acute cytokine signaling. Cell Cycle. 2011 Apr 1;10(7):1043-9. doi: 10.4161/cc.10.7.15206. Epub 2011 Apr 1."
                    },
                    {
                        "pmid": "20405312",
                        "type": "RESULT",
                        "citation": "Bjelakovic G, Beninati S, Bjelakovic B, Sokolovic D, Jevtovic T, Stojanovic I, Rossi S, Tabolacci C, Kocic G, Pavlovic D, Saranac Lj, Zivic S. Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus? Mol Cell Biochem. 2010 Aug;341(1-2):79-85. doi: 10.1007/s11010-010-0439-0. Epub 2010 Apr 20."
                    },
                    {
                        "pmid": "23250488",
                        "type": "RESULT",
                        "citation": "Nishiki Y, Adewola A, Hatanaka M, Templin AT, Maier B, Mirmira RG. Translational control of inducible nitric oxide synthase by p38 MAPK in islet beta-cells. Mol Endocrinol. 2013 Feb;27(2):336-49. doi: 10.1210/me.2012-1230. Epub 2012 Dec 18."
                    },
                    {
                        "pmid": "19968980",
                        "type": "RESULT",
                        "citation": "Higashi K, Yoshida M, Igarashi A, Ito K, Wada Y, Murakami S, Kobayashi D, Nakano M, Sohda M, Nakajima T, Narita I, Toida T, Kashiwagi K, Igarashi K. Intense correlation between protein-conjugated acrolein and primary Sjogren's syndrome. Clin Chim Acta. 2010 Mar;411(5-6):359-63. doi: 10.1016/j.cca.2009.11.032. Epub 2009 Dec 5."
                    },
                    {
                        "pmid": "8295175",
                        "type": "RESULT",
                        "citation": "Furumitsu Y, Yukioka K, Kojima A, Yukioka M, Shichikawa K, Ochi T, Matsui-Yuasa I, Otani S, Nishizawa Y, Morii H. Levels of urinary polyamines in patients with rheumatoid arthritis. J Rheumatol. 1993 Oct;20(10):1661-5."
                    },
                    {
                        "pmid": "10852253",
                        "type": "RESULT",
                        "citation": "Furumitsu Y, Yukioka K, Yukioka M, Ochi T, Morishima Y, Matsui-Yuasa I, Otani S, Inaba M, Nishizawa Y, Morii H. Interleukin-1beta induces elevation of spermidine/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis. J Rheumatol. 2000 Jun;27(6):1352-7."
                    },
                    {
                        "pmid": "17524725",
                        "type": "RESULT",
                        "citation": "Zoumas-Morse C, Rock CL, Quintana EL, Neuhouser ML, Gerner EW, Meyskens FL Jr. Development of a polyamine database for assessing dietary intake. J Am Diet Assoc. 2007 Jun;107(6):1024-7. doi: 10.1016/j.jada.2007.03.012."
                    },
                    {
                        "pmid": "11564949",
                        "type": "RESULT",
                        "citation": "Milovic V. Polyamines in the gut lumen: bioavailability and biodistribution. Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1021-5. doi: 10.1097/00042737-200109000-00004."
                    },
                    {
                        "pmid": "19763038",
                        "type": "RESULT",
                        "citation": "Soda K, Kano Y, Sakuragi M, Takao K, Lefor A, Konishi F. Long-term oral polyamine intake increases blood polyamine concentrations. J Nutr Sci Vitaminol (Tokyo). 2009 Aug;55(4):361-6. doi: 10.3177/jnsv.55.361."
                    },
                    {
                        "pmid": "11208527",
                        "type": "RESULT",
                        "citation": "Sjoholm A, Arkhammar P, Berggren PO, Andersson A. Polyamines in pancreatic islets of obese-hyperglycemic (ob/ob) mice of different ages. Am J Physiol Cell Physiol. 2001 Feb;280(2):C317-23. doi: 10.1152/ajpcell.2001.280.2.C317."
                    },
                    {
                        "pmid": "8408643",
                        "type": "RESULT",
                        "citation": "Sjoholm A, Arkhammar P, Welsh N, Bokvist K, Rorsman P, Hallberg A, Nilsson T, Welsh M, Berggren PO. Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity. J Clin Invest. 1993 Oct;92(4):1910-7. doi: 10.1172/JCI116784."
                    },
                    {
                        "pmid": "18176934",
                        "type": "RESULT",
                        "citation": "Roy UK, Rial NS, Kachel KL, Gerner EW. Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis. Mol Carcinog. 2008 Jul;47(7):538-53. doi: 10.1002/mc.20414."
                    },
                    {
                        "pmid": "12972423",
                        "type": "RESULT",
                        "citation": "Belting M, Mani K, Jonsson M, Cheng F, Sandgren S, Jonsson S, Ding K, Delcros JG, Fransson LA. Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide. J Biol Chem. 2003 Nov 21;278(47):47181-9. doi: 10.1074/jbc.M308325200. Epub 2003 Sep 11."
                    },
                    {
                        "pmid": "10024506",
                        "type": "RESULT",
                        "citation": "Belting M, Persson S, Fransson LA. Proteoglycan involvement in polyamine uptake. Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):317-23."
                    },
                    {
                        "pmid": "18360702",
                        "type": "RESULT",
                        "citation": "Welch JE, Bengtson P, Svensson K, Wittrup A, Jenniskens GJ, Ten Dam GB, Van Kuppevelt TH, Belting M. Single chain fragment anti-heparan sulfate antibody targets the polyamine transport system and attenuates polyamine-dependent cell proliferation. Int J Oncol. 2008 Apr;32(4):749-56."
                    },
                    {
                        "pmid": "16714282",
                        "type": "RESULT",
                        "citation": "Nevins AK, Thurmond DC. Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. J Biol Chem. 2006 Jul 14;281(28):18961-72. doi: 10.1074/jbc.M603604200. Epub 2006 May 19."
                    },
                    {
                        "pmid": "19997760",
                        "type": "RESULT",
                        "citation": "Park MH, Nishimura K, Zanelli CF, Valentini SR. Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids. 2010 Feb;38(2):491-500. doi: 10.1007/s00726-009-0408-7. Epub 2009 Dec 8."
                    },
                    {
                        "pmid": "20956533",
                        "type": "RESULT",
                        "citation": "Robbins RD, Tersey SA, Ogihara T, Gupta D, Farb TB, Ficorilli J, Bokvist K, Maier B, Mirmira RG. Inhibition of deoxyhypusine synthase enhances islet beta cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem. 2010 Dec 17;285(51):39943-52. doi: 10.1074/jbc.M110.170142. Epub 2010 Oct 18."
                    },
                    {
                        "pmid": "7895500",
                        "type": "RESULT",
                        "citation": "Packham G, Cleveland JL. The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr Top Microbiol Immunol. 1995;194:283-90. doi: 10.1007/978-3-642-79275-5_33."
                    },
                    {
                        "pmid": "22442300",
                        "type": "RESULT",
                        "citation": "Tersey SA, Nishiki Y, Templin AT, Cabrera SM, Stull ND, Colvin SC, Evans-Molina C, Rickus JL, Maier B, Mirmira RG. Islet beta-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes. 2012 Apr;61(4):818-27. doi: 10.2337/db11-1293."
                    },
                    {
                        "pmid": "26397425",
                        "type": "RESULT",
                        "citation": "Watkins RA, Evans-Molina C, Terrell JK, Day KH, Guindon L, Restrepo IA, Mirmira RG, Blum JS, DiMeglio LA. Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes. Transl Res. 2016 Feb;168:96-106.e1. doi: 10.1016/j.trsl.2015.08.010. Epub 2015 Sep 4."
                    },
                    {
                        "pmid": "15972654",
                        "type": "RESULT",
                        "citation": "Soda K, Kano Y, Nakamura T, Kasono K, Kawakami M, Konishi F. Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J Immunol. 2005 Jul 1;175(1):237-45. doi: 10.4049/jimmunol.175.1.237."
                    },
                    {
                        "pmid": "10433086",
                        "type": "RESULT",
                        "citation": "Hsu HC, Thomas T, Sigal LH, Thomas TJ. Polyamine-fas interactions: inhibition of polyamine biosynthesis in MRL-lpr/lpr mice is associated with the up-regulation of fas mRNA in thymocytes. Autoimmunity. 1999;29(4):299-309. doi: 10.3109/08916939908994750."
                    },
                    {
                        "pmid": "6422008",
                        "type": "RESULT",
                        "citation": "Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB. Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis. J Clin Oncol. 1984 Feb;2(2):124-30. doi: 10.1200/JCO.1984.2.2.124."
                    },
                    {
                        "pmid": "2891995",
                        "type": "RESULT",
                        "citation": "Pepin J, Milord F, Guern C, Schechter PJ. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness. Lancet. 1987 Dec 19;2(8573):1431-3. doi: 10.1016/s0140-6736(87)91131-7."
                    },
                    {
                        "pmid": "17214730",
                        "type": "RESULT",
                        "citation": "Wolf JE Jr, Shander D, Huber F, Jackson J, Lin CS, Mathes BM, Schrode K; Eflornithine HCl Study Group. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007 Jan;46(1):94-8. doi: 10.1111/j.1365-4632.2006.03079.x. No abstract available."
                    },
                    {
                        "pmid": "19188144",
                        "type": "RESULT",
                        "citation": "Gerner EW, Meyskens FL Jr. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res. 2009 Feb 1;15(3):758-61. doi: 10.1158/1078-0432.CCR-08-2235."
                    },
                    {
                        "pmid": "32391579",
                        "type": "RESULT",
                        "citation": "Lewis EC, Kraveka JM, Ferguson W, Eslin D, Brown VI, Bergendahl G, Roberts W, Wada RK, Oesterheld J, Mitchell D, Foley J, Zage P, Rawwas J, Rich M, Lorenzi E, Broglio K, Berry D, Saulnier Sholler GL. A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma. Int J Cancer. 2020 Dec 1;147(11):3152-3159. doi: 10.1002/ijc.33044. Epub 2020 May 24."
                    },
                    {
                        "pmid": "3093066",
                        "type": "RESULT",
                        "citation": "Bowlin TL, McKown BJ, Davis GF, Sunkara PS. Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice. Cancer Res. 1986 Nov;46(11):5494-8."
                    },
                    {
                        "pmid": "11815483",
                        "type": "RESULT",
                        "citation": "Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes. 2002 Feb;51 Suppl 1:S221-6. doi: 10.2337/diabetes.51.2007.s221."
                    },
                    {
                        "pmid": "34214479",
                        "type": "RESULT",
                        "citation": "Gitelman SE, Bundy BN, Ferrannini E, Lim N, Blanchfield JL, DiMeglio LA, Felner EI, Gaglia JL, Gottlieb PA, Long SA, Mari A, Mirmira RG, Raskin P, Sanda S, Tsalikian E, Wentworth JM, Willi SM, Krischer JP, Bluestone JA; Gleevec Trial Study Group. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2021 Aug;9(8):502-514. doi: 10.1016/S2213-8587(21)00139-X. Epub 2021 Jun 29."
                    },
                    {
                        "type": "RESULT",
                        "citation": "Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP: Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs. Journal of the American Chemical Society 1978;100:2551-2553"
                    },
                    {
                        "pmid": "1730582",
                        "type": "RESULT",
                        "citation": "Poulin R, Lu L, Ackermann B, Bey P, Pegg AE. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J Biol Chem. 1992 Jan 5;267(1):150-8."
                    },
                    {
                        "pmid": "3105526",
                        "type": "RESULT",
                        "citation": "Pegg AE, McGovern KA, Wiest L. Decarboxylation of alpha-difluoromethylornithine by ornithine decarboxylase. Biochem J. 1987 Jan 1;241(1):305-7. doi: 10.1042/bj2410305."
                    },
                    {
                        "pmid": "9719479",
                        "type": "RESULT",
                        "citation": "Selamnia M, Mayeur C, Robert V, Blachier F. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells. Biochem Pharmacol. 1998 Apr 15;55(8):1241-5. doi: 10.1016/s0006-2952(97)00572-8."
                    },
                    {
                        "pmid": "431333",
                        "type": "RESULT",
                        "citation": "Danzin C, Jung MJ, Grove J, Bey P. Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues. Life Sci. 1979 Feb 5;24(6):519-24. doi: 10.1016/0024-3205(79)90173-5. No abstract available."
                    },
                    {
                        "pmid": "6781187",
                        "type": "RESULT",
                        "citation": "Oredsson S, Anehus S, Heby O. Inhibition of cell proliferation by DL-alpha-difluoromethylornithine, a catalytic irreversible inhibitor of ornithine decarboxylase. Acta Chem Scand B. 1980;34(6):457-8. doi: 10.3891/acta.chem.scand.34b-0457. No abstract available."
                    },
                    {
                        "pmid": "8262968",
                        "type": "RESULT",
                        "citation": "Pena A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J Biol Chem. 1993 Dec 25;268(36):27277-85."
                    },
                    {
                        "pmid": "8356088",
                        "type": "RESULT",
                        "citation": "Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8. doi: 10.1073/pnas.90.16.7804."
                    },
                    {
                        "pmid": "3128541",
                        "type": "RESULT",
                        "citation": "Celano P, Baylin SB, Giardiello FM, Nelkin BD, Casero RA Jr. Effect of polyamine depletion on c-myc expression in human colon carcinoma cells. J Biol Chem. 1988 Apr 25;263(12):5491-4."
                    },
                    {
                        "pmid": "10605821",
                        "type": "RESULT",
                        "citation": "Tabib A, Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol. 1999 Nov;31(11):1289-95. doi: 10.1016/s1357-2725(99)00098-9."
                    },
                    {
                        "pmid": "21147316",
                        "type": "RESULT",
                        "citation": "Liu R, Jia Y, Cheng W, Ling J, Liu L, Bi K, Li Q. Determination of polyamines in human urine by precolumn derivatization with benzoyl chloride and high-performance liquid chromatography coupled with Q-time-of-flight mass spectrometry. Talanta. 2011 Jan 15;83(3):751-6. doi: 10.1016/j.talanta.2010.10.039. Epub 2010 Nov 11."
                    },
                    {
                        "pmid": "16011702",
                        "type": "RESULT",
                        "citation": "Ivanova A, Qaqish BF, Schell MJ. Continuous toxicity monitoring in phase II trials in oncology. Biometrics. 2005 Jun;61(2):540-5. doi: 10.1111/j.1541-0420.2005.00311.x."
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "NO"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Type 1 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000000518",
                        "term": "Eflornithine"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000000970",
                        "term": "Antineoplastic Agents"
                    },
                    {
                        "id": "D000014344",
                        "term": "Trypanocidal Agents"
                    },
                    {
                        "id": "D000000981",
                        "term": "Antiprotozoal Agents"
                    },
                    {
                        "id": "D000000977",
                        "term": "Antiparasitic Agents"
                    },
                    {
                        "id": "D000000890",
                        "term": "Anti-Infective Agents"
                    },
                    {
                        "id": "D000065108",
                        "term": "Ornithine Decarboxylase Inhibitors"
                    },
                    {
                        "id": "D000004791",
                        "term": "Enzyme Inhibitors"
                    },
                    {
                        "id": "D000045504",
                        "term": "Molecular Mechanisms of Pharmacological Action"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M10365",
                        "name": "Insulin",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M173166",
                        "name": "Insulin, Globin Zinc",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M3859",
                        "name": "Eflornithine",
                        "asFound": "Loxapine",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M4298",
                        "name": "Antiprotozoal Agents",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4294",
                        "name": "Antiparasitic Agents",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4214",
                        "name": "Anti-Infective Agents",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7951",
                        "name": "Enzyme Inhibitors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "T13",
                        "name": "Ornithine",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Hypo",
                        "name": "Hypoglycemic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    },
                    {
                        "abbrev": "Infe",
                        "name": "Anti-Infective Agents"
                    },
                    {
                        "abbrev": "ANeo",
                        "name": "Antineoplastic Agents"
                    },
                    {
                        "abbrev": "AA",
                        "name": "Amino Acids"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT04291703",
                "orgStudyIdInfo": {
                    "id": "TrialNet TN28"
                },
                "secondaryIdInfos": [
                    {
                        "id": "UC4DK117009",
                        "type": "NIH",
                        "link": "https://reporter.nih.gov/quickSearch/UC4DK117009"
                    }
                ],
                "organization": {
                    "fullName": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                },
                "briefTitle": "STOP-T1D Low-Dose (ATG)",
                "officialTitle": "Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D",
                "acronym": "TN28"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-05",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2023-11-01",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2028-12-31",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2029-12-31",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2020-02-26",
                "studyFirstSubmitQcDate": "2020-02-28",
                "studyFirstPostDateStruct": {
                    "date": "2020-03-02",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-05-24",
                "lastUpdatePostDateStruct": {
                    "date": "2024-05-28",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "A multi-center, placebo-controlled, double blind, 2:1 randomized control clinical trial testing low-dose ATG vs. placebo in subjects with a 2 year 50% risk of progression to stage 3 T1D.",
                "detailedDescription": "This study has an enrollment period of 4 years and once the enrollment phase has concluded, an additional two years of follow-up visits will be conducted for all participants. Participants enrolled in the first year of the study can expect to complete follow-up visits for approximately four additional years if progression to stage 3 (Type 1 Diabetes Onset) does not occur. Participant follow-up visits after the treatment phase of the study includes general assessments (medical history, physical exam, medications and adverse events) and laboratory assessments to determine current health status and glucose tolerance."
            },
            "conditionsModule": {
                "conditions": [
                    "Diabetes Mellitus, Type 1"
                ],
                "keywords": [
                    "TrialNet",
                    "T1D"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE2"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "interventionModelDescription": "Eligible study participants will be randomized in a 2:1 allocation to either ATG vs. placebo treatment arms by the TrialNet Coordinating Center at the baseline visit once eligibility has been confirmed. Randomization will be conducted using block randomization with variable block sizes with stratification on TrialNet study site and age group (\\< 12 years old vs. 12 years old or older). Subjects will be assigned a study randomization number corresponding to the treatment group assignment.",
                    "primaryPurpose": "PREVENTION",
                    "maskingInfo": {
                        "masking": "TRIPLE",
                        "maskingDescription": "The randomization method will be stratified by TrialNet study site. The participants will not be informed regarding the intervention assignment until the end of the study. The investigator and clinic personnel will also be masked as to study assignment. Laboratories performing assays for this protocol will be masked as to the identity of biological material to be studied.",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 101,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Antithymocyte globulin (ATG)",
                        "type": "EXPERIMENTAL",
                        "description": "Antithymocyte globulin (ATG) will be intravenously administered over two days, with a total of 2 infusion periods. The first infusion is given at baseline visit (day 1), the second is given the next day at baseline visit (day 2). Body weight at baseline (Day 0- admission for the ATG/placebo infusion) will be used in calculating the doses for all infusions. The first dose (0.5mg/kg) will be infused over a minimum of 4 hours, and the second dose (2mg/kg) over a minimum of 4 hours with a maximum infusion time for each infusion of 10 hours. The second dose should be given no less than 12 and no more than 30 hours from the start of the first infusion. The final prepared product is to be labeled to protect the blind. Infusions may be administered either in a hospital or outpatient setting at the investigator's or institutions discretion.",
                        "interventionNames": [
                            "Drug: Antithymocyte Globulin"
                        ]
                    },
                    {
                        "label": "Placebo",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "0.9% Sodium Chloride Injection USP (\"Normal\" saline) is to be dispensed as the placebo for this study. The placebo is to be prepared dispensing an infusion bag of 0.9% Sodium Chloride Injection USP (\"Normal\" saline) with no additives (no ATG, no premedications) and label the product to protect the blind. The placebo will also be administered over a minimum of 4 hours for the first and second doses with a maximum infusion time of 10 hours. The second dose of the placebo arm should be given no less than 12 and no more than 30 hours from the start of the first infusion. Infusions may be administered either in a hospital or outpatient setting at the investigator's or institutions discretion.",
                        "interventionNames": [
                            "Drug: Placebo (for ATG)"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Antithymocyte Globulin",
                        "description": "Thymoglobulin",
                        "armGroupLabels": [
                            "Antithymocyte globulin (ATG)"
                        ],
                        "otherNames": [
                            "Thymoglobulin"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Placebo (for ATG)",
                        "description": "Normal Saline administered by IV infusion to mimic ATG",
                        "armGroupLabels": [
                            "Placebo"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Progression to Stage 3 T1D",
                        "description": "The primary outcome is the elapsed time from random treatment assignment to the development of diabetes or time of last contact among those randomized",
                        "timeFrame": "5 years"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Willing to provide informed consent or have a parent or legal guardian provide informed consent when the subject is \\<18 years of age.\n2. Age greater than or equal to 6 and \\< 35 years\n3. At least two or more diabetes-related biochemical autoantibodies (mIAA, GADA, ICA, IA-2A, ZnT8A) present on the same sample. In the absence of other antibodies, ICA and GADA positivity alone will not suffice for eligibility in this trial.\n4. Weight greater than the 5th percentile for age and sex.\n5. BMI \\< 95th and \\> 5th percentile for age for those under age 18 years and \\< 30 and \\> 15 for adults (\u2265 18)\n6. ADA Stage 2 criteria\\* AND at least one of the following high-risk markers (occurring at the same visit) within 7 weeks (52 days) of randomization, defined below (for defining a 2-year 50% risk for progression to Stage 3 T1D):\n\n   a. HbA1c \u2265 5.7 and \\<6.5% b. Index60 \u2265 1.4 i. Index60 = 0.3695 \u00d7 (log fasting C-peptide \\[ng/mL\\]) + 0.0165 \u00d7 60-min glucose (mg/dL) - 0.3644 \u00d7 60-min C-peptide (ng/mL) c. DPTRS \u2265 7.4 DPTRS = (1.57 x log BMI) - (0.06 x age) + (0.81 x glucose sum from 30 to 120 min/100) - (0.85 x C-peptide sum from 30 to 120 min/10) + (0.48 x log fasting C-peptide)\n\n   \\*Dysglycemia is defined as 2-hr glucose \u2265 140 and \\<200 mg/dL or fasting glucose \u2265 110 and \\<126 or 30, 60, or 90 minute glucose \u2265 200 mg/dL from OGTT\n7. All subjects must be CMV and EBV PCR negative within 30 days of randomization and may not have had signs or symptoms of a CMV or EBV-compatible illness lasting longer than 7 days within 30 days of randomization\n8. Seated blood pressure less than 130/80 mmHg for participants \u2265 18 years. For participants \\< 18 years seated blood pressure less than 95th percentile for age, sex and height.\n9. Be at least 4 weeks from last live immunization\n10. Participants are required to receive non-live influenza vaccination at least 2 weeks prior to randomization when vaccine for the current or upcoming flu season is available.\n11. Participants must also have a negative COVID-19 test within 7 days of the first day of treatment if otherwise eligible\n12. Willingness to comply with study directed social distancing and protection from SARS-Cov-2 infection.\n13. Be willing to forgo vaccines (other than killed influenza) during the 3 months after study drug treatment period (Days 0 and 1)\n14. Be up to date on all recommended vaccinations based on age of subject\\*\n15. With the exception of stage 2 T1D, subjects must be healthy, as defined by absence of any other untreated diagnoses that the protocol committee deems to be a potential confounder.\n16. If a female participant with reproductive potential, willing to avoid pregnancy (abstinence or adequate contraceptive method) through the completion of the study infusions and up to 3 months after study drug administration and undergo pregnancy testing prior to each study visit.\n17. Must be residing or have accommodations within 1 hour of the infusion site during the two days of study drug infusions and must be within 1 hour of a medical care facility for 1 day after completion of infusion 2.\n18. Participants must live in a location with rapid access to emergency medical services.\n\n    * Adult participants must be fully immunized. Pediatric participants who have not completed their primary vaccination schedule must receive all vaccinations allowable per the national/country-specific immunization guidelines for their current age prior to study drug delivery. Any remaining vaccinations should be given and continue per the schedule at least 3 months after study drug is administered. For COVID-19 vaccination, all participants will be strongly encouraged to be up-to-date with COVID-19 vaccine(s) as indicated by country-specific guidelines at least 2 weeks prior to randomization.\n\nExclusion Criteria:\n\n1. Immunodeficiency or clinically significant chronic lymphopenia: (Leukopenia (\\< 3,000 leukocytes /\u03bcL), neutropenia (\\<1,500 neutrophils/\u03bcL), lymphopenia (\\<800 lymphocytes/\u03bcL), thrombocytopenia (\\<100,000 platelets/\u03bcL).\n2. Hemoglobin less than 13.5 g/dL for adult men and less than 12 g/dL for adult females and less than 11 g/dL for participants under age 18\n3. Active signs or symptoms of acute infection at the time of randomization including SARS-Cov-2.\n4. Uncontrolled autoimmune thyroid disease and/or celiac disease (participants must be well controlled for the previous 6 months).\n5. Evidence of prior or current tuberculosis infection as assessed interferon gamma release assay (QuantiFERON).\n6. Currently pregnant or lactating or anticipate getting pregnant within the study period.\n7. Require use of other immunosuppressive agents including chronic use of systemic steroids.\n8. Evidence of current or past HIV or Hepatitis B or current Hepatitis C infection.\n9. Any complicating medical issues or abnormal clinical laboratory results that may interfere with study conduct, or cause increased risk to include pre-existing cardiac disease, COPD, sickle cell disease, neurological disease, or blood count abnormalities.\n10. A history of malignancies other than of skin.\n11. Evidence of liver dysfunction with AST or ALT outside of the reference range.\n12. Evidence of renal dysfunction with creatinine outside of the reference range.\n13. Increased bilirubin (total and direct) outside of the normal limit (Participants with documentation of Gilbert's Disease permitted).\n14. Vaccination with a live virus within the last 4 weeks.\n15. Current or ongoing use of non-insulin pharmaceuticals that affect glycemic control within 7 days of screening\n16. Prior treatment with Teplizumab (either in a previous clinical trial or clinically).\n17. Has participated in a clinical trial for diabetes prevention previously and received active study agent within 3 months of randomization.\n18. Known allergy to ATG or any product excipient\n19. Prior treatment with ATG or known allergy to rabbit-derived products or to any product excipient\n20. Prior adverse reactions to heparin.\n21. Any condition that in the investigator's opinion may adversely affect study participation will be reviewed by the Study Chair to ensure consistency and adjudicate whether or not the subject may compromise the study results\n22. Any screening/baseline laboratory result not otherwise stated out of normal reference range and/or medical history that may increase the risk of the subject's participation in this trial.\n23. Previously diagnosed with Stage 3 TID according to ADA criteria (see Appendix 3 for Criteria for diagnosis of diabetes)",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "6 Years",
                "maximumAge": "34 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Melissa A Parker, MHA",
                        "role": "CONTACT",
                        "phone": "8133969378",
                        "email": "MELISSA.PARKER@EPI.USF.EDU"
                    },
                    {
                        "name": "Ryan O'Donnell",
                        "role": "CONTACT",
                        "phone": "8133969551",
                        "email": "Ryan.O'Donnell@epi.usf.edu"
                    }
                ],
                "locations": [
                    {
                        "facility": "University of California - San Francisco",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94143",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Rebecca Wesch",
                                "role": "CONTACT",
                                "phone": "415-476-5984",
                                "email": "rebecca.wesch@ucsf.edu"
                            },
                            {
                                "name": "Karen Ko",
                                "role": "CONTACT",
                                "phone": "415-514-3730",
                                "email": "karen.ko@ucsf.edu"
                            },
                            {
                                "name": "Stephen Gitelman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "status": "RECRUITING",
                        "city": "Stanford",
                        "state": "California",
                        "zip": "94305",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Trudy Esrey",
                                "role": "CONTACT",
                                "phone": "650-498-4450",
                                "email": "tesrey@stanford.edu"
                            },
                            {
                                "name": "Darrell Wilson, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.42411,
                            "lon": -122.16608
                        }
                    },
                    {
                        "facility": "Barbara Davis Center at University of Colorado Anschutz Medical Campus",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Morgan Sooy, RN",
                                "role": "CONTACT",
                                "phone": "303-724-5686",
                                "email": "MORGAN.SOOY@CUANSCHUTZ.EDU"
                            },
                            {
                                "name": "Kimberly Simmons, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Yale University School of Medicine",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06511",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Marcia DeSousa",
                                "role": "CONTACT",
                                "phone": "203-737-4805",
                                "email": "marcia.desousa@yale.edu"
                            },
                            {
                                "name": "Jennifer L. Sherr, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "status": "RECRUITING",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32610",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Danielle Poulton",
                                "role": "CONTACT",
                                "phone": "352-294-5762",
                                "email": "danielle.poulton@peds.ufl.edu"
                            },
                            {
                                "name": "Jennifer Hosford",
                                "role": "CONTACT",
                                "phone": "352-294-5759",
                                "email": "jennifer.hosford@peds.ufl.edu"
                            },
                            {
                                "name": "Michael Haller, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "University of Miami",
                        "status": "RECRUITING",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33136",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Carlos Blaschke",
                                "role": "CONTACT",
                                "phone": "305-243-6616",
                                "email": "cblaschke@med.miami.edu"
                            },
                            {
                                "name": "David Baidal, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "University of South Florida Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Tampa",
                        "state": "Florida",
                        "zip": "33612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Juanita O'Brian",
                                "role": "CONTACT",
                                "phone": "813-974-9817",
                                "email": "jobrian@usf.edu"
                            },
                            {
                                "name": "Henry Rodriguez, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 27.94752,
                            "lon": -82.45843
                        }
                    },
                    {
                        "facility": "Emory Children's Center",
                        "status": "RECRUITING",
                        "city": "Atlanta",
                        "state": "Georgia",
                        "zip": "30322",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Xiaomiao Lan-Pidhainy",
                                "role": "CONTACT",
                                "phone": "404-712-0051",
                                "email": "xlanpid@emory.edu"
                            },
                            {
                                "name": "Andrew Muir, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.749,
                            "lon": -84.38798
                        }
                    },
                    {
                        "facility": "Indiana University - Riley Hospital for Children",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maria Spall",
                                "role": "CONTACT",
                                "phone": "317-278-8879",
                                "email": "malnicho@iu.edu"
                            },
                            {
                                "name": "Linda DiMeglio, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Children's Hospital of Iowa",
                        "status": "RECRUITING",
                        "city": "Iowa City",
                        "state": "Iowa",
                        "zip": "52242",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Carter Johnson",
                                "role": "CONTACT",
                                "phone": "319-335-7434",
                                "email": "carter-johnson-1@uiowa.edu"
                            },
                            {
                                "name": "Michael Tansey, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.66113,
                            "lon": -91.53017
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55455",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kali Johnson",
                                "role": "CONTACT",
                                "phone": "612-624-6682",
                                "email": "joh13933@umn.edu"
                            },
                            {
                                "name": "Toni Moran, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "The Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Missouri",
                        "zip": "64108",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Harding",
                                "role": "CONTACT",
                                "phone": "816-960-8985",
                                "email": "hrharding@cmh.edu"
                            },
                            {
                                "name": "Wayne Moore, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.09973,
                            "lon": -94.57857
                        }
                    },
                    {
                        "facility": "Columbia University-Naomi Berrie Diabetes Center",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10032",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kaisha Mofford",
                                "role": "CONTACT",
                                "phone": "212-851-5512",
                                "email": "km3870@cumc.columbia.edu"
                            },
                            {
                                "name": "Anabel Evans",
                                "role": "CONTACT",
                                "phone": "212 851 5492",
                                "email": "Ae2816@cumc.columbia.edu"
                            },
                            {
                                "name": "Robin Goland, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "University of Pittsburgh",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15224",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kelli DeLallo",
                                "role": "CONTACT",
                                "phone": "412-692-5210",
                                "email": "kelli.delallo@chp.edu"
                            },
                            {
                                "name": "Ingrid Libman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Prisma Health",
                        "status": "RECRUITING",
                        "city": "Greenville",
                        "state": "South Carolina",
                        "zip": "29615",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Amy Hayes",
                                "role": "CONTACT",
                                "phone": "864-454-5168",
                                "email": "amy.hayes@prismahealth.org"
                            },
                            {
                                "name": "Elaine Apperson, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.85262,
                            "lon": -82.39401
                        }
                    },
                    {
                        "facility": "Vanderbilt Eskind Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Nashville",
                        "state": "Tennessee",
                        "zip": "37232",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Brenna Hammel",
                                "role": "CONTACT",
                                "phone": "615-337-9597",
                                "email": "brenna.hammel@vumc.org"
                            },
                            {
                                "name": "William Russell, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 36.16589,
                            "lon": -86.78444
                        }
                    },
                    {
                        "facility": "University of Texas Southwestern Medical Center",
                        "status": "RECRUITING",
                        "city": "Dallas",
                        "state": "Texas",
                        "zip": "75390",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Michelle Murphy",
                                "role": "CONTACT",
                                "phone": "214-456-9238",
                                "email": "michelle.murphy@utsouthwestern.edu"
                            },
                            {
                                "name": "Perrin White, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 32.78306,
                            "lon": -96.80667
                        }
                    },
                    {
                        "facility": "University of Utah",
                        "status": "RECRUITING",
                        "city": "Salt Lake City",
                        "state": "Utah",
                        "zip": "84132",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Hillarie Slater",
                                "role": "CONTACT",
                                "phone": "801-585-6227",
                                "email": "hillarie.slater@hsc.utah.edu"
                            },
                            {
                                "name": "Zoe Raleigh, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.76078,
                            "lon": -111.89105
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kate Bennett",
                                "role": "CONTACT",
                                "phone": "206-341-8945",
                                "email": "kbennett@benaroyaresearch.org"
                            },
                            {
                                "name": "Sandra Lord, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    },
                    {
                        "facility": "Walter and Eliza Hall Institute of Medical Research",
                        "status": "RECRUITING",
                        "city": "Melbourne",
                        "state": "Victoria",
                        "zip": "3050",
                        "country": "Australia",
                        "contacts": [
                            {
                                "name": "Felicity Healy",
                                "role": "CONTACT",
                                "phone": "9342-7063",
                                "email": "felicity.healy@mh.org.au"
                            },
                            {
                                "name": "Leanne Redl",
                                "role": "CONTACT",
                                "phone": "61 3 9342 7063",
                                "email": "leanne.redl@mh.org.au"
                            },
                            {
                                "name": "John Wentworth, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": -37.814,
                            "lon": 144.96332
                        }
                    }
                ]
            },
            "referencesModule": {
                "seeAlsoLinks": [
                    {
                        "label": "TrialNet",
                        "url": "http://www.diabetestrialnet.org"
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "Data will be available at the NIDDK Central Repository"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M20559",
                        "name": "Disease Progression",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Diabetes Mellitus, Type 1",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC23",
                        "name": "Symptoms and General Pathology"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "C000512542",
                        "term": "Thymoglobulin"
                    },
                    {
                        "id": "D000000961",
                        "term": "Antilymphocyte Serum"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000007155",
                        "term": "Immunologic Factors"
                    },
                    {
                        "id": "D000045505",
                        "term": "Physiological Effects of Drugs"
                    },
                    {
                        "id": "D000007166",
                        "term": "Immunosuppressive Agents"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M255823",
                        "name": "Thymoglobulin",
                        "asFound": "Simulation",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M4279",
                        "name": "Antilymphocyte Serum",
                        "asFound": "Cognitive Behavior Therapy",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M10201",
                        "name": "Immunologic Factors",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10212",
                        "name": "Immunosuppressive Agents",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT04419779",
                "orgStudyIdInfo": {
                    "id": "C-00044"
                },
                "organization": {
                    "fullName": "Fractyl Health Inc.",
                    "class": "INDUSTRY"
                },
                "briefTitle": "Evaluation of the Efficacy and Safety of DMR Using the Revita\u00ae in Subjects With Inadequately Controlled Type 2 Diabetes",
                "officialTitle": "A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita\u00ae System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control",
                "acronym": "REVITALIZE 1"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-05",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2021-03-08",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2025-06",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2026-01",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2020-06-03",
                "studyFirstSubmitQcDate": "2020-06-03",
                "studyFirstPostDateStruct": {
                    "date": "2020-06-05",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-07-15",
                "lastUpdatePostDateStruct": {
                    "date": "2024-07-17",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "Fractyl Health Inc.",
                    "class": "INDUSTRY"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": false,
                "isFdaRegulatedDevice": true,
                "isUnapprovedDevice": true
            },
            "descriptionModule": {
                "briefSummary": "The Revita\u00ae system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agents. The purpose of this study is to demonstrate the efficacy and safety of the Fractyl DMR Procedure using the Revita\u00ae System compared to a sham. Subjects randomized to the DMR procedure will be followed per protocol till 48 weeks post treatment. Subjects in the Sham treatment arm will be offered cross over to receive the DMR treatment at 48 weeks and will be followed per protocol for 48 weeks post treatment."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 2 Diabetes"
                ],
                "keywords": [
                    "Type 2 Diabetes",
                    "Diabetes Mellitus",
                    "Glucose Metabolism Disorders",
                    "Metabolic Diseases",
                    "Endocrine System Diseases",
                    "Revita System",
                    "Duodenal Mucosal Resurfacing",
                    "Insulin-Dependent Diabetes Mellitus"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "NA"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "QUADRUPLE",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR",
                            "OUTCOMES_ASSESSOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 320,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Duodenal Mucosal Resurfacing (DMR)",
                        "type": "ACTIVE_COMPARATOR",
                        "description": "Duodenal Mucosal Resurfacing (DMR) treatment will include hydrothermal ablation of the duodenal muscosa in an upper endoscopic procedure in patients with inadequately controlled type 2 diabetes.",
                        "interventionNames": [
                            "Device: Duodenal Mucosal Resurfacing (DMR)"
                        ]
                    },
                    {
                        "label": "Duodenal Mucosal Resurfacing Sham (Sham)",
                        "type": "SHAM_COMPARATOR",
                        "description": "Duodenal Mucosal Resurfacing Sham (Sham) treatment will include an upper endoscopic procedure similar to DMR treatment without hydrothermal ablation of the duodenal mucosa in patients with inadequately controlled type 2 diabetes.",
                        "interventionNames": [
                            "Device: Duodenal Mucosal Resurfacing (Sham)"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DEVICE",
                        "name": "Duodenal Mucosal Resurfacing (DMR)",
                        "description": "The Fractyl DMR Procedure utilizes the Revita\u00ae Catheter to perform hydrothermal ablation of the duodenum. The Catheter is delivered trans-orally over a guide-wire to first inject saline to lift the sub-mucosal space, followed by an ablation of the duodenal mucosa. Subjects who receive the DMR treatment are followed for 48 weeks post treatment.",
                        "armGroupLabels": [
                            "Duodenal Mucosal Resurfacing (DMR)"
                        ]
                    },
                    {
                        "type": "DEVICE",
                        "name": "Duodenal Mucosal Resurfacing (Sham)",
                        "description": "The Sham procedure consists of placing the Revita\u00ae Catheter as described above into the duodenum for a minimum of 30 minutes and then removing it from the patient. Subjects who receive the Sham procedure are followed for 48 weeks post treatment and are offered cross over to undergo the DMR procedure at 48 weeks and are followed for further 48 weeks post treatment. Sham subjects who choose not to cross over are discontinued from the study.",
                        "armGroupLabels": [
                            "Duodenal Mucosal Resurfacing Sham (Sham)"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Demonstrate superiority of Revita DMR to sham in improving glycemic control",
                        "description": "Change from baseline in HbA1c at Week 24",
                        "timeFrame": "Baseline to Week 24"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Demonstrate superiority of Revita DMR to sham in achieving target HbA1c at 24 weeks",
                        "description": "The proportion of subjects who achieve an HbA1c of \u22647.0% at Week 24",
                        "timeFrame": "Baseline to Week 24"
                    },
                    {
                        "measure": "Demonstrate superiority of Revita DMR to sham in fasting glucose at 24 weeks",
                        "description": "Change from baseline in fasting plasma glucose (FPG) at Week 24",
                        "timeFrame": "Baseline to Week 24"
                    },
                    {
                        "measure": "Demonstrate superiority of Revita DMR to sham in weight loss at 24 weeks",
                        "description": "Percentage of total body weight loss (%TBWL) from baseline at Week 24",
                        "timeFrame": "Baseline to Week 24"
                    },
                    {
                        "measure": "To demonstrate superiority of Revita DMR to sham in elimination of insulin use at 24 weeks in those subjects on insulin at baseline",
                        "description": "4. The proportion of subjects who discontinued insulin at Week 24 in those subjects on insulin at baseline",
                        "timeFrame": "Baseline to Week 24"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria\n\nSubjects must meet all of the following criteria for inclusion in the study:\n\n1. Males and non-pregnant non-lactating females\n2. Age between 21 and 70 years (both inclusive)\n3. Subjects on at least one glucose lowering agent (GLA) with no changes in GLA medications or dosing for at least 12 weeks prior to the screening visit\n\n   Permitted GLAs include:\n   * Metformin,\n   * GLP-1 RA including dual peptide agonists and related molecules (e.g., GLP-1/GIP RA),\n   * DPP-4i,\n   * TZDs,\n   * SGLT2is,\n   * SUs,\n   * Meglitinides,\n   * Insulin (basal or basal combined with short-acting), up to a total of 100 units daily\n4. HbA1c of 7.5%-10% (both inclusive)\n5. BMI \\>24 to \u226440 kg/m2\n6. WOCBP should have a negative urine beta hCG pregnancy test and must agree to use two of the established contraceptive methods throughout the study duration\n7. Able to sign an ICF and comply with study requirements\n\nExclusion Criteria\n\nSubjects who meet any of the following exclusion criteria are not allowed to be included in the study:\n\n1. FPG \u2265270 mg/dL\n2. Known case of absolute insulin deficiency as indicated by clinical assessment or a fasting plasma C-peptide of \\<0.6 ng/mL\n3. Subjects on any other class of glucose-lowering agents other than GLAs listed in inclusion criteria Any drugs or concomitant medications (e.g., psychoactive drugs such as carbamazepine phenobarbital; sympathomimetics such as ephedrine corticosteroids; anabolic steroids and male sex hormones such as testosterone) that can interfere with glucose metabolism (refer to prohibited medication on Appendix D: Eligibility Criteria Checklist)\n4. Recurrent or severe urinary tract or genital mycotic infections or history of GU infection within 4 weeks prior to informed consent, for those subjects on SGLT-2\n5. ALT or AST \\>3 times upper limit of normal (ULN) for the reference range, as determined by the central laboratory at screening visit. Patients with NAFLD are eligible if their ALT level is \u22643.0 times the ULN.\n6. Use of an investigational drug within 1 month or 5 half-lives (whichever is longer) before screening\n7. Diagnosed with type 1 diabetes or with a recent history of DKA within one year prior to screening\n8. Ketosis-prone T2D\n9. Known diabetes related non-healing ulcers or amputations (with the exception of a finger or toe amputation occurring \\> 1 year prior to screening.\n10. History of more than 1 severe hypoglycemia episode or hypoglycemia unawareness within the last 6 months\n11. Clinically significant hypoglycemia occurring during the run-in period, defined as a) 2 or more glucose alert values of \u226470 mg/dL (3.9 mmol/L) unless a clear, correctable, precipitating factor can be identified; b) clinically significant hypoglycemia with self-monitored or laboratory plasma glucose level \\<54 mg/dL (3.0 mmol/L); or c) severe hypoglycemic episode requiring third party assistance\n12. Known intestinal autoimmune disease including celiac disease, ulcerative colitis, Crohn's disease, lupus erythematosus, scleroderma, or other autoimmune connective tissue disorder that affects the small intestine\n13. Secondary hypothyroidism or inadequately controlled primary hypothyroidism (thyroid stimulating hormone \\[TSH\\] value outside the normal range at screening as determined by the central laboratory).\n14. Known thyroid cancer or hyperthyroidism with treatment within the past 12 months or inadequately controlled hyperthyroidism (TSH value outside the normal range at screening as determined by the central laboratory).\n15. An uncontrolled endocrine condition such as multiple endocrine neoplasia (except T2D)\n16. Known structural or functional disorder of the esophagus including any swallowing disorder, esophageal chest pain disorders, drug-refractory esophageal reflux symptoms, or active and uncontrolled gastroesophageal reflux disease (GERD) (defined as Los Angeles Grade C or D esophagitis)\n17. Known structural or functional disorder of the stomach including active gastric ulcer, chronic gastritis, gastric varices, hiatal hernia (a large hiatal hernia or type II and higher paraoesophageal hernia), cancer, or any other disorder of the stomach\n18. Previous GI surgery that could affect the ability to treat the duodenum such as subjects who have had a Billroth 2, Roux-en-Y gastric bypass, gastric sleeve, or other similar procedures or conditions\n19. Known history of chronic pancreatitis or a recent history of acute pancreatitis within the past year\n20. Presence of acute or chronic active hepatitis B or C (except if hepatitis C is cured) or cirrhosis, hepatic decompensation/acute liver disease during the last 6 months, or alcoholic or autoimmune chronic hepatitis\n21. Symptomatic gallstones, symptomatic kidney stones, or acute cholecystitis\n22. Clinically active systemic infection\n23. Known immunocompromised status including but not limited to individuals who have undergone organ transplantation, chemotherapy, or radiotherapy within the past 12 months; have clinically significant leukopenia; are positive for the human immunodeficiency virus (HIV); are on potential immunosuppressants; or individuals whose immune status makes the subject a poor candidate for clinical trial participation in the opinion of the investigator\n24. Known active malignancy or partial remission from clinically significant malignancy within the past 5 years (except basal or squamous cell skin cancer, carcinoma in situ, those who received curative treatment and are in complete remission for 5 years, or if the subject is confirmed as cancer free)\n25. Known active coagulopathy or current upper gastro-intestinal bleeding conditions such as ulcers, gastric varices, strictures, or congenital or acquired intestinal telangiectasia\n26. Known cases of sickle cell anemia, thalassemia, or conditions that affect red blood cell (RBC) turnover such as a recent blood transfusion within 90 days. Current persistent anemia, defined as hemoglobin \\<10g/dL\n27. Use of anticoagulation therapy (e.g., warfarin, coumadin, or novel oral anticoagulants \\[NOACs\\]) or anti-platelet agents (e.g., thienopyridine) which cannot be discontinued for 5-7 days or 2 drug half-lives before the procedure\n28. Use of systemic glucocorticoids (excluding topical or ophthalmic applications or inhaled forms) for more than 10 consecutive days within 90 days prior to screening\n29. Use of non-GLA drugs known to affect GI motility (e.g., metoclopramide)\n30. Known moderate to severe chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) of \\<45 mL/min/1.73m2 (estimated by Modification of Diet in Renal Disease \\[MDRD\\]), end-stage renal failure, or on dialysis\n31. History of myocardial infarction, stroke, transient ischemic attack, coronary artery intervention, CHF exacerbation, or any other major cardiac event requiring hospitalization within the last 6 months prior to screening or any cardiac history that would deem subject not eligible for anesthesia (unless documented clearance by cardiologist and/or treating endoscopy team)\n32. History of new or worsening signs or symptoms of coronary heart disease (CHD) within the last 3 months\n33. Known case of severe peripheral vascular disease, defined as AMA Criteria Class 1 or greater75 (Appendix 19.8)\n34. Known case of symptomatic heart failure with reduced ejection fraction (NYHA Class II-IV) requiring pharmacologic therapy to control symptoms\n35. Clinically significant electrocardiogram (ECG) findings such as new clinically significant arrhythmia, ST segment changes, or other conduction disturbances that increase risk of heart disease and require intervention as determined by the investigator\n36. Subjects who are at risk of pancreatitis, particularly those with a recent fasting triglyceride value of \\>600 mg/dL within the past 3 months\n37. Actively participating in a weight-loss program and currently not in the maintenance phase\n38. General contraindications to deep or conscious sedation, general anesthesia, high risk as determined by anesthesiologist (e.g., ASA score 4 or higher), or contraindications to upper GI endoscopy\n39. History of substance use disorder based on the DSM-5 criteria76 within the last 12 months (American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition).\n40. Use of weight loss medication such as Meridia, Xenical, over-the-counter weight-loss medications, or other prescribed medications used specifically for the purpose of weight loss\n41. Use of dietary supplements or herbal preparations that may have unknown effects on glycemic control or risk of bleeding\n42. Participating in another ongoing clinical trial of an investigational drug or device\n43. History of non-adherence to treatment in the previous 6 months, as determined by the investigator based on patient history, HbA1c value, or drug accountability\n44. Any other mental or physical condition which, in the opinion of the investigator, makes the subject a poor candidate for clinical-trial participation. Physical conditions assessed via endoscopy prior to participant study enrollment at visit 4 include, but not limited to:\n\n    1. Active and uncontrolled gastroesophageal reflux disease (GERD) defined as Los Angeles Grade C or D esophagitis\n    2. Abnormalities of the GI tract preventing endoscopic access to the duodenum\n    3. Anatomic abnormalities in the duodenum that would preclude the completion of the DMR procedure, including tortuous anatomy\n    4. Malignancy newly diagnosed by endoscopy\n    5. Upper GI conditions (esophageal, gastric, or intestinal) such as clinically significant ulcers, polyps, varices, strictures, congenital or acquired intestinal telangiectasia, or other conditions listed under exclusion criteria\n45. Unwilling or unable to comply with study visits and other study procedures as required per protocol\n46. Recovered from severe COVID-19 infection (requiring hospitalization) but with persistent long COVID-19 symptoms (i.e., the individual has not recovered for several weeks or months since the start of symptoms that were suggestive of COVID-19, irrespective if the individual was tested or not)",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "21 Years",
                "maximumAge": "70 Years",
                "stdAges": [
                    "ADULT",
                    "OLDER_ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Adelina Paunescu, PhD",
                        "role": "CONTACT",
                        "phone": "(781) 526-8152",
                        "email": "info@fractyl.com"
                    },
                    {
                        "name": "Kelly White",
                        "role": "CONTACT",
                        "email": "info@fractyl.com"
                    }
                ],
                "locations": [
                    {
                        "facility": "Helios CR, Inc",
                        "status": "RECRUITING",
                        "city": "Phoenix",
                        "state": "Arizona",
                        "zip": "85028",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kimberly Kundert",
                                "role": "CONTACT",
                                "phone": "480-229-1615",
                                "email": "Kimberly.Kundert@heliosclinical.com"
                            },
                            {
                                "name": "David Francyk",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.44838,
                            "lon": -112.07404
                        }
                    },
                    {
                        "facility": "HonorHealth Research Institute",
                        "status": "RECRUITING",
                        "city": "Scottsdale",
                        "state": "Arizona",
                        "zip": "85258",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Braun",
                                "role": "CONTACT",
                                "phone": "480-323-1292",
                                "email": "hbraun@honorhealth.com"
                            },
                            {
                                "name": "James Swain",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.50921,
                            "lon": -111.89903
                        }
                    },
                    {
                        "facility": "Mayo Clinic Arizona",
                        "status": "RECRUITING",
                        "city": "Scottsdale",
                        "state": "Arizona",
                        "zip": "85259",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kayla Haeger",
                                "role": "CONTACT",
                                "phone": "480-301-6767",
                                "email": "haegar.kayla@mayo.edu"
                            },
                            {
                                "name": "Rahul Pannala",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Lori Roust",
                                "role": "SUB_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.50921,
                            "lon": -111.89903
                        }
                    },
                    {
                        "facility": "Angel City Research , Inc.",
                        "status": "RECRUITING",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90010",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maira Jackson",
                                "role": "CONTACT",
                                "phone": "213-365-0793",
                                "email": "maira@angelcityresearch.com"
                            },
                            {
                                "name": "Felix Sigal",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "UCLA Health",
                        "status": "RECRUITING",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90095",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Yesenia Calzada",
                                "role": "CONTACT",
                                "email": "ycalzada@mednet.ucla.edu"
                            },
                            {
                                "name": "Adarsh Thaker",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "Care Access Santa Clarita",
                        "status": "RECRUITING",
                        "city": "Newhall",
                        "state": "California",
                        "zip": "91321",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Alyssa Lujan",
                                "role": "CONTACT",
                                "phone": "908-941-2273",
                                "email": "a.Lujan@careaccess.com"
                            },
                            {
                                "name": "Sina Tebi",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.38472,
                            "lon": -118.53092
                        }
                    },
                    {
                        "facility": "Hoag Hospital",
                        "status": "RECRUITING",
                        "city": "Newport Beach",
                        "state": "California",
                        "zip": "92663",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Brittany Dennis",
                                "role": "CONTACT",
                                "phone": "949-764-6896",
                                "email": "brittany.dennis@hoag.org"
                            },
                            {
                                "name": "David Ahn",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 33.61891,
                            "lon": -117.92895
                        }
                    },
                    {
                        "facility": "Stanford University Medical Center",
                        "status": "RECRUITING",
                        "city": "Redwood City",
                        "state": "California",
                        "zip": "94063",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Vyvian Ngo",
                                "role": "CONTACT",
                                "phone": "408-890-9777",
                                "email": "vyviann@stanford.edu"
                            },
                            {
                                "name": "Paul Kwo",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.48522,
                            "lon": -122.23635
                        }
                    },
                    {
                        "facility": "Mills Peninsula Health Center",
                        "status": "RECRUITING",
                        "city": "San Mateo",
                        "state": "California",
                        "zip": "94401",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Irina Nayberg",
                                "role": "CONTACT",
                                "phone": "650-696-4261",
                                "email": "irna.nayberg@sutterhealth.org"
                            },
                            {
                                "name": "David Klonoff",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.56299,
                            "lon": -122.32553
                        }
                    },
                    {
                        "facility": "Yale",
                        "status": "WITHDRAWN",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06519",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "Northeast Research Institute, Llc",
                        "status": "RECRUITING",
                        "city": "Fleming Island",
                        "state": "Florida",
                        "zip": "32003",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Sunshine Snipes",
                                "role": "CONTACT",
                                "phone": "904-541-8225",
                                "email": "sunshine@nerifl.com"
                            },
                            {
                                "name": "Senan Sultan",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 30.0933,
                            "lon": -81.71898
                        }
                    },
                    {
                        "facility": "Jacksonville Center for Clinical Research",
                        "status": "RECRUITING",
                        "city": "Jacksonville",
                        "state": "Florida",
                        "zip": "32216",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Alex Hill",
                                "role": "CONTACT",
                                "phone": "904-732-9257",
                                "email": "ahill@encoredocs.com"
                            },
                            {
                                "name": "Alpa Patel",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 30.33218,
                            "lon": -81.65565
                        }
                    },
                    {
                        "facility": "University of Miami",
                        "status": "RECRUITING",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33136",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Michael Mijares",
                                "role": "CONTACT",
                                "phone": "305-243-6405",
                                "email": "mmijares74@med.miami.edu"
                            },
                            {
                                "name": "Paul Martin",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "West Orange Endocrinology",
                        "status": "RECRUITING",
                        "city": "Ocoee",
                        "state": "Florida",
                        "zip": "34761",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Maria Ines Marulanda",
                                "role": "CONTACT",
                                "phone": "407-480-4830",
                                "email": "mariaines.marulanda@woendo.com"
                            },
                            {
                                "name": "Jose Mandry",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 28.56917,
                            "lon": -81.54396
                        }
                    },
                    {
                        "facility": "Advent Health Orlando",
                        "status": "RECRUITING",
                        "city": "Orlando",
                        "state": "Florida",
                        "zip": "32804",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Veronica Velarde",
                                "role": "CONTACT",
                                "phone": "407-303-1307",
                                "email": "veronica.velarde@adventhealth.com"
                            },
                            {
                                "name": "Tina Thethi",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 28.53834,
                            "lon": -81.37924
                        }
                    },
                    {
                        "facility": "Synexus Research",
                        "status": "RECRUITING",
                        "city": "Orlando",
                        "state": "Florida",
                        "zip": "32806",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lisa Patel",
                                "role": "CONTACT",
                                "phone": "407-426-9299",
                                "email": "lisa.patel@globalaes.com"
                            },
                            {
                                "name": "Akbar Safder",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 28.53834,
                            "lon": -81.37924
                        }
                    },
                    {
                        "facility": "Northwestern Unviersity",
                        "status": "RECRUITING",
                        "city": "Evanston",
                        "state": "Illinois",
                        "zip": "60611",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Andrew Tschida",
                                "role": "CONTACT",
                                "phone": "312-503-3413",
                                "email": "andrew.tschida@northwestern.edu"
                            },
                            {
                                "name": "Grazia Aleppo",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.04114,
                            "lon": -87.69006
                        }
                    },
                    {
                        "facility": "AHN - Avon",
                        "status": "RECRUITING",
                        "city": "Avon",
                        "state": "Indiana",
                        "zip": "46123",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Danielle Heileson",
                                "role": "CONTACT",
                                "phone": "317-718-6615",
                                "email": "danielle_heileson@ahni.com"
                            },
                            {
                                "name": "Daniel Storey",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76282,
                            "lon": -86.39972
                        }
                    },
                    {
                        "facility": "Investigators Research Group",
                        "status": "RECRUITING",
                        "city": "Brownsburg",
                        "state": "Indiana",
                        "zip": "46112",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Annie Raphael",
                                "role": "CONTACT",
                                "phone": "317-796-8093",
                                "email": "araphael@irgresearch.org"
                            },
                            {
                                "name": "Kenneth Maynard",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.84338,
                            "lon": -86.39777
                        }
                    },
                    {
                        "facility": "AHN- Franklin",
                        "status": "RECRUITING",
                        "city": "Franklin",
                        "state": "Indiana",
                        "zip": "46131",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Rebecca Neal",
                                "role": "CONTACT",
                                "phone": "317-738-7400",
                                "email": "rebecca_neal@ahni.com"
                            },
                            {
                                "name": "Mitch Cornett",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.48061,
                            "lon": -86.05499
                        }
                    },
                    {
                        "facility": "AHN - Greenfield",
                        "status": "RECRUITING",
                        "city": "Greenfield",
                        "state": "Indiana",
                        "zip": "46140",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Gorgi Avery",
                                "role": "CONTACT",
                                "phone": "317-462-5252",
                                "email": "gorgi_avery@ahni.com"
                            },
                            {
                                "name": "Talessa Powell",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.78504,
                            "lon": -85.76942
                        }
                    },
                    {
                        "facility": "Indiana University School of Medicine",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Vanessa Patrick, RN",
                                "role": "CONTACT",
                                "phone": "317-278-0692",
                                "email": "vpatrick@iu.edu"
                            },
                            {
                                "name": "Mark Gromski",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "AHN - Muncie",
                        "status": "RECRUITING",
                        "city": "Muncie",
                        "state": "Indiana",
                        "zip": "47304",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Laura Shaeffer",
                                "role": "CONTACT",
                                "phone": "765-213-6310",
                                "email": "laura_shaeffer@ahni.com"
                            },
                            {
                                "name": "Jonathan David Condit",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.19338,
                            "lon": -85.38636
                        }
                    },
                    {
                        "facility": "University of Louisville",
                        "status": "NOT_YET_RECRUITING",
                        "city": "Louisville",
                        "state": "Kentucky",
                        "zip": "40202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Angela Siegwald",
                                "role": "CONTACT",
                                "phone": "502-852-2043",
                                "email": "angela.siegwald@louisville.edu"
                            },
                            {
                                "name": "Prakash Mokshagundam",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 38.25424,
                            "lon": -85.75941
                        }
                    },
                    {
                        "facility": "Tulane University",
                        "status": "RECRUITING",
                        "city": "New Orleans",
                        "state": "Louisiana",
                        "zip": "70112",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Shae Williams",
                                "role": "CONTACT",
                                "phone": "504-988-9127",
                                "email": "swilliams13@tulane.edu"
                            },
                            {
                                "name": "Vivian Fonseca, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.95465,
                            "lon": -90.07507
                        }
                    },
                    {
                        "facility": "Brigham and Women's Hospital",
                        "status": "RECRUITING",
                        "city": "Boston",
                        "state": "Massachusetts",
                        "zip": "02115",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jonah Hoyt",
                                "role": "CONTACT",
                                "email": "jahoyt@bwh.harvard.edu"
                            },
                            {
                                "name": "Vanita Aroda",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.35843,
                            "lon": -71.05977
                        }
                    },
                    {
                        "facility": "Beth Israel",
                        "status": "WITHDRAWN",
                        "city": "Boston",
                        "state": "Massachusetts",
                        "zip": "02215",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 42.35843,
                            "lon": -71.05977
                        }
                    },
                    {
                        "facility": "Alcanza Clinical Research, LLC",
                        "status": "RECRUITING",
                        "city": "Methuen",
                        "state": "Massachusetts",
                        "zip": "01844",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kathleen Bass",
                                "role": "CONTACT",
                                "phone": "978-655-7155",
                                "email": "kathleen.bass@activmedresearch.com"
                            },
                            {
                                "name": "Michael McCartney",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.7262,
                            "lon": -71.19089
                        }
                    },
                    {
                        "facility": "University of Michigan",
                        "status": "RECRUITING",
                        "city": "Ann Arbor",
                        "state": "Michigan",
                        "zip": "48109",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Spring Stonebreaker",
                                "role": "CONTACT",
                                "email": "sprstone@med.umich.edu"
                            },
                            {
                                "name": "Elif Oral",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.27756,
                            "lon": -83.74088
                        }
                    },
                    {
                        "facility": "Jefferson City Medical Group",
                        "status": "RECRUITING",
                        "city": "Jefferson City",
                        "state": "Missouri",
                        "zip": "65109",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lauren Jaegar",
                                "role": "CONTACT",
                                "phone": "573-556-7785",
                                "email": "lauren.jaeger@avacare.com"
                            },
                            {
                                "name": "Christopher Case",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 38.5767,
                            "lon": -92.17352
                        }
                    },
                    {
                        "facility": "Washington University School of Medicine",
                        "status": "RECRUITING",
                        "city": "Saint Louis",
                        "state": "Missouri",
                        "zip": "63110",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Cameron Smith",
                                "role": "CONTACT",
                                "phone": "314-747-1217",
                                "email": "camerons@wustl.edu"
                            },
                            {
                                "name": "Julie Silverstein",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 38.62727,
                            "lon": -90.19789
                        }
                    },
                    {
                        "facility": "IMA Clinical Research St. Louis",
                        "status": "RECRUITING",
                        "city": "Saint Louis",
                        "state": "Missouri",
                        "zip": "63117",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Hector Roa",
                                "role": "CONTACT",
                                "phone": "314-367-0777",
                                "email": "hector.roa@imaresearch.com"
                            },
                            {
                                "name": "Michael Reschak",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 38.62727,
                            "lon": -90.19789
                        }
                    },
                    {
                        "facility": "Dartmouth-Hitchcock Medical Center",
                        "status": "RECRUITING",
                        "city": "Lebanon",
                        "state": "New Hampshire",
                        "zip": "03756",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Grace Tomasetti",
                                "role": "CONTACT",
                                "phone": "603-653-3651",
                                "email": "Grace.E.Tomasetti@hitchcock.org"
                            },
                            {
                                "name": "Sushela Chaidarun",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.64229,
                            "lon": -72.25176
                        }
                    },
                    {
                        "facility": "St. Joseph Medical Center",
                        "status": "WITHDRAWN",
                        "city": "Paterson",
                        "state": "New Jersey",
                        "zip": "07501",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 40.91677,
                            "lon": -74.17181
                        }
                    },
                    {
                        "facility": "Endocrine Associates of West Village",
                        "status": "RECRUITING",
                        "city": "Long Island City",
                        "state": "New York",
                        "zip": "77089",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jamie Hyatt",
                                "role": "CONTACT",
                                "phone": "718-704-5376",
                                "email": "jhyatt@endocrinenyc.com"
                            },
                            {
                                "name": "Anastasios Manessis",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.74482,
                            "lon": -73.94875
                        }
                    },
                    {
                        "facility": "NYU Langone Gastroenterology Associates",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10016",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Peter Emanuel",
                                "role": "CONTACT",
                                "phone": "212-263-6340",
                                "email": "peter.emanuel@nyulangone.org"
                            },
                            {
                                "name": "Roshney Jacob-Issac",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "Synexus Clinical Research, New York",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10017",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Gennie Wyatt",
                                "role": "CONTACT",
                                "phone": "718-969-3005",
                                "email": "gennie.wyatt@globalaes.com"
                            },
                            {
                                "name": "Margarita Nunez",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "Icahn School of Medicine at Mount Sinai",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10029",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Asher Leviton",
                                "role": "CONTACT",
                                "phone": "347-920-1830",
                                "email": "asher.leviton@mssm.edu"
                            },
                            {
                                "name": "Reshmi Srinath",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "Weill Cornell Medicine",
                        "status": "RECRUITING",
                        "city": "New York",
                        "state": "New York",
                        "zip": "10065",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Samantha Nilsson",
                                "role": "CONTACT",
                                "email": "san4015@med.cornell.edu"
                            },
                            {
                                "name": "Reem Sharaiha",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.71427,
                            "lon": -74.00597
                        }
                    },
                    {
                        "facility": "Duke University Medical Center",
                        "status": "RECRUITING",
                        "city": "Durham",
                        "state": "North Carolina",
                        "zip": "27710",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Anna Diocareza",
                                "role": "CONTACT",
                                "phone": "919-681-0220",
                                "email": "Anna.diocareza@duke.edu"
                            },
                            {
                                "name": "Jennifer Rowell",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 35.99403,
                            "lon": -78.89862
                        }
                    },
                    {
                        "facility": "M3 Wake Research",
                        "status": "RECRUITING",
                        "city": "Raleigh",
                        "state": "North Carolina",
                        "zip": "27612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kimberly Carroll",
                                "role": "CONTACT",
                                "phone": "919-781-2514",
                                "email": "kcarroll@wakeresearch.com"
                            },
                            {
                                "name": "Jean Dostou",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 35.7721,
                            "lon": -78.63861
                        }
                    },
                    {
                        "facility": "AcellaCare Salisbury",
                        "status": "RECRUITING",
                        "city": "Salisbury",
                        "state": "North Carolina",
                        "zip": "28144",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Tasha Furman",
                                "role": "CONTACT",
                                "phone": "704-647-9913",
                                "email": "Tasha.furman@accellacare.com"
                            },
                            {
                                "name": "Kishan Maramraj",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 35.67097,
                            "lon": -80.47423
                        }
                    },
                    {
                        "facility": "AcellaCare Piedmont",
                        "status": "RECRUITING",
                        "city": "Statesville",
                        "state": "North Carolina",
                        "zip": "28625",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Jamie Bassey",
                                "role": "CONTACT",
                                "phone": "704-924-2105",
                                "email": "jamie.bassey@accellacare.com"
                            },
                            {
                                "name": "Joseph Moran",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 35.78264,
                            "lon": -80.8873
                        }
                    },
                    {
                        "facility": "AcellaCare Wilmington",
                        "status": "RECRUITING",
                        "city": "Wilmington",
                        "state": "North Carolina",
                        "zip": "28401",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lauren Kruszon",
                                "role": "CONTACT",
                                "phone": "910-799-5500",
                                "email": "Lauren.Kruszon@accellacare.com"
                            },
                            {
                                "name": "John Parker",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.22573,
                            "lon": -77.94471
                        }
                    },
                    {
                        "facility": "Cleveland Clinic",
                        "status": "RECRUITING",
                        "city": "Cleveland",
                        "state": "Ohio",
                        "zip": "44195",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kristen Yheiman",
                                "role": "CONTACT",
                                "phone": "216-445-3611",
                                "email": "Thiemak2@ccf.org"
                            },
                            {
                                "name": "John Vargo",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.4995,
                            "lon": -81.69541
                        }
                    },
                    {
                        "facility": "University of Pennsylvania",
                        "status": "RECRUITING",
                        "city": "Philadelphia",
                        "state": "Pennsylvania",
                        "zip": "19104",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Paola Alvarado",
                                "role": "CONTACT",
                                "phone": "724-506-0653",
                                "email": "Paola.Alvarado@Pennmedicine.upenn.edu"
                            },
                            {
                                "name": "Anastasia Amaro",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.95233,
                            "lon": -75.16379
                        }
                    },
                    {
                        "facility": "Preferred PCP - Pittsburgh",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15201",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Sara L Ohm",
                                "role": "CONTACT",
                                "phone": "412-942-0023",
                                "email": "sohm@ppcp.org"
                            },
                            {
                                "name": "Daniel Austin",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Preferred Primary Care Physicians",
                        "status": "RECRUITING",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15236",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Sarah Dobrosky",
                                "role": "CONTACT",
                                "phone": "412-650-6155",
                                "email": "sdobrosky@ppcp.org"
                            },
                            {
                                "name": "Bryce Palchick",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Care Access Warwick",
                        "status": "RECRUITING",
                        "city": "Warwick",
                        "state": "Rhode Island",
                        "zip": "02886-4463",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Alicia Gervais",
                                "role": "CONTACT",
                                "phone": "351-222-7525",
                                "email": "Alicia.Gervais@careaccess.com"
                            },
                            {
                                "name": "Sudhir Bansal",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.7001,
                            "lon": -71.41617
                        }
                    },
                    {
                        "facility": "Baylor St. Luke's Medical Center",
                        "status": "RECRUITING",
                        "city": "Houston",
                        "state": "Texas",
                        "zip": "77030",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Michael Mercado",
                                "role": "CONTACT",
                                "phone": "713-798-3606",
                                "email": "Michael.Mercado@bcm.edu"
                            },
                            {
                                "name": "Mohamed Othman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.76328,
                            "lon": -95.36327
                        }
                    },
                    {
                        "facility": "Biopharma Informatic, Llc",
                        "status": "RECRUITING",
                        "city": "Houston",
                        "state": "Texas",
                        "zip": "77089",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Francis Mariamma",
                                "role": "CONTACT",
                                "phone": "281-944-3610",
                                "email": "mariamma@biopharmainfo.net"
                            },
                            {
                                "name": "Amir Hassan",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.76328,
                            "lon": -95.36327
                        }
                    },
                    {
                        "facility": "Simcare Medical Research, Llc.",
                        "status": "RECRUITING",
                        "city": "Sugar Land",
                        "state": "Texas",
                        "zip": "77478",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Armgan Khan",
                                "role": "CONTACT",
                                "phone": "832-500-5184",
                                "email": "REGS@SIMCARERESEARCH.COM"
                            },
                            {
                                "name": "Imran Siddiqui",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.61968,
                            "lon": -95.63495
                        }
                    },
                    {
                        "facility": "Virginia Commonwealth University Medical Center",
                        "status": "WITHDRAWN",
                        "city": "Richmond",
                        "state": "Virginia",
                        "zip": "23298",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 37.55376,
                            "lon": -77.46026
                        }
                    },
                    {
                        "facility": "Seattle Cancer Care Alliance",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98104",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Robyn Fahlstrom",
                                "role": "CONTACT",
                                "phone": "206-598-2546",
                                "email": "robynlf@uw.edu"
                            },
                            {
                                "name": "Arthi Thiramulai",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    },
                    {
                        "facility": "West Virginia University",
                        "status": "RECRUITING",
                        "city": "Morgantown",
                        "state": "West Virginia",
                        "zip": "26506",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Erica Blystone",
                                "role": "CONTACT",
                                "phone": "304-293-3415",
                                "email": "erica.blystone2@hsc.wvu.edu"
                            },
                            {
                                "name": "Adnan Haider",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.62953,
                            "lon": -79.9559
                        }
                    },
                    {
                        "facility": "Cliniques Universitaires de Bruxelles Hopital Erasme",
                        "status": "RECRUITING",
                        "city": "Bruxelles",
                        "country": "Belgium",
                        "contacts": [
                            {
                                "name": "Dimitri Oger",
                                "role": "CONTACT",
                                "phone": "+32 (0) 2555 5828",
                                "email": "Dimitri.Oger@erasme.ulb.ac.be"
                            },
                            {
                                "name": "Miriam Cnop",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 50.85045,
                            "lon": 4.34878
                        }
                    },
                    {
                        "facility": "Bichat-Claude Bernard Hospital",
                        "status": "WITHDRAWN",
                        "city": "Paris",
                        "zip": "75877",
                        "country": "France",
                        "geoPoint": {
                            "lat": 48.85341,
                            "lon": 2.3488
                        }
                    },
                    {
                        "facility": "University College Dublin",
                        "status": "RECRUITING",
                        "city": "Dublin",
                        "country": "Ireland",
                        "contacts": [
                            {
                                "name": "Ahmed Al-Humadi",
                                "role": "CONTACT",
                                "email": "alhumadiahmed@gmail.com"
                            },
                            {
                                "name": "Carel le Roux",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 53.33306,
                            "lon": -6.24889
                        }
                    },
                    {
                        "facility": "Italy Gemelli",
                        "status": "RECRUITING",
                        "city": "Roma",
                        "country": "Italy",
                        "contacts": [
                            {
                                "name": "Anna Caprodossi",
                                "role": "CONTACT",
                                "phone": "+39 06 30155323",
                                "email": "anna.caprodossi@policlinicogemelli.it"
                            },
                            {
                                "name": "Geltrude Mingrone",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.89193,
                            "lon": 12.51133
                        }
                    },
                    {
                        "facility": "Universiteit Van Amsterdam Academisch Medisch Centrum",
                        "status": "RECRUITING",
                        "city": "Amsterdam",
                        "country": "Netherlands",
                        "contacts": [
                            {
                                "name": "Kim Van den Hoek",
                                "role": "CONTACT",
                                "phone": "+31205663556",
                                "email": "k.vandenhoek@amsterdamumc.nl"
                            },
                            {
                                "name": "Jacques Bergman",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 52.37403,
                            "lon": 4.88969
                        }
                    },
                    {
                        "facility": "Hospital Universitario Virgen Del Rocio",
                        "status": "WITHDRAWN",
                        "city": "Sevilla",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 37.38283,
                            "lon": -5.97317
                        }
                    },
                    {
                        "facility": "Inselspital",
                        "status": "WITHDRAWN",
                        "city": "Bern",
                        "country": "Switzerland",
                        "geoPoint": {
                            "lat": 46.94809,
                            "lon": 7.44744
                        }
                    },
                    {
                        "facility": "University Hospital Zurich",
                        "status": "RECRUITING",
                        "city": "Z\u00fcrich",
                        "zip": "CH-8091",
                        "country": "Switzerland",
                        "contacts": [
                            {
                                "name": "Thomas Baumgartner",
                                "role": "CONTACT",
                                "email": "thomas.baumgartner@usz.ch"
                            },
                            {
                                "name": "Felix Beuschlein",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.36667,
                            "lon": 8.54999
                        }
                    },
                    {
                        "facility": "Cleveland Clinic London",
                        "status": "RECRUITING",
                        "city": "London",
                        "state": "England",
                        "zip": "SW1X &AW",
                        "country": "United Kingdom",
                        "contacts": [
                            {
                                "name": "Margaret Duku",
                                "role": "CONTACT",
                                "phone": "+44 20 3423 7500",
                                "email": "DUKUM@ccf.org"
                            },
                            {
                                "name": "Rehan Haidry",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 51.50853,
                            "lon": -0.12574
                        }
                    },
                    {
                        "facility": "King's College Hospital",
                        "status": "RECRUITING",
                        "city": "London",
                        "country": "United Kingdom",
                        "contacts": [
                            {
                                "name": "Tony Johnny",
                                "role": "CONTACT",
                                "phone": "+44 (0)203 299 6161",
                                "email": "tony.johny@nhs.net"
                            },
                            {
                                "name": "Prash Vas",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 51.50853,
                            "lon": -0.12574
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "NO"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07",
                "removedCountries": [
                    "Germany"
                ]
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003924",
                        "term": "Diabetes Mellitus, Type 2"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7119",
                        "name": "Diabetes Mellitus, Type 2",
                        "asFound": "Type 2 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "browseLeaves": [
                    {
                        "id": "M10365",
                        "name": "Insulin",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M173166",
                        "name": "Insulin, Globin Zinc",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Hypo",
                        "name": "Hypoglycemic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT05414409",
                "orgStudyIdInfo": {
                    "id": "15498"
                },
                "organization": {
                    "fullName": "Indiana University",
                    "class": "OTHER"
                },
                "briefTitle": "The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action",
                "officialTitle": "The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-05",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2022-09-28",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2026-08-01",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2026-08-01",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2022-05-31",
                "studyFirstSubmitQcDate": "2022-06-08",
                "studyFirstPostDateStruct": {
                    "date": "2022-06-10",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-05-29",
                "lastUpdatePostDateStruct": {
                    "date": "2024-05-31",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR_INVESTIGATOR",
                    "investigatorFullName": "Heba M. Ismail",
                    "investigatorTitle": "Assistant Professor of Pediatrics",
                    "investigatorAffiliation": "Indiana University School of Medicine"
                },
                "leadSponsor": {
                    "name": "Heba M. Ismail",
                    "class": "OTHER"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false,
                "isUsExport": false
            },
            "descriptionModule": {
                "briefSummary": "Obesity prevalence in persons with T1D has increased, which further complicates management and risk for complications. The proposed study is relevant to public health because it helps us understand the role of the gut microbiome in disease pathophysiology in T1D youth with obesity as well as potential mechanisms to modify disease."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 1 Diabetes",
                    "Obesity"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE2"
                ],
                "designInfo": {
                    "allocation": "NON_RANDOMIZED",
                    "interventionModel": "SEQUENTIAL",
                    "interventionModelDescription": "The investigators will examine the differences in the gut microbiome between lean and obese youth with type 1 diabetes and then enroll the obese youth with type 1 diabetes into the clinical trial to receive metformin as an intervention.",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "NONE"
                    }
                },
                "enrollmentInfo": {
                    "count": 114,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Comparison of microbiome by BMI Category",
                        "type": "NO_INTERVENTION",
                        "description": "The gut microbiome and metabolites of 42 lean and 42 obese youth with type 1 diabetes will be evaluated cross-sectionally."
                    },
                    {
                        "label": "Metformin",
                        "type": "EXPERIMENTAL",
                        "description": "This is a group of 30 youth with type 1 diabetes and obesity who will receive metformin for 6 months.",
                        "interventionNames": [
                            "Drug: Metformin"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Metformin",
                        "description": "Metformin is an oral medication that improves insulin sensitivity.",
                        "armGroupLabels": [
                            "Metformin"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Differences in the gut microbiome in lean and obese youth with type 1 diabetes",
                        "description": "cross sectional comparison of stool microbiome using metagenomic sequencing data",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Differences in the gut microbial metabolites in lean and obese youth with type 1 diabetes",
                        "description": "The investigators will measure and compare the stool and serum short chain fatty acids using mass spectrometry",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Differences in the gut microbial metabolites in lean and obese youth with type 1 diabetes",
                        "description": "The investigators will measure and compare the stool and serum secondary bile acids using mass spectrometry",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Changes in the gut microbiome in obese youth with type 1 diabetes in response to metformin",
                        "description": "longitudinal comparison before and after taking metformin for 6 months, stool samples will be collected at baseline, 3 months and 6 months and sequenced for microbiome profile using metagenomic sequencing",
                        "timeFrame": "Baseline, Month 3, and Month 6"
                    },
                    {
                        "measure": "Changes in the gut microbial metabolites in obese youth with type 1 in response to metformin",
                        "description": "The investigators will measure and compare the stool and serum metabolites (short chain fatty acids and secondary bile acids) before, during and after 6 months of daily metformin therapy using mass spectrometry",
                        "timeFrame": "Baseline, Month 3, and Month 6"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Differences in measures of C-peptide as a measure of beta cell health in lean and obese T1D youth",
                        "description": "The investigators will measure serum C-peptide to calculate a ratio of proinsulin to C-peptide as a marker of beta cell health. These measures will then be compared between the lean and obese T1D youth.",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Differences in measures Proinsulin as a measure of beta cell health in lean and obese T1D youth",
                        "description": "The investigators will measure serum proinsulin and calculate a ratio of proinsulin to C-peptide as a marker of beta cell health. These measures will then be compared between the lean and obese T1D youth.",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Differences in measures of insulin sensitivity in lean and obese T1D youth",
                        "description": "Insulin sensitivity will be assessed in individuals using the estimated insulin sensitivity score (eIS), which is based on waist circumference (cm), HbA1c (%) and triglycerides (mg/dl)",
                        "timeFrame": "Baseline"
                    },
                    {
                        "measure": "Changes in measures of C-peptide as a measure of beta cell health in obese T1D youth in response to metformin",
                        "description": "Serum C-peptide will be used to calculate proinsulin to C-peptide ratio as a measure of beta cell health before and after metformin therapy",
                        "timeFrame": "Baseline, Month 3, and Month 6"
                    },
                    {
                        "measure": "Changes in measures of proinsulin as a measure of beta cell health in obese T1D youth in response to metformin",
                        "description": "Serum proinsulin will be used to calculate proinsulin to C-peptide ratio as a measure of beta cell health before and after metformin therapy",
                        "timeFrame": "Baseline, Month 3, and Month 6"
                    },
                    {
                        "measure": "Changes in measures of insulin sensitivity in obese T1D youth in response to metformin",
                        "description": "Estimated insulin sensitivity score will be used to assess response metformin therapy",
                        "timeFrame": "Baseline, Month 3, and Month 6"
                    },
                    {
                        "measure": "Changes in measures of beta cell function using a timed mixed meal tolerance test",
                        "description": "Participants in the metformin trial will undergo a standard 2-hour mixed meal tolerance test at baseline and after 6 months of oral metformin therapy",
                        "timeFrame": "Baseline and Month 6"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. Obese youth 11-18 years of age with T1D at time of enrollment.\n2. Lean youth 11-18 years of age with T1D at time of enrollment.\n\nExclusion Criteria:\n\n1. Known monogenic forms of diabetes or Type 2 diabetes (confirmed clinically and by genetic/antibody testing).\n2. History of ongoing infection or antibiotic treatment within the past month;\n3. History of immune-compromise, recurrent infections, steroid intake (inhaled or oral forms) or other immunosuppressant use in the past 6 months.\n4. History of chronic gastrointestinal disease, possible or confirmed celiac disease;\n5. Participation in any research intervention trials within the past 3 months.\n6. History of treatment or use of metformin, a type 2 diabetes medication.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "11 Years",
                "maximumAge": "18 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ]
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Heba M Ismail",
                        "role": "CONTACT",
                        "phone": "317-274-2114",
                        "email": "heismail@iu.edu"
                    },
                    {
                        "name": "Akane Hawpe",
                        "role": "CONTACT",
                        "phone": "317-274-2114",
                        "email": "ahawpega@iu.edu"
                    }
                ],
                "locations": [
                    {
                        "facility": "Indiana University School of Medicine",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heba Ismail",
                                "role": "CONTACT",
                                "phone": "317-278-7856",
                                "email": "heismail@iu.edu"
                            },
                            {
                                "name": "Katelyn Hagen",
                                "role": "CONTACT",
                                "phone": "317-278-7042",
                                "email": "hagenka@iu.edu"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "NO"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M12701",
                        "name": "Obesity",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M26186",
                        "name": "Overweight",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Type 1 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC23",
                        "name": "Symptoms and General Pathology"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000008687",
                        "term": "Metformin"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000007004",
                        "term": "Hypoglycemic Agents"
                    },
                    {
                        "id": "D000045505",
                        "term": "Physiological Effects of Drugs"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M11667",
                        "name": "Metformin",
                        "asFound": "Assessment",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M10365",
                        "name": "Insulin",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M173166",
                        "name": "Insulin, Globin Zinc",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10054",
                        "name": "Hypoglycemic Agents",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Hypo",
                        "name": "Hypoglycemic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT02734277",
                "orgStudyIdInfo": {
                    "id": "DAIT ITN066AI"
                },
                "secondaryIdInfos": [
                    {
                        "id": "NIAID CRMS ID#: 20722",
                        "type": "OTHER",
                        "domain": "DAIT NIAID"
                    }
                ],
                "organization": {
                    "fullName": "National Institute of Allergy and Infectious Diseases (NIAID)",
                    "class": "NIH"
                },
                "briefTitle": "Type 1 Diabetes Extension Study",
                "officialTitle": "Type 1 Diabetes Extension Study",
                "acronym": "T1DES"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-04",
                "overallStatus": "RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2016-08-18",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2025-03",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2025-03",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2016-04-06",
                "studyFirstSubmitQcDate": "2016-04-06",
                "studyFirstPostDateStruct": {
                    "date": "2016-04-12",
                    "type": "ESTIMATED"
                },
                "lastUpdateSubmitDate": "2024-04-23",
                "lastUpdatePostDateStruct": {
                    "date": "2024-04-25",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "National Institute of Allergy and Infectious Diseases (NIAID)",
                    "class": "NIH"
                },
                "collaborators": [
                    {
                        "name": "Immune Tolerance Network (ITN)",
                        "class": "NETWORK"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true
            },
            "descriptionModule": {
                "briefSummary": "This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D).\n\nThis observational study will:\n\n* follow participants to determine how long they continue to produce insulin, and\n* will also assess how changes in the immune system over time relate to the ability to produce insulin.\n\nThis information could help design better therapies for type 1 diabetes in the future.",
                "detailedDescription": "Depending upon a participant's level of insulin production, participation may be as short as one return visit or a maximum of five years. Evaluation visits will include:\n\n* Overall health assessments\n* Blood and urine collections\n* Mixed meal tolerance test (MMTTs) for certain participants, per protocol."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 1 Diabetes Mellitus",
                    "T1DM",
                    "T1D"
                ],
                "keywords": [
                    "Insulin",
                    "Glucose Intolerance"
                ]
            },
            "designModule": {
                "studyType": "OBSERVATIONAL",
                "patientRegistry": false,
                "designInfo": {
                    "observationalModel": "COHORT",
                    "timePerspective": "PROSPECTIVE"
                },
                "bioSpec": {
                    "retention": "SAMPLES_WITHOUT_DNA",
                    "description": "* Blood or urine tests as needed to follow-up on potential long term safety concerns with a particular therapeutic agent\n* Blood and urine samples for additional studies related to your diabetes"
                },
                "enrollmentInfo": {
                    "count": 111,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Group 1: Detectable C-peptide by MMTT",
                        "description": "Participants with detectable C-peptide at their:\n\n* Last Immune Tolerance Network (ITN) T1DM week 104 study visit,\n* Last AbATE (NCT00129259) follow-up visit, or\n* Last ITN066AI T1DES visit\n\nDetectable C-peptide is defined as a value above the lower limit of detection."
                    },
                    {
                        "label": "Group 2:Undetectable C-peptide by MMTT",
                        "description": "Participants without detectable C-peptide at their:\n\n* Last ITN T1DM week 104 study visit,\n* Last AbATE follow-up visit, or last\n* ITN066AI T1DES visit\n\nUndetectable C-peptide is defined as a value below the lower limit of detection."
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Change in Beta Cell Function by MMTT-Stimulated Mean C-peptide Area Under the Curve (AUC)",
                        "description": "Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC).\n\nC-peptide is released by the pancreas into the bloodstream in equal amounts to insulin and reflects how much insulin pancreatic beta cells are making. The standardized MMTT evaluates whether beta cells are producing endogenous insulin.\n\nDetectable C-peptide is defined as any value during a MMTT of \u22650.15 ng/mL.",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Change in Insulin Use in Units per Kilogram Body Weight Per Day",
                        "description": "The need to use exogenous insulin is an indication that the body is not producing enough endogenous insulin. Higher amounts of insulin use indicate higher disease activity.",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    },
                    {
                        "measure": "Change in HbA1C",
                        "description": "Glycosylated hemoglobin (HbA1c) is a measure of the average plasma concentration of blood sugar (glucose) over the previous three months and measures the level of optimal management of underlying disease.",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    },
                    {
                        "measure": "Count of Participant-Reported Major Hypoglycemic Events",
                        "description": "Major hypoglycemic events are defined as a glucose concentration \\<55 mg/dL (grades 2-5, NCI-CTCAE version 4.03), or clinically: involving seizure(s) or involving loss of consciousness (coma), or requiring assistance from another individual in order to recover.",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    },
                    {
                        "measure": "Time to Undetectable C-Peptide",
                        "description": "To assess the longevity of beta cell function, time to undetectable C-peptide will be evaluated using Kaplan-Meier survival estimates.",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    },
                    {
                        "measure": "Frequency of Grade 3 or Higher Adverse Events (AEs) of Interest",
                        "description": "Events of interest include but are not limited to:\n\n* Opportunistic and serious infections\n* Malignancy\n* Cardiovascular disease\n* Development of autoimmune disease(s)\n* Hypersensitivity reactions to unrelated allergens\n\nReference for Grade 3 or higher AEs: National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 4.03 (June 14, 2010).",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    },
                    {
                        "measure": "Severity of Grade 3 or Higher Adverse Events (AEs) of Interest",
                        "description": "Events of interest include but are not limited to:\n\n* Opportunistic and serious infections\n* Malignancy\n* Cardiovascular disease\n* Development of autoimmune disease(s)\n* Hypersensitivity reactions to unrelated allergens\n\nReference for Grade 3 or higher AEs: National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 4.03 (June 14, 2010).",
                        "timeFrame": "Baseline (Visit 0) to Month 60 (Year 5)"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n* Prior participant in an Immune Tolerance Network (ITN) executive committee approved T1DM study.\n* Ability to sign informed consent/assent (as applicable for children).\n\nExclusion Criteria:\n\n* Any medical condition that in the opinion of the principal investigator would interfere with safe completion of the trial; or\n* Inability to comply with the study visit schedule and required assessments.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "8 Years",
                "maximumAge": "35 Years",
                "stdAges": [
                    "CHILD",
                    "ADULT"
                ],
                "studyPopulation": "Former participants in Immune Tolerance Network (ITN) new-onset Type 1 Diabetes Mellitus (T1DM) studies with immunomodulatory agents as the intervention.",
                "samplingMethod": "NON_PROBABILITY_SAMPLE"
            },
            "contactsLocationsModule": {
                "overallOfficials": [
                    {
                        "name": "Linda A. DiMeglio, MD, MPH,MA",
                        "affiliation": "Riley Hospital for Children at Indiana University Health",
                        "role": "STUDY_CHAIR"
                    }
                ],
                "locations": [
                    {
                        "facility": "UCSF School of Medicine",
                        "status": "RECRUITING",
                        "city": "San Francisco",
                        "state": "California",
                        "zip": "94143",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Rebecca Wesch",
                                "role": "CONTACT",
                                "phone": "415-476-5984",
                                "email": "rebecca.wesch@ucsf.edu"
                            },
                            {
                                "name": "Stephen Gitelman, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.77493,
                            "lon": -122.41942
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "status": "RECRUITING",
                        "city": "Stanford",
                        "state": "California",
                        "zip": "94305",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Trudy Esrey",
                                "role": "CONTACT",
                                "phone": "650-498-4450",
                                "email": "tesrey@stanford.edu"
                            },
                            {
                                "name": "Darrell Wilson, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.42411,
                            "lon": -122.16608
                        }
                    },
                    {
                        "facility": "University of Colorado School of Medicine: Barbara Davis Center for Diabetes",
                        "status": "RECRUITING",
                        "city": "Aurora",
                        "state": "Colorado",
                        "zip": "80045",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Mara Kinney",
                                "role": "CONTACT",
                                "phone": "303-724-8272",
                                "email": "MARA.KINNEY@ucdenver.edu"
                            },
                            {
                                "name": "Peter Gottlieb, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.72943,
                            "lon": -104.83192
                        }
                    },
                    {
                        "facility": "Yale University",
                        "status": "RECRUITING",
                        "city": "New Haven",
                        "state": "Connecticut",
                        "zip": "06519",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Linda Ryall",
                                "role": "CONTACT",
                                "phone": "203-737-4510",
                                "email": "linda.ryall@yale.edu"
                            },
                            {
                                "name": "Mikhail Smolgovsky",
                                "role": "CONTACT",
                                "phone": "203-785-6248",
                                "email": "mikhail.smolgovsky@yale.edu"
                            },
                            {
                                "name": "Kevan Herold, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.30815,
                            "lon": -72.92816
                        }
                    },
                    {
                        "facility": "Emory University",
                        "status": "WITHDRAWN",
                        "city": "Atlanta",
                        "state": "Georgia",
                        "zip": "30322",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.749,
                            "lon": -84.38798
                        }
                    },
                    {
                        "facility": "Indiana University Riley Hospital for Children",
                        "status": "RECRUITING",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Ellie Ryan",
                                "role": "CONTACT",
                                "phone": "317-278-7037",
                                "email": "elmryan@iu.edu"
                            },
                            {
                                "name": "Maria Spall",
                                "role": "CONTACT",
                                "phone": "317-278-7034",
                                "email": "malnicho@iu.edu"
                            },
                            {
                                "name": "Linda DiMeglio, MD, MPH",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "University of Iowa Health Care Division of Pediatric Endocrinology",
                        "status": "RECRUITING",
                        "city": "Iowa City",
                        "state": "Iowa",
                        "zip": "52242",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Joanne Cabbage",
                                "role": "CONTACT",
                                "phone": "319-356-4035",
                                "email": "joanne-cabbage@uiowa.edu"
                            },
                            {
                                "name": "Michael Tansey, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.66113,
                            "lon": -91.53017
                        }
                    },
                    {
                        "facility": "Joslin Diabetes Center",
                        "status": "RECRUITING",
                        "city": "Boston",
                        "state": "Massachusetts",
                        "zip": "02215",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Site Public Contact",
                                "role": "CONTACT",
                                "phone": "888-813-8669",
                                "email": "T1DTrials@joslin.harvard.edu"
                            },
                            {
                                "name": "Jason Gaglia, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 42.35843,
                            "lon": -71.05977
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "status": "RECRUITING",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55454",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Anne Street",
                                "role": "CONTACT",
                                "phone": "612-625-9709",
                                "email": "stree065@umn.edu"
                            },
                            {
                                "name": "Antoinette Moran, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "Children's Mercy Hospital",
                        "status": "RECRUITING",
                        "city": "Kansas City",
                        "state": "Missouri",
                        "zip": "64108",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Marissa Beidelschies",
                                "role": "CONTACT",
                                "phone": "816-760-5918",
                                "email": "mkbeidelschies@cmh.edu"
                            },
                            {
                                "name": "Jennifer Dolan",
                                "role": "CONTACT",
                                "phone": "(816) 760-8876",
                                "email": "jldolan@cmh.edu"
                            },
                            {
                                "name": "Wayne Moore, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.09973,
                            "lon": -94.57857
                        }
                    },
                    {
                        "facility": "Sanford Research",
                        "status": "RECRUITING",
                        "city": "Sioux Falls",
                        "state": "South Dakota",
                        "zip": "57104",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Sarah Hedeen",
                                "role": "CONTACT",
                                "email": "Sarah.Hedeen@SanfordHealth.org"
                            },
                            {
                                "name": "Kurt Griffin, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 43.54997,
                            "lon": -96.70033
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "status": "RECRUITING",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Katie Bennett",
                                "role": "CONTACT",
                                "phone": "206-341-8945",
                                "email": "kbennett@benaroyaresearch.org"
                            },
                            {
                                "name": "Sandra Lord, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    }
                ]
            },
            "referencesModule": {
                "references": [
                    {
                        "pmid": "23835333",
                        "type": "BACKGROUND",
                        "citation": "Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA; AbATE Study Team. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes. 2013 Nov;62(11):3766-74. doi: 10.2337/db13-0345. Epub 2013 Jul 8."
                    },
                    {
                        "pmid": "26193635",
                        "type": "BACKGROUND",
                        "citation": "Rigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Keyes-Elstein L, Long SA, Kanaparthi S, Lim N, Phippard D, Soppe CL, Fitzgibbon ML, McNamara J, Nepom GT, Ehlers MR. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest. 2015 Aug 3;125(8):3285-96. doi: 10.1172/JCI81722. Epub 2015 Jul 20."
                    },
                    {
                        "pmid": "24622414",
                        "type": "BACKGROUND",
                        "citation": "Rigby MR, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR; T1DAL Study Team. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol. 2013 Dec;1(4):284-94. doi: 10.1016/S2213-8587(13)70111-6. Epub 2013 Sep 23."
                    }
                ],
                "seeAlsoLinks": [
                    {
                        "label": "ITN T1D Extended Study (T1DES) website",
                        "url": "https://www.immunetolerance.org/studies/t1d-extended-study-t1des"
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "The plan is to share data in: 1.)ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network that makes data from the consortium's clinical trials publicly available without charge.",
                "timeFrame": "After completion of the study.",
                "accessCriteria": "Will be available to the public.",
                "url": "http://www.immport.org/immport-open/public/home/home"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D000003922",
                        "term": "Diabetes Mellitus, Type 1"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D000008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D000004700",
                        "term": "Endocrine System Diseases"
                    },
                    {
                        "id": "D000001327",
                        "term": "Autoimmune Diseases"
                    },
                    {
                        "id": "D000007154",
                        "term": "Immune System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "asFound": "Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M20295",
                        "name": "Glucose Intolerance",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "asFound": "Type 1 Diabetes",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M11639",
                        "name": "Metabolic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M25403",
                        "name": "Glucose Metabolism Disorders",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7862",
                        "name": "Endocrine System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M4629",
                        "name": "Autoimmune Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M10200",
                        "name": "Immune System Diseases",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "browseLeaves": [
                    {
                        "id": "M10365",
                        "name": "Insulin",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M173166",
                        "name": "Insulin, Globin Zinc",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Hypo",
                        "name": "Hypoglycemic Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT06401577",
                "orgStudyIdInfo": {
                    "id": "STUDY00015937"
                },
                "organization": {
                    "fullName": "Milton S. Hershey Medical Center",
                    "class": "OTHER"
                },
                "briefTitle": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics",
                "officialTitle": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON) - An Observational Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)",
                "acronym": "DREAM-ON"
            },
            "statusModule": {
                "statusVerifiedDate": "2024-07",
                "overallStatus": "NOT_YET_RECRUITING",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2024-09-01",
                    "type": "ESTIMATED"
                },
                "primaryCompletionDateStruct": {
                    "date": "2026-12-31",
                    "type": "ESTIMATED"
                },
                "completionDateStruct": {
                    "date": "2027-03-31",
                    "type": "ESTIMATED"
                },
                "studyFirstSubmitDate": "2024-05-02",
                "studyFirstSubmitQcDate": "2024-05-02",
                "studyFirstPostDateStruct": {
                    "date": "2024-05-06",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2024-07-30",
                "lastUpdatePostDateStruct": {
                    "date": "2024-07-31",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "PRINCIPAL_INVESTIGATOR",
                    "investigatorFullName": "Vernon Michael Chinchilli",
                    "investigatorTitle": "Distinguished Professor",
                    "investigatorAffiliation": "Milton S. Hershey Medical Center"
                },
                "leadSponsor": {
                    "name": "Milton S. Hershey Medical Center",
                    "class": "OTHER"
                },
                "collaborators": [
                    {
                        "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                        "class": "NIH"
                    },
                    {
                        "name": "Benaroya Research Institute",
                        "class": "OTHER"
                    },
                    {
                        "name": "Cedars-Sinai Medical Center",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Southern California",
                        "class": "OTHER"
                    },
                    {
                        "name": "Indiana University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Johns Hopkins University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Ohio State University",
                        "class": "OTHER"
                    },
                    {
                        "name": "Stanford University",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Florida",
                        "class": "OTHER"
                    },
                    {
                        "name": "AdventHealth",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Illinois at Chicago",
                        "class": "OTHER"
                    },
                    {
                        "name": "Northwestern University",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Minnesota",
                        "class": "OTHER"
                    },
                    {
                        "name": "University of Pittsburgh",
                        "class": "OTHER"
                    }
                ]
            },
            "oversightModule": {
                "oversightHasDmc": true,
                "isFdaRegulatedDrug": false,
                "isFdaRegulatedDevice": true,
                "isUsExport": false
            },
            "descriptionModule": {
                "briefSummary": "The DREAM-ON study will investigate whether continuous glucose monitoring (CGM) is useful to predict risk for developing diabetes mellitus (DM) and pre-diabetes mellitus (PDM), the need for insulin therapy among those who develop DM, and to determine whether CGM can provide insight into the pathophysiology and DM subtype among participants who have experienced an episode of acute pancreatitis (AP). Thus, the results of the DREAM-ON study could inform future clinical practice guidelines for the management AP as well as potentially extending the licensing authorization for CGM to include use in patients with pancreatogenic (Type 3c) DM.",
                "detailedDescription": "The primary objective of the DREAM-ON study is to determine if continuous glucose monitoring (CGM) metrics can predict the incidence of prediabetes mellitus (PDM) and diabetes mellitus (DM) after an episode of acute pancreatitis (AP). Secondary objectives of the DREAM-ON study include determining if CGM metrics predict the need for insulin therapy in participants who develop diabetes mellitus after AP, and if CGM metrics correlate with measures of insulin secretion and insulin resistance.\n\nThe specific aims of the DREAM-ON study are as follows:\n\nAim 1: To test whether standard CGM metrics predict incident DM. The investigators will perform blinded CGM in DREAM-ON participants at their scheduled visits at months 3, 12, 24 and subsequent annual visits. The investigators will test whether standard CGM metrics (mean glucose, time in tight range 70-140, time in range 70-180, time above 180 mg/dL, time above 250 mg/dL and glucose CV) predict incident DM determined by fasting plasma glucose (FPG), HbA1c, oral glucose tolerance testing (OGTT) and clinical report.\n\nAim 2: To test whether CGM metrics predict need for insulin therapy in patients who develop DM after AP. From blinded CGM, we will test whether standard CGM metrics (mean glucose, time in tight range 70-140, time in range 70-180, time above 180 mg/dL, time above 250 mg/dL and glucose CV) as well as other indices of glucose variability, including mean amplitude of glycemic excursions (MAGE), predict need for long-term insulin therapy.\n\nAim 3: To determine whether CGM metrics correlate with measures of insulin secretion and insulin resistance. The investigators will test whether standard and advanced CGM metrics correlate with measures of insulin secretion and insulin resistance derived from the OGTT, the mixed meal tolerance test (MMT) and the frequently sampled intravenous glucose tolerance test (FSIGTT). The investigators also will test whether these metrics can be used as a surrogate to predict diabetes subtype (i.e., insulin deficient vs. insulin resistant)."
            },
            "conditionsModule": {
                "conditions": [
                    "Acute Pancreatitis"
                ],
                "keywords": [
                    "Diabetes",
                    "Continuous Glucose Monitoring"
                ]
            },
            "designModule": {
                "studyType": "OBSERVATIONAL",
                "patientRegistry": false,
                "designInfo": {
                    "observationalModel": "COHORT",
                    "timePerspective": "PROSPECTIVE"
                },
                "enrollmentInfo": {
                    "count": 800,
                    "type": "ESTIMATED"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "CGM",
                        "description": "Continuous Glucose Monitoring (CGM)",
                        "interventionNames": [
                            "Device: Dexcom Continuous Glucose Monitor (CGM)"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DEVICE",
                        "name": "Dexcom Continuous Glucose Monitor (CGM)",
                        "description": "Dexcom Continuous Glucose Monitor which measures and records a participant's serum glucose level",
                        "armGroupLabels": [
                            "CGM"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "pre-diabetes mellitus following an episode of acute pancreatitis",
                        "description": "time to onset of pre-diabetes mellitus during the 36-month longitudinal follow-up period",
                        "timeFrame": "any time during the 36-month longitudinal follow-up period"
                    },
                    {
                        "measure": "diabetes mellitus following an episode of acute pancreatitis",
                        "description": "time to onset of diabetes mellitus during the 36-month longitudinal follow-up period",
                        "timeFrame": "any time during the 36-month longitudinal follow-up period"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "initiation of insulin therapy",
                        "description": "time to onset of the initiation of insulin therapy of any type (basal, mixed, prandial, basal/bolus) for two or more weeks in a non-hospitalized setting after developing diabetes mellitus",
                        "timeFrame": "any time during the 36-month longitudinal follow-up period"
                    },
                    {
                        "measure": "insulin secretion",
                        "description": "insulin secretion during the oral glucose tolerance test (OGTT)",
                        "timeFrame": "during the oral glucose tolerance test (OGTT) administered at 3, 12, 24, and 36 months"
                    },
                    {
                        "measure": "insulin sensitivity",
                        "description": "insulin sensitivity during the oral glucose tolerance test (OGTT)",
                        "timeFrame": "during the oral glucose tolerance test (OGTT) administered at 3, 12, 24, and 36 months"
                    },
                    {
                        "measure": "fasting glucose",
                        "description": "fasting glucose during the mixed meal tolerance test (MMTT)",
                        "timeFrame": "during the mixed meal tolerance test (MMTT) administered at 3, 12, 24, and 36 months"
                    },
                    {
                        "measure": "peak value glucose",
                        "description": "peak value glucose during the mixed meal tolerance test (MMTT)",
                        "timeFrame": "during the mixed meal tolerance test (MMTT) administered at 3, 12, 24, and 36 months"
                    },
                    {
                        "measure": "meal-stimulated insulin",
                        "description": "meal-stimulated insulin during the mixed meal tolerance test (MMTT)",
                        "timeFrame": "during the mixed meal tolerance test (MMTT) administered at 3, 12, 24, and 36 months"
                    },
                    {
                        "measure": "acute insulin response to glucose",
                        "description": "acute insulin response to glucose during the frequently samples intravenous glucose tolerance test (FSIGTT)",
                        "timeFrame": "during the frequently sampled intravenous glucose tolerance test (FSIGTT) administered at 3 and 12 months"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of acute pancreatitis (AP) 0-90 days prior to enrollment\n* Participant fully understands and is able to participate in all aspects of the study, including providing informed consent, completion of case report forms, telephone interviews, metabolic testing, and planned longitudinal follow-ups\n\nExclusion Criteria:\n\n* Diagnosis of definite chronic pancreatitis (CP) at enrollment (see also study definitions) based on either of the following criteria met by computed tomography (CT) scan (including non-contrast enhanced) or Magnetic Resonance Imaging (MRI) or Magnetic Resonance Cholangiopancreatography (MRCP): (a) Parenchymal or ductal calcifications on CT scan (after excluding the possibility that calcifications are vascular); (b) Intraductal filling defects suggestive of calcifications on MRI and/or MRCP\n* Potential participants with post-endoscopic retrograde cholangiopancreatography (ERCP) AP who are hospitalized for \\<48 hours.\n* Prior (i.e., before enrollment) direct endoscopic necrosectomy of the pancreas or percutaneous necrosectomy or drainage of necrotic collection(s). Participants who require this during follow-up will remain in the study\n* Pancreatic tumors, including ductal adenocarcinoma, neuroendocrine tumors, and metastasis\n* Confirmed or suspected cystic tumor associated with main pancreatic duct dilation, or believed to be the cause of AP (in the site-PI's judgement).\n* Prior pancreatic surgery, including, but not limited to: distal pancreatectomy, pancreaticoduodenectomy, pancreatic necrosectomy, Frey procedure.\n* Use of disallowed concomitant medications within 30 days prior to enrollment. A comprehensive list of disallowed medications will be included and routinely updated in the study's Manual of Procedures\n* Severe systemic illness that in the judgement of the investigative team will confound outcome assessments of diabetes mellitus and immunological outcomes or pose additional risk for harms, including: history of solid organ transplant, acquired immunodeficiency syndrome (AIDS), active treatment for cancer (except non-melanoma skin cancer) within 12 months prior to enrollment, chronic kidney disease with estimated glomerular filtration rate (eGFR) \\< 30 or on dialysis prior to AP, and decompensated cirrhosis (based on imaging or biopsy), or any other medical condition that in the opinion of the site-PI carries a life expectancy of \\<12 months\n* Known pregnancy at the time of enrollment. Participants who become pregnant during follow-up will remain in the study, but may have modified study assessments for safety as detailed in the Manual of Procedures\n* Incarceration\n* Any other condition or factor that would compromise the participant's safety or the scientific integrity of the study",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "18 Years",
                "maximumAge": "75 Years",
                "stdAges": [
                    "ADULT",
                    "OLDER_ADULT"
                ],
                "studyPopulation": "Patients hospitalized for acute pancreatitis",
                "samplingMethod": "NON_PROBABILITY_SAMPLE"
            },
            "contactsLocationsModule": {
                "centralContacts": [
                    {
                        "name": "Melissa A Butt, DrPH",
                        "role": "CONTACT",
                        "phone": "717-531-1258",
                        "email": "mbutt1@pennstatehealth.psu.edu"
                    },
                    {
                        "name": "Ron Zimmerman, MPA",
                        "role": "CONTACT",
                        "phone": "717-531-3851",
                        "email": "rzimmerman1@pennstatehealth.psu.edu"
                    }
                ],
                "overallOfficials": [
                    {
                        "name": "Vernon M Chinchilli, PhD",
                        "affiliation": "Penn State College of Medicine",
                        "role": "PRINCIPAL_INVESTIGATOR"
                    },
                    {
                        "name": "Richard E Pratley, MD",
                        "affiliation": "AdventHealth",
                        "role": "PRINCIPAL_INVESTIGATOR"
                    }
                ],
                "locations": [
                    {
                        "facility": "University of Southern California",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90033",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "Cedars-Sinai Medical Center",
                        "city": "Los Angeles",
                        "state": "California",
                        "zip": "90048",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Eleanor Chang",
                                "role": "CONTACT",
                                "phone": "310-423-0747",
                                "email": "eleanor.chang@cshs.org"
                            },
                            {
                                "name": "Mark O Goodarzi, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Stephen J Pandol, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 34.05223,
                            "lon": -118.24368
                        }
                    },
                    {
                        "facility": "Stanford University",
                        "city": "Stanford",
                        "state": "California",
                        "zip": "94305",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Lorena Pineda",
                                "role": "CONTACT",
                                "phone": "650-723-4519",
                                "email": "ljpineda@stanford.edu"
                            },
                            {
                                "name": "Walter Park, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Marina Basina, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 37.42411,
                            "lon": -122.16608
                        }
                    },
                    {
                        "facility": "University of Florida",
                        "city": "Gainesville",
                        "state": "Florida",
                        "zip": "32610-0214",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Amber Bouton",
                                "role": "CONTACT",
                                "phone": "352-273-9774",
                                "email": "amber.bouton@surgery.ufl.edu"
                            },
                            {
                                "name": "Chris Forsmark, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Steven J Hughes, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 29.65163,
                            "lon": -82.32483
                        }
                    },
                    {
                        "facility": "AdventHealth",
                        "city": "Orlando",
                        "state": "Florida",
                        "zip": "32804",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Gina Mercouffer",
                                "role": "CONTACT",
                                "phone": "407-303-7106",
                                "email": "gina.mercouffer@adventhealth.com"
                            },
                            {
                                "name": "Richard E Pratley, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 28.53834,
                            "lon": -81.37924
                        }
                    },
                    {
                        "facility": "Northwestern University",
                        "city": "Chicago",
                        "state": "Illinois",
                        "zip": "60611",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Christine Nelson",
                                "role": "CONTACT",
                                "phone": "312-695-4513",
                                "email": "c-ebert@northwestern.edu"
                            },
                            {
                                "name": "Rajesh N Keswani, MD, MS",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.85003,
                            "lon": -87.65005
                        }
                    },
                    {
                        "facility": "University of Illinois at Chicago",
                        "city": "Chicago",
                        "state": "Illinois",
                        "zip": "60612",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Haya Al Rashdan",
                                "role": "CONTACT",
                                "phone": "312-413-0306",
                                "email": "halras2@iuc.edu"
                            },
                            {
                                "name": "Cemal Yazici, MD, MSc",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Brian Layden, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 41.85003,
                            "lon": -87.65005
                        }
                    },
                    {
                        "facility": "Indiana University",
                        "city": "Indianapolis",
                        "state": "Indiana",
                        "zip": "46202",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.76838,
                            "lon": -86.15804
                        }
                    },
                    {
                        "facility": "Johns Hopkins University",
                        "city": "Baltimore",
                        "state": "Maryland",
                        "zip": "21205",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Mahya Faghih",
                                "role": "CONTACT",
                                "phone": "443-287-4680",
                                "email": "mfaghih2@jhu.edu"
                            },
                            {
                                "name": "Vikesh Singh, MD, MSc",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Zhaoli Sun, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.29038,
                            "lon": -76.61219
                        }
                    },
                    {
                        "facility": "University of Minnesota",
                        "city": "Minneapolis",
                        "state": "Minnesota",
                        "zip": "55454",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Heather Hodgkins",
                                "role": "CONTACT",
                                "phone": "612-626-5293",
                                "email": "hodg0007@umn.edu"
                            },
                            {
                                "name": "Melena D Bellin, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Guru Trikudanathan, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 44.97997,
                            "lon": -93.26384
                        }
                    },
                    {
                        "facility": "Ohio State University",
                        "city": "Columbus",
                        "state": "Ohio",
                        "zip": "43210",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Zoe Krebs",
                                "role": "CONTACT",
                                "phone": "614-685-6374",
                                "email": "zoe.krebs@osumc.edu"
                            },
                            {
                                "name": "Phillip A Hart, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Georgios Papachristou, MD, PhD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 39.96118,
                            "lon": -82.99879
                        }
                    },
                    {
                        "facility": "University of Pittsburgh",
                        "city": "Pittsburgh",
                        "state": "Pennsylvania",
                        "zip": "15213",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Shari Reynolds",
                                "role": "CONTACT",
                                "phone": "412-383-0570",
                                "email": "reynoldss12@upmc.edu"
                            },
                            {
                                "name": "Dhiraj Yadav, MD, MPH",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Frederico GS Toledo, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 40.44062,
                            "lon": -79.99589
                        }
                    },
                    {
                        "facility": "Benaroya Research Institute",
                        "city": "Seattle",
                        "state": "Washington",
                        "zip": "98101",
                        "country": "United States",
                        "contacts": [
                            {
                                "name": "Kim Varner",
                                "role": "CONTACT",
                                "phone": "206-341-8936",
                                "email": "kvarner@benaroyaresearch.org"
                            },
                            {
                                "name": "Carla J Greenbaum, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            },
                            {
                                "name": "Richard A Kozarek, MD",
                                "role": "PRINCIPAL_INVESTIGATOR"
                            }
                        ],
                        "geoPoint": {
                            "lat": 47.60621,
                            "lon": -122.33207
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "Data from final locked datasets will be made available to other researchers outside the DREAM-ON investigative team. The plan for data sharing incorporates a strategy that recognizes the importance of protecting participants' rights to individual privacy and is compliant with HIPAA regulations and NIH requirements (https://grants.nih.gov/grants/policy/data_sharing).",
                "infoTypes": [
                    "STUDY_PROTOCOL",
                    "SAP",
                    "ICF"
                ],
                "timeFrame": "The data will be available one year after publication of the primary manuscript of the DREAM-ON manuscript. The data will be available indefinitely at the NIDDK Central Repository.",
                "accessCriteria": "Instructions for requesting data from the NIDDK Central Repository appear at the following web site: https://repository.niddk.nih.gov/pages/overall_instructions/",
                "url": "https://repository.niddk.nih.gov/home/"
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2024-08-07"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D000010195",
                        "term": "Pancreatitis"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000010182",
                        "term": "Pancreatic Diseases"
                    },
                    {
                        "id": "D000004066",
                        "term": "Digestive System Diseases"
                    }
                ],
                "browseLeaves": [
                    {
                        "id": "M7115",
                        "name": "Diabetes Mellitus",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M13115",
                        "name": "Pancreatitis",
                        "asFound": "Pancreatitis",
                        "relevance": "HIGH"
                    },
                    {
                        "id": "M7117",
                        "name": "Diabetes Mellitus, Type 1",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M13102",
                        "name": "Pancreatic Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M8883",
                        "name": "Gastrointestinal Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "M7255",
                        "name": "Digestive System Diseases",
                        "relevance": "LOW"
                    },
                    {
                        "id": "T170",
                        "name": "Acute Graft Versus Host Disease",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "BC18",
                        "name": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "abbrev": "BC19",
                        "name": "Gland and Hormone Related Diseases"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Conditions"
                    },
                    {
                        "abbrev": "BC06",
                        "name": "Digestive System Diseases"
                    },
                    {
                        "abbrev": "BC20",
                        "name": "Immune System Diseases"
                    },
                    {
                        "abbrev": "Rare",
                        "name": "Rare Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "browseLeaves": [
                    {
                        "id": "M11767",
                        "name": "Metronidazole",
                        "relevance": "LOW"
                    }
                ],
                "browseBranches": [
                    {
                        "abbrev": "Infe",
                        "name": "Anti-Infective Agents"
                    },
                    {
                        "abbrev": "All",
                        "name": "All Drugs and Chemicals"
                    }
                ]
            }
        },
        "hasResults": false
    }
]